FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Neto, MFD
   dos Santos, CBR
   Magalhaes, JT
   Leite, FHA
AF de Araujo Neto, Moyses Fagundes
   Rodrigues dos Santos, Cleydson Breno
   Magalhaes-Junior, Jairo Torres
   Andrade Leite, Franco Henrique
TI Identification of novelAedes aegyptiodorant-binding protein 1 modulators
   by ligand and structure-based approaches and bioassays
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article; Early Access
DE Aedes aegypti; molecular dynamics; odorant binding protein 1; repellency
   assays; virtual screening
ID MOLECULAR-DYNAMICS; DISCOVERY; MODELS; CHALLENGES; REDUCTASE; GALAHAD
AB Arboviruses are a group of viruses (e.g. Dengue, Chikungunya and Yellow fever virus) that are transmitted by arthropod vectors, whichAedes aegiptyis the vector of main viruses in Americas. This vector is responsible to 2.4 millions of arboviruses cases in Brazil with less than a thousand deaths annually. Despite of epidemiological data, arboviruses treatment is symptomatic and the vaccine control is not effective, which makes the vector control againstA. aegiptya promising strategy to diseases control. One way to achieve this goal is to development ofA. aegiptysensitive olfactory modulators. Odorant binding protein 1 fromA. aegypti(AaegOBP1) is essential in sensory communication, and is the first filter in odorant selection, which makes this target promising to development of new repellents. For this reason, hierarchical virtual screening (ligand-based pharmacophore model and molecular docking) together volatility filter was applied at Sigma-Aldrich database (n = 126.851) to prioritize potential molecules to repellency assays. Three compounds showed adequate stereo-electronic requirements (QFIT> 81.53), score toAaegOBP1 binding site (Score > 36.0) and volatile properties and it was chosen for repellency assays. ZINC00170981 and ZINC00131924 showed a dose-response behavior, while ZINC01621824 did not showed activity in repellency assays. Finally, Molecular Dynamics (MD) was employed to hypothesize the stability of protein-ligand complexes. According to RMSD, RMSF and binding free energy data, ZINC00170981 and ZINC00131924 were able to stabilize AaegOBP1 binding-site during the trajectory by interactions with key residues such as His77, Leu89 and Trp114). Communicated by Ramaswamy H. Sarma
C1 [de Araujo Neto, Moyses Fagundes; Andrade Leite, Franco Henrique] Univ Estadual Feira de Santana, Dept Saude, Lab Modelagem Mol, Feira De Santana, BA, Brazil.
   [Rodrigues dos Santos, Cleydson Breno] Univ Fed Amapa, Dept Ciencias Biol & Saude, Lab Modelagem & Quim Computac, Macapa, Brazil.
   [Magalhaes-Junior, Jairo Torres] Univ Fed Oeste Bahia, Ctr Multidisciplinar, Campus Barra, Barreiras, BA, Brazil.
RP Leite, FHA (corresponding author), Univ Estadual Feira de Santana, Dept Saude, Lab Modelagem Mol, Feira De Santana, BA, Brazil.
EM fhenrique@uefs.br
OI Leite, Franco Henrique/0000-0003-3166-6051
CR Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375
   Leite FHA, 2017, EUR J MED CHEM, V132, P322, DOI 10.1016/j.ejmech.2017.03.043
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Bittencourt JAHM, 2019, MOLECULES, V24, DOI 10.3390/molecules24081476
   Caballero J, 2010, J MOL GRAPH MODEL, V29, P363, DOI 10.1016/j.jmgm.2010.08.005
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   ChemAxon, 2015, MARVINSKETCH VERS 15
   Chen YC, 2015, TRENDS PHARMACOL SCI, V36, P78, DOI 10.1016/j.tips.2014.12.001
   CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804
   Clark RD, 2009, J COMPUT AID MOL DES, V23, P765, DOI 10.1007/s10822-008-9227-2
   Cruz JN, 2020, J CHEM INF MODEL, V60, P766, DOI 10.1021/acs.jcim.9b00741
   Cruz JN, 2020, J BIOMOL STRUCT DYN, V38, P1425, DOI 10.1080/07391102.2019.1607560
   da Costa KS, 2019, ACS OMEGA, V4, P22475, DOI 10.1021/acsomega.9b03157
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Daura X., 1999, PROTEIN-STRUCT FUNCT, V34, DOI [10.1002/(SICI)1097-0134, 10.1002/(SICI)1097-0134(19990215)34:3269::AID-PROT13.0.CO;2-3, DOI 10.1002/(SICI)1097-0134]
   Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736
   dos Santos KLB, 2020, MOLECULES, V25, DOI 10.3390/molecules25051245
   Fan J, 2011, GENET MOL RES, V10, P3056, DOI 10.4238/2011.December.8.2
   Ganesan A, 2017, DRUG DISCOV TODAY, V22, P249, DOI 10.1016/j.drudis.2016.11.001
   Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q
   Hilbe JM, 2007, AM STAT, V61, P91, DOI 10.1198/000313007X172998
   Hodges TK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1089
   Larsson J, 2007, J NAT PROD, V70, P789, DOI 10.1021/np070002y
   Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635
   Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006
   Lemon S. M., 2008, VECTOR BORNE DIS EME
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   Manoharan M, 2013, BIOINFORM BIOL INSIG, V7, P231, DOI 10.4137/BBI.S11096
   Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w
   Mascarenhas AMS, 2020, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2020.1796791
   METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e
   Oliferenko PV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064547
   Paluch G, 2010, PEST MANAG SCI, V66, P925, DOI 10.1002/ps.1974
   Pinto VD, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12010036
   Pirani F, 2008, PHYS CHEM CHEM PHYS, V10, P5489, DOI 10.1039/b808524b
   Ramos RS, 2020, J BIOMOL STRUCT DYN, V38, P4687, DOI 10.1080/07391102.2019.1688192
   Rogers ME, 2007, PLOS PATHOG, V3, P818, DOI 10.1371/journal.ppat.0030091
   Rosen J, 2009, J COMPUT AID MOL DES, V23, P253, DOI 10.1007/s10822-008-9255-y
   Sacconnay L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002689
   Santana IB, 2018, J CHEM-NY, V2018, DOI 10.1155/2018/4173479
   Santos CBR, 2020, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2020.1761878
   Schrodinger L, 2015, MESQUITE MODULAR SYS, V1, P8
   Shepphird JK, 2006, J COMPUT AID MOL DES, V20, P763, DOI 10.1007/s10822-006-9070-2
   Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559
   Takken W., 2013, ECOLOGY PARASITE VEC, DOI [10.3920/978-90-8686-744-8_9, DOI 10.3920/978-90-8686-744-8_9]
   Tripos Associates, 2012, SYB X MOL MOD SOFTW
   Tsitsanou KE, 2012, CELL MOL LIFE SCI, V69, P283, DOI 10.1007/s00018-011-0745-z
   Turner P. J., 2005, XMGRACE VERSION 5 1
   Vale VV, 2020, MED CHEM RES, V29, P487, DOI 10.1007/s00044-019-02498-z
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5
   Wagoner JA, 2006, P NATL ACAD SCI USA, V103, P8331, DOI 10.1073/pnas.0600118103
   WHO, 2009, GUID EFF TEST MOSQ R
   WHO, 2008, VECT BORN DIS, DOI [10.17226/11950, DOI 10.17226/11950]
   Wild DJ, 2005, J CHEM INF MODEL, V45, P212, DOI 10.1021/ci040130h
   World Health Organization, 2020, DENG SEV DENG
   Yang SY, 2010, DRUG DISCOV TODAY, V15, P444, DOI 10.1016/j.drudis.2010.03.013
   YOSHINO M, 2006, PLOS BIOL, V4, DOI DOI 10.1186/1477-7827-4-50
   Yuriev E, 2011, J MOL RECOGNIT, V24, P149, DOI 10.1002/jmr.1077
   Zhao X, 2010, J MOL GRAPH MODEL, V29, P126, DOI 10.1016/j.jmgm.2010.05.002
NR 64
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
DI 10.1080/07391102.2020.1808074
EA AUG 2020
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA NC4GS
UT WOS:000561171900001
PM 32815781
DA 2020-12-09
ER

PT J
AU Mascarenhas, AMS
   de Almeida, RBM
   Neto, MFD
   Mendes, GO
   da Cruz, JN
   dos Santos, CBR
   Botura, MB
   Leite, FHA
AF Mascarenhas, Ana Mercia Silva
   de Almeida, Raquel Bianca Marchesine
   de Araujo Neto, Moyses Fagundes
   Mendes, Gessica Oliveira
   da Cruz, Jorddy Neves
   dos Santos, Cleydson Breno Rodrigues
   Botura, Mariana Borges
   Leite, Franco Henrique Andrade
TI Pharmacophore-based virtual screening and molecular docking to identify
   promising dual inhibitors of human acetylcholinesterase and
   butyrylcholinesterase
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article; Early Access
DE Alzheimer disease; dual inhibitor; human acetylcholinesterase; human
   butyrylcholinesterase
ID ALZHEIMERS-DISEASE; IN-VITRO; HYBRIDS; DESIGN; LIGANDS; FIND
AB The dual inhibition of human acetylcholinesterase (hAChE) and butyrylcholinesterase (hBuChE) plays an important role in Alzheimer's disease treatment. Thus, this study aims identify promising dual inhibitors against hAChE and hBuChE byin silicoapproaches (pharmacophore-based virtual screening and molecular docking). Ten 3 D pharmacophore models for dual inhibitors using default genetic parameters were built by GALAHAD (TM) available on SYBYL-X 2.0. Validation steps were carried out according to Energy (<100.0 kcal/mol), Pareto = 0, Area under the ROC Curve (>0.70), Boltzmann-Enhanced Discrimination of ROC curve (BEDROC >0.50) and structure-activity relationship (SAR) for known inhibitors. The best dual pharmacophore model based on internal/external statistical parameters and SAR data (one hydrogen bond acceptor, two hydrogen bond donors and four hydrophobic centers) was employed in virtual screening at Sigma-Aldrich (R) subset (n = 214,446) of ZINC database by UNITY module of SYBYL-X 2.0. According to superposition values (QFIT), the best ranked compounds were prioritized for molecular docking and partition coefficient analysis (clogp < 5.0). 37 top-ranked compounds (QFIT > 64.22) from pharmacophore model showed affinity in hAChE (-10.2 < Affinity energy < -6.3 kcal/mol) and hBuChE (-10.9 < Affinity energy < -2.3 kcal/mol) binding sites. Next, liposolubity prediction and commercially available showed that ZINC43198636, ZINC43198637 and ZINC00390718 can be potential dual inhibitors against hAChE and hBuChE. Communicated by Ramaswamy H. Sarma
C1 [Mascarenhas, Ana Mercia Silva; de Araujo Neto, Moyses Fagundes; Mendes, Gessica Oliveira; Leite, Franco Henrique Andrade] Univ Estadual Feira de Santana, Dept Saude, Lab Modelagem Mol, Feira De Santana, BA, Brazil.
   [de Almeida, Raquel Bianca Marchesine; Botura, Mariana Borges] Univ Estadual Feira de Santana, Dept Saude, Lab Toxicol, Feira De Santana, BA, Brazil.
   [da Cruz, Jorddy Neves; dos Santos, Cleydson Breno Rodrigues] Univ Fed Amapa, Dept Ciencias Biol & Saude, Lab Modelagem & im Computac, Macapa, Brazil.
RP Leite, FHA (corresponding author), Univ Estadual Feira de Santana, Dept Saude, Lab Modelagem Mol, Feira De Santana, BA, Brazil.; dos Santos, CBR (corresponding author), Univ Fed Amapa, Dept Ciencias Biol & Saude, Lab Modelagem & im Computac, Macapa, Brazil.
EM breno@unifap.br; fhenrique@uefs.br
RI Botura, Mariana B/C-7941-2018; Cruz, Jorddy Neves/N-8524-2018
OI Botura, Mariana B/0000-0002-6404-0314; Cruz, Jorddy
   Neves/0000-0003-0529-3714; Leite, Franco Henrique/0000-0003-3166-6051
FU Fundacao de Amparoa Pesquisa do Estado da Bahia (FAPESB); Universidade
   Estadual de Feira de Santana (UEFS)
FX The authors appreciate the support of the Fundacao de Amparoa Pesquisa
   do Estado da Bahia (FAPESB) and Universidade Estadual de Feira de
   Santana (UEFS).
CR Ambure P, 2019, J BIOMOL STRUCT DYN, V37, P1282, DOI 10.1080/07391102.2018.1456975
   Benek O, 2016, CHEMMEDCHEM, V11, P1264, DOI 10.1002/cmdc.201500383
   BITTENCOURT JAHM, 2019, MOLECULES, V24, DOI DOI https://doi.org/10.3390/molecules24081476
   Chaput L, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0167-x
   ChemAxon, 2015, CHEMAXON MARV SKETCH
   Chen Y, 2017, RSC ADV, V7, P3429, DOI 10.1039/c6ra25887e
   Cheung J, 2013, ACS MED CHEM LETT, V4, P1091, DOI 10.1021/ml400304w
   CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804
   Cruz JN, 2020, J CHEM INF MODEL, V60, P766, DOI 10.1021/acs.jcim.9b00741
   Cruz JN, 2020, J BIOMOL STRUCT DYN, V38, P1425, DOI 10.1080/07391102.2019.1607560
   da Costa KS, 2019, ACS OMEGA, V4, P22475, DOI 10.1021/acsomega.9b03157
   da Silva CHTP, 2007, J BIOMOL STRUCT DYN, V24, P515, DOI 10.1080/07391102.2007.10507140
   da Silva VB, 2011, FUTURE MED CHEM, V3, P947, DOI [10.4155/FMC.11.67, 10.4155/fmc.11.67]
   Dhanjal JK, 2015, BIOMED PHARMACOTHER, V71, P146, DOI 10.1016/j.biopha.2015.02.010
   Di Pietro O, 2014, EUR J MED CHEM, V73, P141, DOI 10.1016/j.ejmech.2013.12.008
   Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381
   dos Santos KLB, 2020, MOLECULES, V25, DOI 10.3390/molecules25051245
   Ece A, 2020, J BIOMOL STRUCT DYN, V38, P565, DOI 10.1080/07391102.2019.1583606
   Fahrrolfes R, 2017, NUCLEIC ACIDS RES, V45, pW337, DOI 10.1093/nar/gkx333
   Ferreira-Vieira TH, 2016, CURR NEUROPHARMACOL, V14, P101, DOI 10.2174/1570159X13666150716165726
   GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2
   Greig NH, 2002, INT PSYCHOGERIATR, V14, P77, DOI 10.1017/S1041610203008676
   Hampel H, 2018, BRAIN, V141, P1917, DOI 10.1093/brain/awy132
   Hamulakova S, 2014, INT J BIOL MACROMOL, V70, P435, DOI 10.1016/j.ijbiomac.2014.06.064
   Ismaili L, 2017, PROG NEUROBIOL, V151, P4, DOI 10.1016/j.pneurobio.2015.12.003
   Kumar S, 2015, INDIAN J PHARMACOL, V47, P444, DOI 10.4103/0253-7613.161274
   Larik FA, 2018, INT J BIOL MACROMOL, V116, P144, DOI 10.1016/j.ijbiomac.2018.05.001
   Latti S, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0158-y
   Li SY, 2014, ORG BIOMOL CHEM, V12, P801, DOI 10.1039/c3ob42010h
   Masters CL, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.56
   METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2
   Mizutani MY, 2006, PROTEINS, V63, P878, DOI 10.1002/prot.20931
   Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e
   Nachon F, 2013, BIOCHEM J, V453, P393, DOI 10.1042/BJ20130013
   Najafi Z, 2017, EUR J MED CHEM, V125, P1200, DOI 10.1016/j.ejmech.2016.11.008
   de Aquino RAN, 2013, ORG BIOMOL CHEM, V11, P8395, DOI 10.1039/c3ob41762j
   Pandolfi F, 2017, EUR J MED CHEM, V141, P197, DOI 10.1016/j.ejmech.2017.09.022
   PINTO VD, 2019, PHARMACEUTICALS BASE, V12, DOI DOI https://doi.org/10.3390/ph12010036
   RAMOS RD, 2019, PHARMACEUTICALS, V12, DOI DOI https://doi.org/10.3390/ph12010020
   RAMOS RS, 2019, J BIOMOL STRUCT 1109, DOI DOI https://doi.org/10.1080/07391102.2019.1688192
   Rouleau J, 2011, EUR J MED CHEM, V46, P2193, DOI 10.1016/j.ejmech.2011.02.073
   Sun Q, 2014, BIOORGAN MED CHEM, V22, P4784, DOI 10.1016/j.bmc.2014.06.057
   SYSTAT, 2012, SYSTAT SOFTW VERS 12
   Tanarro CMG, 2011, J ENZYM INHIB MED CH, V26, P350, DOI 10.3109/14756366.2010.504674
   Tell V, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00189
   TRIPOS Associates Inc., 2012, SYBYL X MOL MOD SOFT
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e
   Vale VV, 2020, MED CHEM RES, V29, P487, DOI 10.1007/s00044-019-02498-z
   Wang DJ, 2017, MOLECULES, V22, DOI 10.3390/molecules22020229
   WANG YH, 2012, CHEM CENT J, V6, DOI DOI https://doi.org/10.1186/1752-153X-6-96
   WHO, 2018, KEY MESS PREV DEM WO
   Zhao XB, 2009, APPL MICROBIOL BIOT, V82, P815, DOI 10.1007/s00253-009-1883-1
   Zhou S, 2019, CHEM-BIOL INTERACT, V308, P372, DOI 10.1016/j.cbi.2019.05.051
NR 54
TC 4
Z9 4
U1 10
U2 10
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
DI 10.1080/07391102.2020.1796791
EA JUL 2020
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA MO5ZZ
UT WOS:000551605000001
PM 32705955
DA 2020-12-09
ER

PT J
AU do Bomfim, MR
   Araujo, JSC
   Macedo, WJD
   dos Santos, CBR
   Leite, FHA
AF do Bomfim, Mayra Ramos
   Carneiro Araujo, Janay Stefany
   da Cruz Macedo, Williams Jorge
   Rodrigues dos Santos, Cleydson Breno
   Andrade Leite, Franco Henrique
TI Identification of potential modulator ofAnopheles gambiaeodorant binding
   protein 1 by hierarchical virtual screening and molecular dynamics
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article; Early Access
DE AgOBP1; 2D-chemical similarity; Malaria; docking; molecular dynamics
ID DRUG DISCOVERY; ANOPHELES; PERFORMANCE; VALIDATION; SELECTION; DESIGN;
   2D
AB Malaria is a protozoan infection transmitted by the bite of the infected female mosquito belonging to the genusAnopheles spp., which causes more than 445 million annual deaths worldwide. Available drugs have serious adverse effects (e.g.blurred vision, hypotension and headache) and species-dependent efficacy. An alternative to overcome these problems involve the use of molecules with affinity to theAnopheles gambiaemosquito odor receptors, minimizing the reinfection process as well as reducing the problems related to pharmacological therapy. The vector control can interrupt the epidemiological cycle and, therefore, control the malaria incidence. In the olfactory pathway, odorant binding protein 1 acts on the first level of odor recognition on malarial vector and thus can be used to modulate mosquito behavior and development of new attracts or repellents. Thus, this study applied ligand-based (2D-chemical similarity) and structure-based (docking and molecular dynamics) computational approaches to prioritize potential olfactory modulators on natural products catalogs at ZINC(15)database (n = 98,379). Hierarchical virtual screening prioritized a potential olfactory modulator (Z8217) againstAnopheles gambiaeodorant binding protein 1 (AgOBP1). Next, it was submitted to molecular dynamics routine to identify structural requirements and the interactions profile required for binding-site affinity. This promising natural compound can interact like experimental ligand and will be used in repellency assay to confirm its sensorial behavior. Communicated by Ramaswamy H. Sarma
C1 [do Bomfim, Mayra Ramos; Andrade Leite, Franco Henrique] Univ Estadual Feira de Santana, Lab Modelagem Mol, BR-44036900 Feira De Santana, BA, Brazil.
   [Carneiro Araujo, Janay Stefany; Andrade Leite, Franco Henrique] Univ Estadual Feira de Santana, Programa Posgrad Biotecnol, Feira De Santana, BA, Brazil.
   [da Cruz Macedo, Williams Jorge] Univ Fed Rural Amazonia, Lab Modelagem Mol & Simulacao Sistemas, Capanema, Brazil.
   [Rodrigues dos Santos, Cleydson Breno] Univ Fed Amapa, Programa Posgrad Biodiversidade & Biotecnol Rede, Macapa, Brazil.
   [Andrade Leite, Franco Henrique] Univ Estadual Feira de Santana, Programa Posgrad Ciencias Farmaceut, Feira De Santana, BA, Brazil.
RP Leite, FHA (corresponding author), Univ Estadual Feira de Santana, Lab Modelagem Mol, BR-44036900 Feira De Santana, BA, Brazil.
EM fhenrique@uefs.br
OI Leite, Franco Henrique/0000-0003-3166-6051; Carneiro Araujo, Janay
   Stefany/0000-0002-5691-8676
FU  [01/2015];  [01/2016]
FX The authors are grateful to PROBIC-UEFS (No 01/2015 and No 01/2016) for
   the financial resource.
CR Affonso RD, 2013, J BRAZIL CHEM SOC, V24, P473, DOI 10.5935/0103-5053.20130059
   Aguiar ACC, 2012, MEM I OSWALDO CRUZ, V107, P831, DOI 10.1590/S0074-02762012000700001
   Arend D. N., 2010, MINITAB 17 STAT SOFT
   Baldi P, 2010, J CHEM INF MODEL, V50, P1205, DOI 10.1021/ci100010v
   BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038
   Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471
   Braga RC, 2013, CURR TOP MED CHEM, V13, P1127, DOI 10.2174/1568026611313090010
   Brozell SR, 2012, J COMPUT AID MOL DES, V26, P749, DOI 10.1007/s10822-012-9565-y
   Camargo EP, 2003, CIENC CULT, V55, P26
   Chemaxon, 2015, MARV SKETCH VERS 15
   CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804
   Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Daura X, 1999, PROTEINS, V34, P269, DOI 10.1002/(SICI)1097-0134(19990215)34:3<269::AID-PROT1>3.0.CO;2-3
   Davrazou F, 2011, J BIOL CHEM, V286, P34175, DOI 10.1074/jbc.M111.274712
   Dobi K, 2014, MOLECULES, V19, P7008, DOI 10.3390/molecules19067008
   Dror O, 2009, J CHEM INF MODEL, V49, P2333, DOI 10.1021/ci900263d
   Fan J, 2011, GENET MOL RES, V10, P3056, DOI 10.4238/2011.December.8.2
   GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2
   Ghosh Saikat, 2015, Trop Parasitol, V5, P61, DOI 10.4103/2229-5070.149928
   Gigliarano C, 2014, COMPUT STAT DATA AN, V77, P300, DOI 10.1016/j.csda.2014.03.008
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460
   Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277
   Kelly M, 2015, MBIO, V6, DOI 10.1128/mBio.00235-15
   Koziara KB, 2014, J COMPUT AID MOL DES, V28, P221, DOI 10.1007/s10822-014-9713-7
   Kristensen TG, 2013, COMPUT STRUCT BIOTEC, V5, DOI 10.5936/csbj.201302009
   Langer T., 2006, PHARMACOPHORES PHARM, P395
   Larsson J, 2007, J NAT PROD, V70, P789, DOI 10.1021/np070002y
   Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635
   Leite F. H. A., 2015, THESIS
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   Lobanov MY, 2008, MOL BIOL+, V42, P623, DOI 10.1134/S0026893308040195
   Lorenzo M. G., 2012, TOPICOS AVANCADOS EN
   Mantsyzov Alexey B, 2012, Adv Appl Bioinform Chem, V5, P61, DOI 10.2147/AABC.S30881
   Matsubara E. T., 2008, THESIS, DOI [https://doi.org/10.11606/T.55.2008.tde-04032009-114050, DOI 10.11606/T.55.2008.TDE-04032009-114050]
   Ministerio da Saude, 2010, GUIA PRAT TRAT MAL B
   Moraes M., 2008, EMBRAPA RECURSOS GEN
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Murphy EJ, 2013, J BIOL CHEM, V288, P4475, DOI 10.1074/jbc.M112.436386
   Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e
   Namba A. M., 2008, ECLET QUIM, V33, P13, DOI [10.1590/S0100-46702008000400002., DOI 10.1590/S0100-46702008000400002]
   Pickett JA, 2010, J CHEM ECOL, V36, P113, DOI 10.1007/s10886-010-9739-9
   Rodrigues RP, 2012, REV VIRTUAL QUIM, V4, P739, DOI 10.5935/1984-6835.20120055
   Rosen J, 2009, J COMPUT AID MOL DES, V23, P253, DOI 10.1007/s10822-008-9255-y
   Salentin S, 2015, NUCLEIC ACIDS RES, V43, pW443, DOI 10.1093/nar/gkv315
   Santana I. B., 2016, THESIS
   Systat, 2014, SIGMA PLOT 12 0 VERS
   Tice CM, 2001, PEST MANAG SCI, V57, P3, DOI 10.1002/1526-4998(200101)57:1<3::AID-PS269>3.0.CO;2-6
   Tomori T, 2012, MOL DIVERS, V16, P59, DOI 10.1007/s11030-011-9335-0
   TORDA AE, 1994, J COMPUT CHEM, V15, P1331, DOI 10.1002/jcc.540151203
   Tripos, 2012, DISC SOFTW COMP CHEM
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Tsitsanou KE, 2012, CELL MOL LIFE SCI, V69, P283, DOI 10.1007/s00018-011-0745-z
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Vanagas Giedrius, 2004, Interact Cardiovasc Thorac Surg, V3, P319, DOI 10.1016/j.icvts.2004.01.008
   Verli H., 2014, BIOINFORMATICA BIOL, P173
   Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5
   WHO, 2017, LEISHMANIASIS
   WHO, 2017, WORLD MALARIA REPORT
   Willett P, 2006, DRUG DISCOV TODAY, V11, P1046, DOI 10.1016/j.drudis.2006.10.005
NR 63
TC 0
Z9 0
U1 1
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
DI 10.1080/07391102.2020.1796807
EA JUL 2020
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA MN6LV
UT WOS:000550951300001
PM 32696721
DA 2020-12-09
ER

PT J
AU Keita, H
   dos Santos, CBR
   Ramos, MM
   Padilha, EC
   Serafim, RB
   Castro, AN
   Amado, JRR
   da Silva, GM
   Ferreira, IM
   Giuliatti, S
   Carvalho, JCT
AF Keita, Hady
   dos Santos, Cleydson Breno Rodrigues
   Ramos, Matheus Merces
   Padilha, Elias Carvalho
   Serafim, Rodolfo Bortolozo
   Castro, Andres Navarrete
   Amado, Jesus Rafael Rodriguez
   da Silva, Gabriel Monteiro
   Ferreira, Irlon Maciel
   Giuliatti, Silvana
   Carvalho, Jose Carlos Tavares
TI Assessment of the hypoglycemic effect of Bixin in alloxan-induced
   diabetic rats: in vivo and in silico studies
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article; Early Access
DE Bixin; hypoglycemia; PPAR gamma; in vivo; in silico
ID ACTIVATED-RECEPTOR-GAMMA; BONE-MINERAL DENSITY; PPAR-GAMMA;
   MYOCARDIAL-INFARCTION; ROSIGLITAZONE; AGONISTS; THIAZOLIDINEDIONES;
   IDENTIFICATION; HYPERGLYCEMIA; COMPLICATIONS
AB The objectives of this study were to extract and purify Bixin from the seeds of Bixa orellana and to evaluate its hypoglycemic activity in vivo, as well as, to conduct an in silico study of selectivity on peroxisome proliferator-activated receptors via molecular docking and molecular dynamics simulations. Oral administration of Bixin (10 mg/kg) significantly reduced their glucose level that was alloxan-induced diabetic rats. Bixin showed in silico selectivity on peroxisome proliferator-activated receptors (PPARs), particularly by the peroxisome proliferator-activated receptor gamma (PPAR gamma), which supports the hypoglycemic activity of Bixin. From the results obtained, it can be inferred that Bixin presents hypoglycemic characteristics, which was confirmed by the results obtained from the in vivo and in silico tests. Bixin may act by other pathways to control blood glucose and thus it is possible that it presents a different toxicity profile than troglitazone, rosiglitazone and pioglitazone. However, more studies on the activity and toxicity of Bixin are needed to evaluate for further clinical use.
C1 [Keita, Hady; dos Santos, Cleydson Breno Rodrigues; Amado, Jesus Rafael Rodriguez; Carvalho, Jose Carlos Tavares] Univ Fed Amapa, Dept Biol Sci & Hlth, Lab Drugs Discovery, Macapa, Brazil.
   [Keita, Hady] Univ Sierra, Div Postgrade, Ixtlan De Juarez, Mexico.
   [dos Santos, Cleydson Breno Rodrigues; Carvalho, Jose Carlos Tavares] Univ Fed Amapa, Dept Biol Sci & Hlth, Lab Modeling & Computat Chem, Macapa, Brazil.
   [Ramos, Matheus Merces; Ferreira, Irlon Maciel; Carvalho, Jose Carlos Tavares] Univ Fed Amapa, Res Grp Biocatalysis & Apllied Organ Synth, Macapa, Brazil.
   [Padilha, Elias Carvalho] Sao Paulo State Univ, Dept Nat Act Principles & Toxicol, Fac Pharmaceut Sci, Araraquara, SP, Brazil.
   [Serafim, Rodolfo Bortolozo] Univ Sao Paulo, Dept Cellular & Mol Biol, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil.
   [Castro, Andres Navarrete] Univ Nacl Autonoma Mexico, Fac Chem, Dept Pharm, Lab Pharmacol Nat Prod, Mexico City, DF, Mexico.
   [da Silva, Gabriel Monteiro; Giuliatti, Silvana] Univ Sao Paulo, Ribeirao Preto Med Sch, Bioinformat Grp, Dept Genet, Ribeirao Preto, Brazil.
RP Keita, H; dos Santos, CBR (corresponding author), Univ Fed Amapa, Dept Biol Sci & Hlth, Lab Drugs Discovery, Macapa, Brazil.; Keita, H (corresponding author), Univ Sierra, Div Postgrade, Ixtlan De Juarez, Mexico.; dos Santos, CBR (corresponding author), Univ Fed Amapa, Dept Biol Sci & Hlth, Lab Modeling & Computat Chem, Macapa, Brazil.
EM hadykeith@yahoo.fr; breno.unifap@gmail.com
RI Navarrete, Andres/ABB-6148-2020; Giuliatti, Silvana/E-4715-2013;
   Rodriguez Amado, Jesus Rafael/Q-1739-2015; Padilha, Elias/J-5671-2015
OI Giuliatti, Silvana/0000-0002-7520-6420; Rodriguez Amado, Jesus
   Rafael/0000-0001-7574-6219; Monteiro da Silva,
   Gabriel/0000-0002-9665-7597; Padilha, Elias/0000-0002-3794-9389;
   Navarrete, Andres/0000-0002-2858-8710
FU CAPES - PNPD/CAPESCAPES [PNPD/20130076-14001012005P1]; Procad Amazonia
   [Auxpe - 1723/2018]; National Council for Scientific and Technological
   Development - CNPq - RAPBioFarNational Council for Scientific and
   Technological Development (CNPq) [407768/2013-0]
FX The authors thank CAPES - PNPD/CAPES (Program/Project:
   PNPD/20130076-14001012005P1), Procad Amazonia Proc. Auxpe - 1723/2018
   and National Council for Scientific and Technological Development - CNPq
   - RAPBioFar Proc. 407768/2013-0 for the financial support.
CR Abou Khalil NS, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8408326
   Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   Acton JJ, 2005, BIOORG MED CHEM LETT, V15, P357, DOI 10.1016/j.bmcl.2004.10.068
   Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735
   Alsaif MA, 2009, PAK J NUTR, V8, P745, DOI DOI 10.3923/pjn.2009.745.754
   Bakopanos E, 2000, DIABETES, V49, P2108, DOI 10.2337/diabetes.49.12.2108
   Berger JP, 2003, MOL ENDOCRINOL, V17, P662, DOI 10.1210/me.2002-0217
   Bittencourt JAHM, 2019, MOLECULES, V24, DOI 10.3390/molecules24081476
   Borges RS, 2019, MOLECULES, V24, DOI 10.3390/molecules24010143
   Carvajal Karla, 2007, ARCHIVOS DE CARDIOLOGIA DE MEXICO, V77, pS66
   Carvalho HD, 2016, REV BRAS FARMACOGN, V26, P634, DOI 10.1016/j.bjp.2016.04.004
   Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1
   Chandel U., 2014, INT J PHARM BIOMEDIC, V1, P17
   Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232
   Chikezie P. C., 2014, PHARMACOGNOSY COMMUN, V4, P1, DOI [10.5530/pc.2014.2.4, DOI 10.5530/PC.2014.2.4]
   Chiste RC, 2011, FOOD CHEM, V127, P419, DOI 10.1016/j.foodchem.2010.12.139
   Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291
   Costa JD, 2018, MOLECULES, V23, DOI 10.3390/molecules23112801
   Cruz JV, 2018, MOLECULES, V23, DOI 10.3390/molecules23020453
   da Costa GV, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020061
   da Silva FMC, 2013, BIOORG MED CHEM LETT, V23, P5795, DOI 10.1016/j.bmcl.2013.09.010
   Lobato KBD, 2013, FOOD CHEM, V141, P3906, DOI 10.1016/j.foodchem.2013.04.135
   EDER E, 1991, CHEM RES TOXICOL, V4, P50, DOI 10.1021/tx00019a007
   Festuccia WT, 2008, ENDOCRINOLOGY, V149, P2121, DOI 10.1210/en.2007-1553
   Goto T, 2012, J AGR FOOD CHEM, V60, P11952, DOI 10.1021/jf303639f
   Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000
   Gregoire FM, 2009, MOL ENDOCRINOL, V23, P975, DOI 10.1210/me.2008-0473
   Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646
   Hsu LA, 2003, ARTERIOSCL THROM VAS, V23, P1869, DOI 10.1161/01.ATV.0000082525.84814.A9
   Jenkins AJ, 2003, DIABETES CARE, V26, P810, DOI 10.2337/diacare.26.3.810
   Keita H, 2016, INDO AM J PHARM SCI, V3, P1102, DOI 10.5281/zenodo.163852
   Keita H, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-53
   Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.16
   Kumar V, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-76
   Lans CA, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-45
   Lee WH, 2010, PPAR RES, V2010, DOI 10.1155/2010/549101
   Li L, 2017, SCI REP-UK, V7, DOI 10.1038/srep44217
   Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634
   MacDonald MR, 2011, DIABETES CARE, V34, P1394, DOI 10.2337/dc10-2398
   Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m
   Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w
   Matteucci E, 2008, J ETHNOPHARMACOL, V115, P163, DOI 10.1016/j.jep.2007.08.040
   Moghadasian MH, 2002, LIFE SCI, V70, P855, DOI 10.1016/S0024-3205(01)01479-5
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Mourao RH, 2005, EUR J MED CHEM, V40, P1129, DOI 10.1016/j.ejmech.2005.06.002
   Nagy M.A., 2014, AM J BIOCH, V4, P59, DOI DOI 10.5923/j.ajb.20140404.01
   Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761
   Ohkawara E, 2002, BIOL PHARM BULL, V25, P1121, DOI 10.1248/bpb.25.1121
   Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019
   Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843
   Ostberg T, 2004, J BIOL CHEM, V279, P41124, DOI 10.1074/jbc.M401552200
   Oyama T, 2009, ACTA CRYSTALLOGR D, V65, P786, DOI 10.1107/S0907444909015935
   Padilha EC, 2016, J BRAZIL CHEM SOC, V27, P1636, DOI 10.5935/0103-5053.20160043
   Pereira ALE, 2018, J BIOMOL STRUCT DYN, V36, P318, DOI 10.1080/07391102.2016.1277163
   Peter A. I., 2015, AM J LIFE SCI, V3, P395, DOI [10.11648/j.ajls.20150306.13, DOI 10.11648/J.AJLS.20150306.13]
   Ramadan G, 2009, BRIT J NUTR, V102, P1611, DOI 10.1017/S000711450999208X
   Ramesh B, 2006, J MED FOOD, V9, P562, DOI 10.1089/jmf.2006.9.562
   Ramos RD, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12010020
   Ran JM, 2017, INT J NEPHROL, V2017, DOI 10.1155/2017/2739539
   Rao M. U., 2010, International Journal of PharmTech Research, V2, P1883
   Rigano D, 2017, ACTA PHARMACOL SIN B, V7, P427, DOI 10.1016/j.apsb.2017.05.005
   Garcia CER, 2012, CIENC RURAL, V42, P1510, DOI 10.1590/S0103-84782012000800029
   dos Santos CBR, 2018, J ETHNOPHARMACOL, V222, P107, DOI 10.1016/j.jep.2018.04.041
   dos Santos CBR, 2015, CURR PHARM DESIGN, V21, P4112, DOI 10.2174/1381612821666150528121423
   Roehrs M, 2014, INT J ENDOCRINOL, DOI 10.1155/2014/839095
   Russell KRM, 2005, PHYTOTHER RES, V19, P433, DOI 10.1002/ptr.1650
   Sales-Campos H, 2013, MINI-REV MED CHEM, V13, P201
   Scheen Andre J., 2001, Drug Safety, V24, P873, DOI 10.2165/00002018-200124120-00002
   Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9
   Schwartz AV, 2006, J CLIN ENDOCR METAB, V91, P3349, DOI 10.1210/jc.2005-2226
   Shah Prediman K, 2003, Rev Cardiovasc Med, V4, P136
   Su JH, 2014, DRUG DES DEV THER, V8, P2555, DOI 10.2147/DDDT.S73476
   Takahashi N, 2009, BIOCHEM BIOPH RES CO, V390, P1372, DOI 10.1016/j.bbrc.2009.10.162
   Teles Flávio, 2014, MedicalExpress (São Paulo, online), V1, P36, DOI 10.5935/MedicalExpress.2014.01.08
   Fujishima MAT, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11030072
   Tolman Keith G, 2003, Clin Liver Dis, V7, P369, DOI 10.1016/S1089-3261(03)00020-5
   van de Waterbeemd H, 2003, NAT REV DRUG DISCOV, V2, P192, DOI 10.1038/nrd1032
   Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341
   Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a
   Yaturu S, 2007, DIABETES CARE, V30, P1574, DOI 10.2337/dc06-2606
   Zafar M, 2010, INT J MORPHOL, V28, P135, DOI 10.4067/S0717-95022010000100019
   Zhang LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048453
   Zhao GJ, 2011, CHEM PHYS LIPIDS, V164, P251, DOI 10.1016/j.chemphyslip.2011.02.002
NR 83
TC 1
Z9 1
U1 5
U2 6
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
DI 10.1080/07391102.2020.1724567
EA FEB 2020
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA KM2UT
UT WOS:000513979000001
PM 32028848
DA 2020-12-09
ER

PT J
AU Fujishima, MAT
   Sa, DMC
   Lima, CMD
   Bittencourt, JPAHM
   Pereira, WLA
   Muribeca, ADB
   Silva, CYYE
   da Silva, MN
   de Sousa, FFO
   dos Santos, CBR
   da Silva, JO
AF Teles Fujishima, Mayara Amoras
   Cunha Sa, Dayse Maria
   de Sousa Lima, Carolina Miranda
   Bittencourt, Jose Prime Adolfo H. M.
   Assuncao Pereira, Washington Luiz
   Barbosa Muribeca, Abraao de Jesus
   Yoshioka e Silva, Consuelo Yumiko
   da Silva, Milton Nascimento
   Oliveira de Sousa, Francisco Fabio
   dos Santos, Cleydson B. R.
   da Silva, Jocivania Oliveira
TI Chemical profiling of Curatella americana Linn leaves by UPLC-HRMS and
   its wound healing activity in mice
SO PLOS ONE
LA English
DT Article
ID MEDICINAL-PLANTS; HUMAN SKIN; IN-VITRO; INFLAMMATION; EXTRACTS;
   ANTIOXIDANTS; MECHANISMS; QUERCETIN; CHEMISTRY; CATECHIN
AB Based on ethnopharmacological studies, a lot of plants, as well as its compounds, have been investigated for the potential use as wound healing agents. In Brazil, Curatella americana is traditionally used by local people to treat wounds, ulcers and inflammations. However, to the best of our knowledge, its traditional use in the treatment of wounds has not been validated by a scientific study. Here, some compounds, many of them flavonoids, were identified in the hydroethanolic extract from the leaves of C. americana (HECA) by LC-HRMS and LC-MS/MS. Besides that, solutions containing different concentrations of HECA and a gel produced with this extract were evaluated for its antimicrobial, coagulant and wound healing activities on an excision mouse wound model as well as its acute dermal safety. A total of thirteen compounds were identified in HECA, mainly quercetin, kaempferol and glucoside derivatives of both, besides catechin and epicatechin known as wound healing agents. The group treated with 1% of HECA exhibited highest wound healing activity and best rate of wound contraction confirmed by histopathology results. The present study provides scientific evidence of, this extract (HECA) possess remarkable wound healing activity, thereby, supporting the traditional use.
C1 [Teles Fujishima, Mayara Amoras; Cunha Sa, Dayse Maria; de Sousa Lima, Carolina Miranda; Bittencourt, Jose Prime Adolfo H. M.; Oliveira de Sousa, Francisco Fabio; dos Santos, Cleydson B. R.; da Silva, Jocivania Oliveira] Univ Fed Amapa, Postgrad Program Pharmaceut Innovat, Macapa, AP, Brazil.
   [Teles Fujishima, Mayara Amoras; Cunha Sa, Dayse Maria; de Sousa Lima, Carolina Miranda; da Silva, Jocivania Oliveira] Univ Fed Amapa, Dept Biol & Hlth Sci, Lab Toxicol, Macapa, AP, Brazil.
   [Teles Fujishima, Mayara Amoras; Bittencourt, Jose Prime Adolfo H. M.; dos Santos, Cleydson B. R.] Univ Fed Amapa, Dept Biol & Hlth Sci, Lab Modeling & Computat Chem, Macapa, AP, Brazil.
   [Assuncao Pereira, Washington Luiz] Fed Rural Univ Amazonia, Inst Anim Prod, Lab Anim Pathol, Belem, Para, Brazil.
   [Barbosa Muribeca, Abraao de Jesus; Yoshioka e Silva, Consuelo Yumiko; da Silva, Milton Nascimento] Fed Univ Para, Dept Chem, Lab Liquid Chromatog, Belem, Para, Brazil.
RP Fujishima, MAT (corresponding author), Univ Fed Amapa, Postgrad Program Pharmaceut Innovat, Macapa, AP, Brazil.; Fujishima, MAT (corresponding author), Univ Fed Amapa, Dept Biol & Hlth Sci, Lab Toxicol, Macapa, AP, Brazil.; Fujishima, MAT (corresponding author), Univ Fed Amapa, Dept Biol & Hlth Sci, Lab Modeling & Computat Chem, Macapa, AP, Brazil.
EM mayarafuji@hotmail.com
RI de Sousa, Francisco Fabio Oliveira/O-7585-2019
OI de Sousa, Francisco Fabio Oliveira/0000-0002-7366-1622
FU Postgraduate Program of Pharmaceutical Innovation
FX This study was supported by the Postgraduate Program of Pharmaceutical
   Innovation. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Agyare C, 2016, J ETHNOPHARMACOL, V177, P85, DOI 10.1016/j.jep.2015.11.008
   Ahmed OM, 2018, BIOMED PHARMACOTHER, V101, P58, DOI 10.1016/j.biopha.2018.02.040
   Alexandre-Moreira MS, 1999, J ETHNOPHARMACOL, V67, P171, DOI 10.1016/S0378-8741(99)00009-4
   Barros ASA, 2017, BIOMED PHARMACOTHER, V96, P182, DOI 10.1016/j.biopha.2017.09.142
   Amaral DD, 2016, BRAZ J BIOSC, V14, P257
   Anchisi C, 2001, FARMACO, V56, P427, DOI 10.1016/S0014-827X(01)01055-2
   [Anonymous], 2004, COSM PROD STAB GUID, V1
   [Anonymous], 2010, BRAZ PHARM, V1, P546
   [Anonymous], 2012, NAT FORM BRAZ PHARM
   Baillon H, 1871, NATURAL HIST PLANTS, P1827
   Barbosa Reinaldo Imbrozio, 2005, Acta Bot. Bras., V19, P323, DOI 10.1590/S0102-33062005000200015
   Cabral MS, 2015, THESIS
   Canuto J Z., 2011, FILOGEOGRAFIA CURATE
   Corrêa Nágila Maluf, 2005, Rev. Bras. Cienc. Farm., V41, P73, DOI 10.1590/S1516-93322005000100008
   Costa ES, 2008, PHYTOTHER RES, V22, P705, DOI 10.1002/ptr.2397
   de Medeiros PM, 2013, J ETHNOPHARMACOL, V150, P729, DOI 10.1016/j.jep.2013.09.026
   de Toledo CEM, 2011, J ETHNOPHARMACOL, V133, P420, DOI 10.1016/j.jep.2010.10.021
   ELAZIZI MM, 1980, J PHARM SCI, V69, P360, DOI 10.1002/jps.2600690333
   Fernandez ML, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-013-0396-1
   FORM DM, 1983, P SOC EXP BIOL MED, V172, P214
   Futagami A, 2002, LAB INVEST, V82, P1503, DOI 10.1097/01.LAB.0000035024.75914.39
   Ghosh PK, 2013, J PHARM PHARM SCI, V16, P760, DOI 10.18433/J3831V
   Gomathi K, 2003, BIOMATERIALS, V24, P2767, DOI 10.1016/S0142-9612(03)00059-0
   Guerrero MF, 2002, J ETHNOPHARMACOL, V80, P37, DOI 10.1016/S0378-8741(01)00420-2
   GURNI AA, 1981, BIOCHEM SYST ECOL, V9, P109, DOI 10.1016/0305-1978(81)90028-4
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5
   Hiruma-Lima CA, 2009, J ETHNOPHARMACOL, V121, P425, DOI 10.1016/j.jep.2008.10.017
   Iwasaki Y, 2004, J GASTROENTEROL, V39, P831, DOI 10.1007/s00535-004-1399-5
   Jeong WS, 2004, PHARM BIOL, V42, P84, DOI 10.3109/13880200490893500
   Kant V, 2014, ACTA HISTOCHEM, V116, P5, DOI 10.1016/j.acthis.2013.04.010
   Kim HP, 2004, J PHARMACOL SCI, V96, P229, DOI 10.1254/jphs.CRJ04003X
   KING D J, 1989, Reviews on Environmental Health, V8, P3
   Kumara B, 2007, J ETHNOPHARMACOL, V114, P103, DOI 10.1016/j.jep.2007.08.010
   Parente LML, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/375671
   Leonardi GR, 2002, BRAS DERMATOL, V77, P563, DOI DOI 10.1590/S0365-05962002000500006
   Lima C.C., 2014, J PHARMACOGN PHYTOCH, V3, P181
   Lobmann R, 2005, DIABETES CARE, V28, P461, DOI 10.2337/diacare.28.2.461
   Lopes TRM, 2014, BIOL, DOI [10.3109/13880209.2014.948634, DOI 10.3109/13880209.2014.948634]
   Mandelbaum Samuel Henrique, 2003, An. Bras. Dermatol., V78, P393, DOI 10.1590/S0365-05962003000400002
   Mercer PF, 2013, BBA-MOL BASIS DIS, V1832, P1018, DOI 10.1016/j.bbadis.2012.12.013
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Moura LD, 2014, MAR DRUGS, V12, P2471, DOI 10.3390/md12052471
   Mulisa E, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0878-y
   NCCLS, 2006, METH DIL ANT SUSC TE
   Negrao R, 2013, J NUTR BIOCHEM, V24, P435, DOI 10.1016/j.jnutbio.2011.12.011
   OECD, 2017, TEST 402 AC DERM TOX, DOI [10.1787/9789264070585-en, DOI 10.1787/9789264070585-EN]
   Lopes RHO, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9681425
   Ousey K, 2016, J WOUND CARE, V25, P122, DOI 10.12968/jowc.2016.25.3.122
   Pamplona S, 2015, MOLECULES, V20, P18777, DOI 10.3390/molecules201018777
   Panchatcharam M, 2006, MOL CELL BIOCHEM, V290, P87, DOI 10.1007/s11010-006-9170-2
   Ratter J. A., 2003, Edinburgh Journal of Botany, V60, P57, DOI 10.1017/S0960428603000064
   Rhodes LE, 2013, BRIT J NUTR, V110, P891, DOI 10.1017/S0007114512006071
   Rodriguez M, 2014, MOL PHARMACOL, V85, P187, DOI 10.1124/mol.113.089573
   Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x
   Shrivastava R, 2011, DIABETES RES CLIN PR, V92, P92, DOI 10.1016/j.diabres.2010.12.021
   Singer AJ, 2008, NEW ENGL J MED, V359, P1037, DOI 10.1056/NEJMra0707253
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Souza CD, 2006, ACTA BOT BRAS, V20, P135, DOI DOI 10.1590/S0102-33062006000100013
   Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4
   Suriyamoorthy S, 2012, REV BRAS FARMACOGN, V22, P1338, DOI 10.1590/S0102-695X2012005000121
   Swamy HMK, 2007, J ETHNOPHARMACOL, V109, P529, DOI 10.1016/j.jep.2006.09.003
   Talekar YP, 2017, J AYURVEDA INTEGR ME, V8, P73, DOI 10.1016/j.jaim.2016.11.007
   Fujishima MAT, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11030072
   Tsuruya M, 2014, APPL BIOCHEM BIOTECH, V174, P2223, DOI 10.1007/s12010-014-1124-7
   Tulio AZ, 2014, FOOD CHEM, V157, P540, DOI 10.1016/j.foodchem.2014.02.047
   Vila Verde GM, 2003, VER BRAS FARMACOG, V13, P64, DOI [10.1590/S0102-695X200300024, DOI 10.1590/S0102-695X200300024]
   Villarroel Daniel, 2010, Ecología en Bolivia, V45, P116
   World Health Organization, 2007, WHO GUID ASS QUAL HE
   Yoon JJ, 2010, BIOCHEM BIOPH RES CO, V391, P96, DOI 10.1016/j.bbrc.2009.11.009
   Zielins ER, 2015, EXPERT OPIN EMERG DR, V20, P235, DOI 10.1517/14728214.2015.1018176
NR 72
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 13
PY 2020
VL 15
IS 1
AR e0225514
DI 10.1371/journal.pone.0225514
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LP5IZ
UT WOS:000534352500004
PM 31929529
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Ramos, RS
   Macedo, WJC
   Costa, JS
   da Silva, CHTD
   Rosa, JMC
   da Cruz, JN
   de Oliveira, MS
   Andrade, EHD
   Silva, RBLE
   Souto, RNP
   Santos, CBR
AF Ramos, Ryan S.
   Macedo, Williams J. C.
   Costa, Josivan S.
   da Silva, Carlos H. T. de P.
   Rosa, Joaquin M. C.
   da Cruz, Jorddy Neves
   de Oliveira, Mozaniel S.
   de Aguiar Andrade, Eloisa H.
   e Silva, Raullyan B. L.
   Souto, Raimundo N. P.
   Santos, Cleydson B. R.
TI Potential inhibitors of the enzyme acetylcholinesterase and juvenile
   hormone with insecticidal activity: study of the binding mode via
   docking and molecular dynamics simulations
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article
DE Validation; docking; molecular dynamics; Aedes aegypti
ID ACUTE INTERSTITIAL NEPHRITIS; PREDICTING DRUG-METABOLISM; VIRUS PROTEASE
   INHIBITORS; AEDES-AEGYPTI; FREE-ENERGIES; DENGUE; CARCINOGENESIS;
   DISCOVERY; MECHANISMS; HEPATOTOXICITY
AB Models validation in QSAR, pharmacophore, docking and others can ensure the accuracy and reliability of future predictions in design and selection of molecules with biological activity. In this study, pyriproxyfen was used as a pivot/template to search the database of the Maybridge Database for potential inhibitors of the enzymes acetylcholinesterase and juvenile hormone as well. The initial virtual screening based on the 3D shape resulted in 2000 molecules with Tanimoto index ranging from 0.58 to 0.88. A new reclassification was performed on the overlapping of positive and negative charges, which resulted in 100 molecules with Tanimoto's electrostatic score ranging from 0.627 to 0.87. Using parameters related to absorption, distribution, metabolism and excretion and the pivot molecule, the molecules selected in the previous stage were evaluated regarding these criteria, and 21 were then selected. The pharmacokinetic and toxicological properties were considered and for 12 molecules, the DEREK software not fired any alert of toxicity, which were thus considered satisfactory for prediction of biological activity using the Web server PASS. In the molecular docking with insect acetylcholinesterase, the Maybridge3_002654 molecule had binding affinity of -11.1 kcal/mol, whereas in human acetylcholinesterase, the Maybridge4_001571molecule show in silico affinity of -10.2 kcal/mol, and in the juvenile hormone, the molecule MCULE-8839595892 show in silico affinity value of -11.6 kcal/mol. Subsequent long-trajectory molecular dynamics studies indicated considerable stability of the novel molecules compared to the controls.
C1 [Ramos, Ryan S.; Santos, Cleydson B. R.] Univ Fed Amapa, Grad Program Biotechnol & Biodivers Network BIONO, Macapa, Brazil.
   [Ramos, Ryan S.; Macedo, Williams J. C.; Costa, Josivan S.; Santos, Cleydson B. R.] Univ Fed Amapa, Dept Biol & Hlth Sci, Lab Modeling & Computat Chem, Macapa, Brazil.
   [Ramos, Ryan S.; Macedo, Williams J. C.; Costa, Josivan S.] Fed Rural Univ Amazonia, Lab Mol Modeling & Simulat Syst, Capanema, Brazil.
   [da Silva, Carlos H. T. de P.] Fac Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, Sao Paulo, Brazil.
   [Rosa, Joaquin M. C.] Univ Granada, Dept Pharmaceut Organ Chem, Granada, Spain.
   [da Cruz, Jorddy Neves; de Aguiar Andrade, Eloisa H.] Museu Paraense Emilio Goeldi, Adolpho Ducke Lab, Belem, Para, Brazil.
   [de Oliveira, Mozaniel S.] Fed Univ Para, Program Postgrad Food Sci & Technol, Belem, Para, Brazil.
   [de Aguiar Andrade, Eloisa H.] Fed Univ Para, Program Postgrad Biodivers & Biotechnol BIONORTE, Belem, Para, Brazil.
   [e Silva, Raullyan B. L.] Inst Sci & Technol Res Amapa IEPA, Ctr Biodivers, Macapa, Brazil.
   [Souto, Raimundo N. P.] Univ Fed Amapa, Lab Arthropoda, Macapa, Brazil.
RP Ramos, RS (corresponding author), Fed Univ Amapa UNIFAP, Rod Juscelino Kubitschek, BR-68903419 Macapa, AP, Brazil.
EM ryanquimico@gmail.com
RI Ramos, Ryan/X-5824-2019; Cruz, Jorddy Neves/N-8524-2018; da Silva Costa,
   Josivan/AAA-9565-2020; de Oliveira, Mozaniel Santana/L-9553-2017
OI Ramos, Ryan/0000-0003-1802-1320; Cruz, Jorddy Neves/0000-0003-0529-3714;
   da Silva Costa, Josivan/0000-0001-5069-5283; de Oliveira, Mozaniel
   Santana/0000-0002-4076-2443; Macedo, Williams/0000-0002-0457-6993; de
   Aguiar Andrade, Eloisa Helena/0000-0003-0640-7496; Souto,
   Raimundo/0000-0002-8795-1217
FU Federal University of Amapa, Graduate Program in Biotechnology and
   Biodiversity-Network BIONORTE; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES)CAPES; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq)
FX The authors thank Federal University of Amapa, Graduate Program in
   Biotechnology and Biodiversity-Network BIONORTE, Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for funding
   in the publication of this article.
CR ANDERSEN RA, 1964, CANCER RES, V24, P128
   Andrighetti MTM, 2008, DENGUE B, V32, P186
   Angel Annette, 2017, VirusDisease, V28, P205, DOI 10.1007/s13337-017-0377-5
   Areiza M., 2018, THESIS
   Banerjee P, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00362
   Banerjee P, 2018, NUCLEIC ACIDS RES, V46, pW257, DOI 10.1093/nar/gky318
   Bardiot D, 2018, J MED CHEM, V61, P8390, DOI 10.1021/acs.jmedchem.8b00913
   BARRATT MD, 1992, CONTACT DERMATITIS, V27, P98, DOI 10.1111/j.1600-0536.1992.tb05217.x
   Basketter DA, 1999, CONTACT DERMATITIS, V40, P175, DOI 10.1111/j.1600-0536.1999.tb06029.x
   Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653
   Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biscarini L., 2000, MEYLERS SIDE EFFECTS, P246, DOI [10.1016/B978-0-444-53717-1.01165-3, DOI 10.1016/B978-0-444-53717-1.01165-3]
   Blenau W, 2012, APIDOLOGIE, V43, P334, DOI 10.1007/s13592-011-0108-7
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   Budryn G, 2015, FOOD CHEM, V168, P276, DOI 10.1016/j.foodchem.2014.07.056
   Burkert U., 1982, ACS MONOGRAPH, V177
   Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x
   Citro V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165463
   Collado-Gonzalez M, 2017, CARBOHYD POLYM, V161, P63, DOI 10.1016/j.carbpol.2016.12.043
   CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030
   Coscolla C, 2008, J CHROMATOGR A, V1200, P100, DOI 10.1016/j.chroma.2008.05.075
   Costa J. S., 2018, CURRENT PHARM DESIGN, V23, P1
   Cronin M T, 1994, SAR QSAR Environ Res, V2, P159, DOI 10.1080/10629369408029901
   Cruz JN, 2020, J BIOMOL STRUCT DYN, V38, P1425, DOI 10.1080/07391102.2019.1607560
   da Costa GV, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020061
   Dalvie DK, 2002, CHEM RES TOXICOL, V15, P269, DOI 10.1021/tx015574b
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Cavalcanti LPD, 2017, MEM I OSWALDO CRUZ, V112, P583, DOI 10.1590/0074-02760160537
   de Oliveira MS, 2019, J SUPERCRIT FLUID, V145, P74, DOI 10.1016/j.supflu.2018.12.003
   Martinez-Ballesta MD, 2016, COLLOID SURFACE B, V143, P318, DOI 10.1016/j.colsurfb.2016.03.056
   Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381
   Drwal MN, 2014, NUCLEIC ACIDS RES, V42, pW53, DOI 10.1093/nar/gku401
   Engdahl C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138598
   Ferreira JV, 2017, CHEMMEDCHEM, V12, P1408, DOI 10.1002/cmdc.201700129
   FOURNIER D, 1993, CHEM-BIOL INTERACT, V87, P233, DOI 10.1016/0009-2797(93)90047-3
   Frisch MJ, 2016, GAUSSIAN 16 REV C 01
   Gaddaguti V, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-015-0346-x
   GNAGEY AL, 1987, J BIOL CHEM, V262, P13290
   Goel RK, 2011, MED CHEM RES, V20, P1509, DOI 10.1007/s00044-010-9398-y
   Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7
   Gowthaman U, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S14
   Harburguer LV, 2009, PEST MANAG SCI, V65, P1208, DOI 10.1002/ps.1811
   Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063
   Harwood JF, 2016, J AM MOSQUITO CONTR, V32, P217, DOI 10.2987/16-6553.1
   Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k
   Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n
   Holder JW, 1999, TOXICOL IND HEALTH, V15, P445
   Hostettmann K, 2006, CURR ORG CHEM, V10, P825, DOI 10.2174/138527206776894410
   Inoue M, 2008, CLIN EXP NEPHROL, V12, P296, DOI 10.1007/s10157-008-0039-4
   Iswardy E, 2017, BIOSENS BIOELECTRON, V97, P400, DOI 10.1016/j.bios.2017.05.038
   ITOH M, 1982, Journal of Dermatology (Tokyo), V9, P223
   Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996
   JALOTA R, 1974, American Journal of Tropical Medicine and Hygiene, V23, P676
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kalgutkar AS, 2005, CURR DRUG METAB, V6, P161, DOI 10.2174/1389200054021799
   Kang G, 2015, ACTA CRYSTALLOGR E, V71, pO588, DOI 10.1107/S2056989015013481
   Kayser D., 2001, CHEM KONTAKTALLERGIE
   Kim IH, 2017, J BIOL CHEM, V292, P15329, DOI [10.1074/jbc.M117.802009, 10.1074/jbc.m117.802009]
   Kirchmair J, 2015, NAT REV DRUG DISCOV, V14, P387, DOI 10.1038/nrd4581
   Kobayashi H., 2011, ANTICHOLINESTERASE P, V3, P3
   Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j
   Kovacic P, 2001, CURR MED CHEM, V8, P773, DOI 10.2174/0929867013373084
   Kroupova A, 2019, NUCLEIC ACIDS RES, V47, P1030, DOI 10.1093/nar/gky1164
   Leal ES, 2017, BIOORG MED CHEM LETT, V27, P3851, DOI 10.1016/j.bmcl.2017.06.049
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Meric A, 2017, BULG CHEM COMMUN, V49, P5
   MILLER EC, 1978, CANCER RES, V38, P1479
   Miyazawa M, 2001, NAT PROD LETT, V15, P205, DOI 10.1080/10575630108041281
   Mizutani T, 1996, TOXICOL LETT, V85, P101, DOI 10.1016/0378-4274(96)03646-6
   Navarro-Fernandez J, 2012, J MED CHEM, V55, P6403, DOI 10.1021/jm300621j
   Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150
   Nitsche C, 2013, J MED CHEM, V56, P8389, DOI 10.1021/jm400828u
   O'Donnell JP, 2003, DRUG METAB DISPOS, V31, P1369, DOI 10.1124/dmd.31.11.1369
   Olmstead AW, 2003, ENVIRON HEALTH PERSP, V111, P919, DOI 10.1289/ehp.5982
   OPDYKE DLJ, 1979, FOOD COSMET TOXICOL, V17, P509, DOI 10.1016/0015-6264(79)90012-9
   Osman H, 2017, ACTA PHARM SIN B, V7, P479, DOI 10.1016/j.apsb.2017.04.009
   Parvez MK, 2017, INTERVIROLOGY, V60, P1, DOI 10.1159/000478729
   PASCOE MD, 1986, S AFR MED J, V70, P232
   Paul A, 2006, J MED ENTOMOL, V43, P55, DOI 10.1603/0022-2585(2006)043[0055:EONIFC]2.0.CO;2
   Picard O, 1998, ANN INTERN MED, V129, P670, DOI 10.7326/0003-4819-129-8-199810150-00026
   Pizova H, 2017, MOLECULES, V22, DOI 10.3390/molecules22111969
   PORILE JL, 1990, J CLIN PHARMACOL, V30, P468, DOI 10.1002/j.1552-4604.1990.tb03487.x
   Ramos RD, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12010020
   Rindings J.E, 1996, TOXICOLOGY, V106, P267, DOI DOI 10.1016/0300-483X(95)03190-Q
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Saez-Llorens X, 2017, LANCET INFECT DIS, V17, P615, DOI 10.1016/S1473-3099(17)30166-4
   Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121
   Sanchez-Linares I, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S13
   SANDERSON DM, 1991, HUM EXP TOXICOL, V10, P261, DOI 10.1177/096032719101000405
   Savelev S, 2003, PHARMACOL BIOCHEM BE, V75, P661, DOI 10.1016/S0091-3057(03)00125-4
   Schmitt H, 2000, CHEM RES TOXICOL, V13, P441, DOI 10.1021/tx9901635
   Schrodinger, 2011, QIKPROP RAP ADME PRE
   Silva R. C., 2018, J SERB CHEM, V83, P1
   Silva SG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213393
   Sittivicharpinyo T, 2017, MEM I OSWALDO CRUZ, V112, P580, DOI 10.1590/0074-02760170022
   Skandrani K., 2008, GASTROENTEROLOGIE CL, V21, P623
   Sullivan JJ, 2008, J PESTIC SCI, V33, P339, DOI 10.1584/jpestics.R08-02
   TAKAHASHI K, 1978, GANN, V69, P499
   Testa B, 2005, CHEM BIODIVERS, V2, P872, DOI 10.1002/cbdv.200590064
   Treiber A, 1997, J AM CHEM SOC, V119, P1565, DOI 10.1021/ja962466g
   Vale Allister, 2015, Handb Clin Neurol, V131, P149, DOI 10.1016/B978-0-444-62627-1.00010-X
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005
   Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612
   Williams G. M., 1993, CASARETT DOULLS TOXI, P127
   World Health Organization, 2009, WHO REC CLASS PEST H
   WORLD HEALTH ORGANIZATION (WHO); Special Programme for Research and Training in Tropical Diseases (TDR), 2009, DENG GUID DIAGN TREA
   Yamashita S, 2000, EUR J PHARM SCI, V10, P195, DOI 10.1016/S0928-0987(00)00076-2
   Yang YJ, 2014, RICE SCI, V21, P181, DOI 10.1016/S1672-6308(13)60181-X
   Zhang LT, 1998, J CHEM SOC PERK T 2, P2553, DOI 10.1039/a801684d
NR 112
TC 18
Z9 18
U1 4
U2 12
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
PD NOV 1
PY 2020
VL 38
IS 16
BP 4687
EP 4709
DI 10.1080/07391102.2019.1688192
EA NOV 2019
PG 23
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA NS0SI
UT WOS:000495544400001
PM 31674282
DA 2020-12-09
ER

PT J
AU da Costa, GV
   Ferreira, EFB
   Ramos, RD
   da Silva, LB
   de Sa, EMF
   da Silva, AKP
   Lobato, CM
   Souto, RNP
   da Silva, CHTD
   Federico, LB
   Rosa, JMC
   dos Santos, CBR
AF da Costa, Glauber, V
   Ferreira, Elenilze F. B.
   Ramos, Ryan da S.
   da Silva, Luciane B.
   de Sa, Ester M. F.
   da Silva, Alicia K. P.
   Lobato, Cassio M.
   Souto, Raimundo N. P.
   da Silva, Carlos Henrique T. de P.
   Federico, Leonardo B.
   Rosa, Joaquin M. C.
   dos Santos, Cleydson B. R.
TI Hierarchical Virtual Screening of Potential Insectides Inhibitors of
   Acetylcholinesterase and Juvenile Hormone from Temephos
SO PHARMACEUTICALS
LA English
DT Article
DE acetylcholinesterase; juvenile hormone; temephos; molecular docking
ID ACUTE TOXICITY; MOLECULAR DOCKING; DESIGN; DERIVATIVES; DISCOVERY;
   PYMETROZINE; VALIDATION; ABATE(R); ANALOGS; FAMILY
AB Aedes aegypti (Linnaeus, 1762; Diptera: Culicidae) is the main vector transmitting viral diseases such as dengue fever, dengue haemorrhagic fever, urban yellow fever, zika and chikungunya. Worldwide, especially in the Americas and Brazil, many cases of dengue have been reported in recent years, which have shown significant growth. The main control strategy is the elimination of the vector, carried out through various education programs, to change human habits, but the most usual is biological control, together with environmental management and chemical control. The most commonly insecticide used is temephos (an organophosphorus compound), but Aedes aegypti populations have shown resistance and the product is highly toxic, so we chose it as a template molecule to perform a ligand-based virtual screening in the ChemBrigde (DIVERSet-CL subcollection) database, searching for derivatives with similarity in shape (ROCS) and electrostatic potential (EON). Thus, fourty-five molecules were filtered based on their pharmacokinetic and toxicological properties and 11 molecules were selected by a molecular docking study, including binding affinity and mode of interaction. The L46, L66 and L68 molecules show potential inhibitory activity for both the insect (-9.28, -10.08 and -6.78 Kcal/mol, respectively) and human (-6.05, 6.25 and 7.2 Kcal/mol respectively) enzymes, as well as the juvenile hormone protein (-9.2; -10.96 and -8.16 kcal/mol, respectively), showing a significant difference in comparison to the template molecule temephos. Molecules L46, L66 and L68 interacted with important amino acids at each catalytic site of the enzyme reported in the literature. Thus, the molecules here investigated are potential inhibitors for both the acetylcholinesterase enzymes and juvenile hormone protein-from insect and humans, characterizing them as a potential insecticide against the Aedes aegypti mosquito.
C1 [da Costa, Glauber, V; Ferreira, Elenilze F. B.; dos Santos, Cleydson B. R.] Univ Fed Amapa, Postgrad Program Network Pharmaceut Innovat, BR-68902280 Macapa, AP, Brazil.
   [da Costa, Glauber, V; Ferreira, Elenilze F. B.; Ramos, Ryan da S.; da Silva, Luciane B.; dos Santos, Cleydson B. R.] Univ Fed Amapa, Lab Modeling & Computat Chem, Dept Biol & Hlth Sci, BR-68902280 Macapa, AP, Brazil.
   [da Costa, Glauber, V; de Sa, Ester M. F.; da Silva, Alicia K. P.; Lobato, Cassio M.] Univ Fed Amapa, Dept Biol & Hlth Sci, Lab Biotechnol Nat Prod, BR-68902280 Macapa, AP, Brazil.
   [Souto, Raimundo N. P.] Univ Fed Amapa, Lab Arthropoda, BR-68902280 Macapa, AP, Brazil.
   [da Silva, Carlos Henrique T. de P.; Federico, Leonardo B.; dos Santos, Cleydson B. R.] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, BR-14040903 Sao Paulo, Brazil.
   [Rosa, Joaquin M. C.] Univ Granada, Dept Pharmaceut & Organ Chem, Fac Pharm, Inst Biosanit Res Ibs GRANADA, Granada 18071, Spain.
RP dos Santos, CBR (corresponding author), Univ Fed Amapa, Postgrad Program Network Pharmaceut Innovat, BR-68902280 Macapa, AP, Brazil.; dos Santos, CBR (corresponding author), Univ Fed Amapa, Lab Modeling & Computat Chem, Dept Biol & Hlth Sci, BR-68902280 Macapa, AP, Brazil.; dos Santos, CBR (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, BR-14040903 Sao Paulo, Brazil.
EM vilhenac@hotmail.com; elenilze.batista@ueap.edu.br;
   ryanquimico@hotmail.com; luciaanebarros@hotmail.com;
   estersa07@gmail.com; aliciakarine1@gmail.com; cassio153bio@gmail.com;
   nonatoiepa@hotmail.com; tomich@fcfrp.usp.br; lbfederico@usp.br;
   jmcampos@ugr.es; breno@unifap.br
RI Federico, Leonardo Bruno/S-5368-2019; Ramos, Ryan/X-5824-2019; Campos,
   Joaquin/L-8436-2014
OI Federico, Leonardo Bruno/0000-0002-2943-8802; Ramos,
   Ryan/0000-0003-1802-1320; Rodrigues dos Santos, Cleydson
   Breno/0000-0002-0271-335X; Souto, Raimundo/0000-0002-8795-1217; Campos,
   Joaquin/0000-0002-9035-8123
CR Aiub Claudia Alessandra Fortes, 2002, Genetics and Molecular Research, V1, P159
   Anadu DI, 1996, J ENVIRON SCI HEAL B, V31, P1363, DOI 10.1080/03601239609373072
   Areiza M., 2018, THESIS
   Atanasova M, 2015, BIOORGAN MED CHEM, V23, P5382, DOI 10.1016/j.bmc.2015.07.058
   Ausborn J, 2005, J EXP BIOL, V208, P4451, DOI 10.1242/jeb.01917
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Borges NM, 2018, J MOL MODEL, V24, DOI 10.1007/s00894-017-3548-9
   Brown SM, 2012, J PHARMACOL EXP THER, V343, P53, DOI 10.1124/jpet.112.193433
   Burt B.P.E., 1970, PESTIC SCI, V1, P88, DOI [10.1002/ps.2780010303, DOI 10.1002/PS.2780010303]
   Cabarcas-Montalvo M, 2016, EUR J MED CHEM, V110, P87, DOI 10.1016/j.ejmech.2015.12.030
   Cannalire R, 2018, EUR J MED CHEM, V143, P1667, DOI 10.1016/j.ejmech.2017.10.064
   Chauhan N, 2012, CHEM BIOL DRUG DES, V80, P54, DOI 10.1111/j.1747-0285.2012.01329.x
   Costa JD, 2018, CURR PHARM DESIGN, V24, P576, DOI 10.2174/1381612823666170711112510
   Dulin F, 2012, ECOTOX ENVIRON SAFE, V79, P13, DOI 10.1016/j.ecoenv.2012.01.007
   Duvall L.B., 2018, NOVEL SMALL MOL AGON, DOI [10.1101/393793, DOI 10.1101/393793]
   Duvall LB, 2019, CELL, V176, P687, DOI 10.1016/j.cell.2018.12.004
   Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545
   Emerson C.L., 1995, J COMPUT CHEM, V16, P1170
   FITZPATRICK GE, 1981, ENVIRON ENTOMOL, V10, P728, DOI 10.1093/ee/10.5.728
   GEROLT P., 1970, Pesticide Science, V1, P209, DOI 10.1002/ps.2780010511
   Gholivand K, 2014, J AGR FOOD CHEM, V62, P5761, DOI 10.1021/jf5011726
   Ghose AK, 2012, ACS CHEM NEUROSCI, V3, P50, DOI 10.1021/cn200100h
   Guo JX, 2006, CHEM RES TOXICOL, V19, P209, DOI 10.1021/tx050090r
   Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063
   Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n
   Hochreiter S, 2018, J CHEM INF MODEL, V58, P1723, DOI 10.1021/acs.jcim.8b00478
   Horowitz AR, 2004, INSECT PEST MANAGEMENT, FIELD AND PROTECTED CROPS, P1
   Hu J, 2018, BIOINFORMATICS, V34, P2209, DOI 10.1093/bioinformatics/bty081
   Hurst H, 1943, T FARADAY SOC, V39, P0390, DOI 10.1039/tf9433900390
   Junges CM, 2017, WATER AIR SOIL POLL, V228, DOI 10.1007/s11270-017-3324-6
   Kim IH, 2017, J BIOL CHEM, V292, P15329, DOI [10.1074/jbc.M117.802009, 10.1074/jbc.m117.802009]
   Klebe G, 2006, DRUG DISCOV TODAY, V11, P580, DOI 10.1016/j.drudis.2006.05.012
   Kobayashi H., 2011, ANTICHOLINESTERASE P, V3, P3
   Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008
   Kua J, 2002, J AM CHEM SOC, V124, P8260, DOI 10.1021/ja020429l
   Lauger P, 1944, HELV CHIM ACTA, V27, P892, DOI 10.1002/hlca.194402701115
   LEE BM, 1989, B ENVIRON CONTAM TOX, V43, P827, DOI 10.1007/BF01702051
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   Loza-Mejia MA, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8040121
   Maienfisch P, 2019, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 3RD EDITION, P1501
   MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y
   Matthews BJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2239-0
   Milan D., 2013, U.S. Patent, P1, DOI 10.1016/j.(73), Patent No. 2009005354
   Mofidifar S, 2018, BIOGERONTOLOGY, V19, P133, DOI 10.1007/s10522-018-9744-x
   MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405
   Noriega FG, 2006, INSECT BIOCHEM MOLEC, V36, P366, DOI 10.1016/j.ibmb.2006.01.013
   Onguene Pascal Amoa, 2014, Org Med Chem Lett, V4, P6, DOI 10.1186/s13588-014-0006-x
   Ozturk H, 2018, BIOINFORMATICS, V34, P821, DOI 10.1093/bioinformatics/bty593
   Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896
   Poli G, 2019, J ENZYM INHIB MED CH, V34, P589, DOI 10.1080/14756366.2019.1571271
   Poupardin R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002743
   Print I., 2015, WORLD J PHARM SCI, V3, P2273
   Printes LB, 2004, ENVIRON TOXICOL CHEM, V23, P1241, DOI 10.1897/03-202
   Ramos RD, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12010020
   Sechser B, 2002, ANZ SCHADL-J PEST SC, V75, P72, DOI 10.1034/j.1399-5448.2002.02021.x
   Sikka S., 2006, TOXICOLOGY ORGANOPHO, P447
   Silva RC, 2019, J SERB CHEM SOC, V84, P153, DOI 10.2298/JSC180129047S
   Sparling DW, 1997, B ENVIRON CONTAM TOX, V58, P475, DOI 10.1007/s001289900359
   Srivastava P, 2019, EUR J MED CHEM, V163, P116, DOI 10.1016/j.ejmech.2018.11.049
   Trosset JY, 1998, P NATL ACAD SCI USA, V95, P8011, DOI 10.1073/pnas.95.14.8011
   ul-Haq Z, 2003, J MED CHEM, V46, P5087, DOI 10.1021/jm0309194
   Vincent J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00833-9
   Voutchkova AM, 2010, TETRAHEDRON, V66, P1031, DOI 10.1016/j.tet.2009.11.002
   Wan YF, 2020, J BIOMOL STRUCT DYN, V38, P410, DOI 10.1080/07391102.2019.1576543
   WEBB JE, 1945, J EXP BIOL, V22, P8
   WHO, 2009, TEM DRINK WAT US VEC
   Wiggers P., 2011, P 12 INT C COMP SYST, P411
   WINTERINGHAM FPW, 1955, PHYSIOL REV, V35, P701
   Yusuf D, 2008, J CHEM INF MODEL, V48, P1411, DOI 10.1021/ci800084x
   Zhang YZ, 2008, J FLUORESC, V18, P109, DOI 10.1007/s10895-007-0247-4
NR 72
TC 7
Z9 7
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD JUN
PY 2019
VL 12
IS 2
AR 61
DI 10.3390/ph12020061
PG 19
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA IL0ZM
UT WOS:000477028700016
PM 31003398
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Ramos, RD
   Costa, JD
   Silva, RC
   da Costa, GV
   Rodrigues, ABL
   Rabelo, EDM
   Souto, RNP
   Taft, CA
   da Silva, CHTD
   Rosa, JMC
   dos Santos, CBR
   Macedo, WJD
AF Ramos, Ryan da Silva
   Costa, Josivan da Silva
   Silva, Rai Campos
   da Costa, Glauber Vilhena
   Lobato Rodrigues, Alex Bruno
   Rabelo, Erica de Menezes
   Picanco Souto, Raimundo Nonato
   Taft, Carlton Anthony
   Tomich de Paula da Silva, Carlos Henrique
   Campos Rosa, Joaquin Maria
   Rodrigues dos Santos, Cleydson Breno
   da Cruz Macedo, Williams Jorge
TI Identification of Potential Inhibitors from Pyriproxyfen with
   Insecticidal Activity by Virtual Screening
SO PHARMACEUTICALS
LA English
DT Article
DE acetylcholinesterase; juvenile hormone; PASS; molecular docking
ID PREDICTING DRUG-METABOLISM; AEDES-AEGYPTI DIPTERA; EXPERIMENTAL
   INTERSEXUALITY; SEXUAL DEVELOPMENT; DENGUE VECTOR; ACETYLCHOLINESTERASE;
   DERIVATIVES; SKIN; MUTAGENICITY; PERMEABILITY
AB Aedes aegypti is the main vector of dengue fever transmission, yellow fever, Zika, and chikungunya in tropical and subtropical regions and it is considered to cause health risks to millions of people in the world. In this study, we search to obtain new molecules with insecticidal potential against Ae. aegypti via virtual screening. Pyriproxyfen was chosen as a template compound to search molecules in the database Zinc_Natural_Stock (ZNSt) with structural similarity using ROCS (rapid overlay of chemical structures) and EON (electrostatic similarity) software, and in the final search, the top 100 were selected. Subsequently, in silico pharmacokinetic and toxicological properties were determined resulting in a total of 14 molecules, and these were submitted to the PASS online server for the prediction of biological insecticide and acetylcholinesterase activities, and only two selected molecules followed for the molecular docking study to evaluate the binding free energy and interaction mode. After these procedures were performed, toxicity risk assessment such as LD50 values in mg/kg and toxicity class using the PROTOX online server, were undertaken. Molecule ZINC00001624 presented potential for inhibition for the acetylcholinesterase enzyme (insect and human) with a binding affinity value of -10.5 and -10.3 kcal/mol, respectively. The interaction with the juvenile hormone was -11.4 kcal/mol for the molecule ZINC00001021. Molecules ZINC00001021 and ZINC00001624 had excellent predictions in all the steps of the study and may be indicated as the most promising molecules resulting from the virtual screening of new insecticidal agents.
C1 [Ramos, Ryan da Silva; Lobato Rodrigues, Alex Bruno; Rabelo, Erica de Menezes; Rodrigues dos Santos, Cleydson Breno; da Cruz Macedo, Williams Jorge] Univ Fed Amapa, Postgrad Program Biotechnol & Biodivers Network B, BR-68903419 Macapa, Amapa, Brazil.
   [Ramos, Ryan da Silva; Costa, Josivan da Silva; Silva, Rai Campos; da Costa, Glauber Vilhena; Lobato Rodrigues, Alex Bruno; Rodrigues dos Santos, Cleydson Breno; da Cruz Macedo, Williams Jorge] Univ Fed Amapa, Lab Modeling & Computat Chem, Dept Biol & Hlth Sci, BR-68902280 Macapa, AP, Brazil.
   [Ramos, Ryan da Silva; Costa, Josivan da Silva; Tomich de Paula da Silva, Carlos Henrique; da Cruz Macedo, Williams Jorge] Fed Rural Univ Amazonia, Lab Mol Modeling & Simulat Syst, BR-68700030 Capanema, Para, Brazil.
   [Silva, Rai Campos; Tomich de Paula da Silva, Carlos Henrique; Rodrigues dos Santos, Cleydson Breno] Fac Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, BR-14040903 Sao Paulo, Brazil.
   [Picanco Souto, Raimundo Nonato] Univ Fed Amapa, Lab Arthropoda, BR-68902280 Macapa, AP, Brazil.
   [Taft, Carlton Anthony] Brazilian Ctr Phys Res, BR-22290180 Urca, RJ, Brazil.
   [Campos Rosa, Joaquin Maria] Univ Granada, Dept Organ Pharmaceut Chem, E-18071 Granada, Spain.
RP dos Santos, CBR (corresponding author), Univ Fed Amapa, Postgrad Program Biotechnol & Biodivers Network B, BR-68903419 Macapa, Amapa, Brazil.; dos Santos, CBR (corresponding author), Univ Fed Amapa, Lab Modeling & Computat Chem, Dept Biol & Hlth Sci, BR-68902280 Macapa, AP, Brazil.; dos Santos, CBR (corresponding author), Fac Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, BR-14040903 Sao Paulo, Brazil.
EM ryanquimico@hotmail.com; josivan.chemistry@gmail.com;
   camposchemistry@gmail.com; vilhenac@hotmail.com;
   alexrodrigues.quim@gmail.com; ericamrabelo@gmail.com;
   nonatoiepa@hotmail.com; catff@terra.com.br; tomich@fcfrp.usp.br;
   jmcampos@ugr.es; breno@unifap.br; williamsmacedo@yahoo.com.br
RI Rodrigues, Alex/AAM-3606-2020; Rosa, Joaquin/L-8436-2014; Ramos,
   Ryan/X-5824-2019; da Silva Costa, Josivan/AAA-9565-2020
OI Rodrigues, Alex/0000-0003-2170-1773; Rosa, Joaquin/0000-0002-9035-8123;
   Ramos, Ryan/0000-0003-1802-1320; da Silva Costa,
   Josivan/0000-0001-5069-5283; Rodrigues dos Santos, Cleydson
   Breno/0000-0002-0271-335X; Souto, Raimundo/0000-0002-8795-1217
FU Federal University of Amapa; Program in Biotechnology and
   Biodiversity-Network BIONORTE; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES)CAPES; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq)
FX Federal University of Amapa, Program in Biotechnology and
   Biodiversity-Network BIONORTE, Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) for funding in the publication of this
   article.
CR Ahmadi F, 2012, DNA CELL BIOL, V31, P259, DOI 10.1089/dna.2011.1303
   Anderson JA, 2012, PESTIC BIOCHEM PHYS, V102, P124, DOI 10.1016/j.pestbp.2011.12.002
   Andrighetti MTM, 2008, DENGUE B, V32, P186
   [Anonymous], 2009, STUD DISC INS
   Anstead GM, 1997, STEROIDS, V62, P268, DOI 10.1016/S0039-128X(96)00242-5
   Atanasova M, 2015, BIOORGAN MED CHEM, V23, P5382, DOI 10.1016/j.bmc.2015.07.058
   Banerjee P, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00362
   Banerjee P, 2018, NUCLEIC ACIDS RES, V46, pW257, DOI 10.1093/nar/gky318
   BARBER ED, 1981, MUTAT RES, V90, P31, DOI 10.1016/0165-1218(81)90048-3
   BARRATT MD, 1994, TOXICOL IN VITRO, V8, P823, DOI 10.1016/0887-2333(94)90077-9
   Berankova M, 2017, FOOD CHEM TOXICOL, V108, P224, DOI 10.1016/j.fct.2017.07.060
   Blenau W, 2012, APIDOLOGIE, V43, P334, DOI 10.1007/s13592-011-0108-7
   Botas GD, 2017, MOLECULES, V22, DOI 10.3390/molecules22111990
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   Burkert U., 1982, ACS MONOGRAPH, V177
   Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x
   Chigurupati S, 2016, BIOORG CHEM, V67, P9, DOI 10.1016/j.bioorg.2016.05.002
   Coscolla C, 2008, J CHROMATOGR A, V1200, P100, DOI 10.1016/j.chroma.2008.05.075
   Costa JD, 2018, CURR PHARM DESIGN, V24, P576, DOI 10.2174/1381612823666170711112510
   Cronin M T, 1994, SAR QSAR Environ Res, V2, P159, DOI 10.1080/10629369408029901
   Cruz JV, 2018, MOLECULES, V23, DOI 10.3390/molecules23020453
   da Silva Ramos Ryan, 2017, ScientificWorldJournal, V2017, P4927214, DOI 10.1155/2017/4927214
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Drwal MN, 2014, NUCLEIC ACIDS RES, V42, pW53, DOI 10.1093/nar/gku401
   Engdahl C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138598
   ERIKSSON L, 1991, ACTA CHEM SCAND, V45, P935, DOI 10.3891/acta.chem.scand.45-0935
   Fang H, 2001, CHEM RES TOXICOL, V14, P280, DOI 10.1021/tx000208y
   Ferreira JV, 2017, CHEMMEDCHEM, V12, P1408, DOI 10.1002/cmdc.201700129
   FOURNIER D, 1993, CHEM-BIOL INTERACT, V87, P233, DOI 10.1016/0009-2797(93)90047-3
   Gaddaguti V, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-015-0346-x
   GNAGEY AL, 1987, J BIOL CHEM, V262, P13290
   Goel RK, 2011, MED CHEM RES, V20, P1509, DOI 10.1007/s00044-010-9398-y
   Gowthaman U, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S14
   Greene RR, 1939, ANAT REC, V74, P429, DOI 10.1002/ar.1090740405
   Greene RR, 1940, AM J ANAT, V67, P305, DOI 10.1002/aja.1000670206
   Harburguer LV, 2009, PEST MANAG SCI, V65, P1208, DOI 10.1002/ps.1811
   Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063
   Harriott ND, 2018, PROGR MED CHEM, V57, P87, DOI 10.1016/bs.pmch.2017.12.002
   Harwood JF, 2016, J AM MOSQUITO CONTR, V32, P217, DOI 10.2987/16-6553.1
   Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k
   Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n
   Hostettmann K, 2006, CURR ORG CHEM, V10, P825, DOI 10.2174/138527206776894410
   International Agency for Research on Cancer (IARC), 2007, IARC MONOGRAPHS EVAL, V91, P543
   Itoh T., 1994, TROP MED, V35, P259
   Jorgensen WL, 2002, ADV DRUG DELIVER REV, V54, P355, DOI 10.1016/S0169-409X(02)00008-X
   Kang G, 2015, ACTA CRYSTALLOGR E, V71, pO588, DOI 10.1107/S2056989015013481
   Kim IH, 2017, J BIOL CHEM, V292, P15329, DOI [10.1074/jbc.M117.802009, 10.1074/jbc.m117.802009]
   Kirchmair J, 2015, NAT REV DRUG DISCOV, V14, P387, DOI 10.1038/nrd4581
   Kroupova A, 2019, NUCLEIC ACIDS RES, V47, P1030, DOI 10.1093/nar/gky1164
   Lagunin A, 2010, CURR PHARM DESIGN, V16, P1703, DOI 10.2174/138161210791164063
   Lekweiry KM, 2015, J MED ENTOMOL, V52, P730, DOI 10.1093/jme/tjv051
   Lhasa Limited, 2007, DER NEX VERSAO 10 0
   Li B, 2010, PESTIC BIOCHEM PHYS, V98, P19, DOI 10.1016/j.pestbp.2010.04.004
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   MARCHAND B, 1982, ARCH DERMATOL RES, V272, P61
   Meric A, 2017, BULG CHEM COMMUN, V49, P5
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P7
   Miyazawa M, 2001, NAT PROD LETT, V15, P205, DOI 10.1080/10575630108041281
   Mossa A. T. H., 2016, Journal of Environmental Science and Technology, V9, P354
   Mostafiz MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208552
   Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150
   Noriega FG, 2006, INSECT BIOCHEM MOLEC, V36, P366, DOI 10.1016/j.ibmb.2006.01.013
   Olmstead AW, 2003, ENVIRON HEALTH PERSP, V111, P919, DOI 10.1289/ehp.5982
   Opdyke D.L.J., 1974, FOOD COSMETICS TOXIC, V12, P521, DOI [10.1016/0015-6264(74)90068-6, DOI 10.1016/0015-6264(74)90068-6]
   Padilha EC, 2016, J BRAZIL CHEM SOC, V27, P1636, DOI 10.5935/0103-5053.20160043
   Paul A, 2006, J MED ENTOMOL, V43, P55, DOI 10.1603/0022-2585(2006)043[0055:EONIFC]2.0.CO;2
   PAYNE MP, 1994, J CHEM INF COMP SCI, V34, P154, DOI 10.1021/ci00017a019
   Pereira ALE, 2018, J BIOMOL STRUCT DYN, V36, P318, DOI 10.1080/07391102.2016.1277163
   Perry MD, 2015, J PHYSIOL-LONDON, V593, P2575, DOI 10.1113/JP270095
   Costa IMP, 2016, EPIDEMIOL SERV SAUDE, V25, P735, DOI [10.5123/s1679-49742016000400007, 10.5123/S1679-49742016000400007]
   Pizova H, 2017, MOLECULES, V22, DOI 10.3390/molecules22111969
   Ponlawat A, 2013, SE ASIAN J TROP MED, V44, P167
   Rindings J.E, 1996, TOXICOLOGY, V106, P267, DOI DOI 10.1016/0300-483X(95)03190-Q
   dos Santos CBR, 2018, J ETHNOPHARMACOL, V222, P107, DOI 10.1016/j.jep.2018.04.041
   SANDERSON DM, 1991, HUM EXP TOXICOL, V10, P261, DOI 10.1177/096032719101000405
   Savelev S, 2003, PHARMACOL BIOCHEM BE, V75, P661, DOI 10.1016/S0091-3057(03)00125-4
   Schmidt RJ, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/EHP604, 10.1289/ehp604]
   Schrodinger, 2011, QIKPROP RAP ADME PRE
   Silva RC, 2019, J SERB CHEM SOC, V84, P153, DOI 10.2298/JSC180129047S
   Simoes M.O., 2003, FARMACOGNOSIA PLANTA
   Sullivan JJ, 2008, J PESTIC SCI, V33, P339, DOI 10.1584/jpestics.R08-02
   TAN EL, 1983, J TOXICOL ENV HEALTH, V11, P373, DOI 10.1080/15287398309530351
   Tan L., 2015, IEEE T POWER ELECTR, VPP, P1, DOI DOI 10.1155/2015/896314
   Testa B, 2005, CHEM BIODIVERS, V2, P872, DOI 10.1002/cbdv.200590064
   Timms BG, 2005, P NATL ACAD SCI USA, V102, P7014, DOI 10.1073/pnas.0502544102
   Vale Allister, 2015, Handb Clin Neurol, V131, P149, DOI 10.1016/B978-0-444-62627-1.00010-X
   Whitehorn J, 2010, BRIT MED BULL, V95, P161, DOI 10.1093/bmb/ldq019
   World Health Organization, 2009, WHO REC CLASS PEST H
   World Health Organizations, 2012, GLOB STRAT DENG PREV, V43
   Yamamoto J.E.C., 1999, NICOTINOID INSECTICI, P1
   Yamashita S, 2000, EUR J PHARM SCI, V10, P195, DOI 10.1016/S0928-0987(00)00076-2
   Yang YJ, 2014, RICE SCI, V21, P181, DOI 10.1016/S1672-6308(13)60181-X
   YASUDA Y, 1985, TERATOLOGY, V32, P219, DOI 10.1002/tera.1420320210
   Zimmerman HJ, 1999, HEPATOTOXICITY ADVER
NR 94
TC 9
Z9 9
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD JAN 25
PY 2019
VL 12
IS 1
AR 20
DI 10.3390/ph12010020
PG 22
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA HS8ZR
UT WOS:000464158100001
PM 30691028
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU da Costa, RA
   Silva, SG
   Silva, SD
   Cruz, JN
   da Costa, WA
   Brasil, LSND
   Silva, RC
   Santos, CBR
   Alves, CN
   Brasil, DDB
AF da Costa, Renato A.
   Silva, Sebastiao G.
   Silva, Silvana de O.
   Cruz, Jorddy N.
   da Costa, Wanessa A.
   dos Santos Brasil, Luciane S. N.
   Silva, Rai C.
   Santos, Cleydson B. R.
   Alves, Claudio N.
   Barros Brasil, Davi de S.
TI Theoretical study via DFT for the prediction of C-13- and H-1-NMR data
   for two diterpenoids derived from the root of Salvia grandifolia
SO JOURNAL OF THE SERBIAN CHEMICAL SOCIETY
LA English
DT Article
DE statistical analysis; B3LYP/cc-pVDZ; linear regression
ID NATURAL-PRODUCT; CRYSTAL-STRUCTURE; NMR; IDENTIFICATION; B3LYP/CC-PVDZ;
   ENERGY; MODELS
AB The DFT method has become a promising alternative in the support of traditional NMR experimental techniques, comparing experimental data with theoretical data, thereby achieving accurate and satisfactory results. In the present study, the experimental data of two diterpenes were compared to the theoretical data obtained by the GIAO method, applying DFT at the B3LYP/cc-pVDZ and B3PW91/DGDZVP levels to verify the degree of correlation, significance and predictability of the models obtained with the purpose of proving which of the computational methods is the most efficient for this class of substances. The theoretical NMR values obtained at B3LYP/cc-pVDZ were the more satisfactory, showing better linear correlations, presenting greater degrees of adjustments, significance and predictability compared to the B3PW91/DGDZVP method. Thus, these values were used to define H-alpha and H-beta 1, 2, 3, 6 and 7 for diterpene 1 and 1, 2, 3, 6 and 7 for diterpene 2, which was not possible using experimental data. This showed that the quantum method used could help in the structural elucidation of natural products.
C1 [da Costa, Renato A.; Silva, Sebastiao G.; Silva, Silvana de O.; Alves, Claudio N.; Barros Brasil, Davi de S.] Fed Univ Para, Program Postgrad Chem, Rua Augusto Correa S-N, BR-66075900 Belem, Para, Brazil.
   [da Costa, Renato A.] Fed Inst Para, Rodovia 275,S-N Uniao, BR-68515000 Parauapebas, Para, Brazil.
   [Cruz, Jorddy N.] Fed Univ Para, Lab Preparat & Computat Nanomat, CP 479, BR-66075110 Belem, PA, Brazil.
   [Silva, Rai C.; Santos, Cleydson B. R.] Univ Fed Amapa, Lab Modeling & Computat Chem, BR-68902280 Macapa, Amapa, Brazil.
   [da Costa, Wanessa A.] Fed Univ Para, Program Postgrad Nat Resources Engn PRODERNA ITEC, Rua Augusto Correa S-N, BR-66075900 Belem, Para, Brazil.
   [dos Santos Brasil, Luciane S. N.] State Univ Para, Ctr Nat Sci & Technol CCNT, Dept Food Technol, Travessa Angustura 2219, BR-66087310 Belem, Para, Brazil.
RP da Costa, RA (corresponding author), Fed Univ Para, Program Postgrad Chem, Rua Augusto Correa S-N, BR-66075900 Belem, Para, Brazil.; da Costa, RA (corresponding author), Fed Inst Para, Rodovia 275,S-N Uniao, BR-68515000 Parauapebas, Para, Brazil.
EM renato.costa@ifpa.edu.br
RI Alves, Claudio N/P-8973-2014; Silva, Sebastiao/S-9772-2019; Cruz, Jorddy
   Neves/N-8524-2018; da Costa, Renato Araujo/AAP-3365-2020
OI Alves, Claudio N/0000-0001-6576-4229; Silva,
   Sebastiao/0000-0002-7348-4961; Cruz, Jorddy Neves/0000-0003-0529-3714;
   da Costa, Renato Araujo/0000-0002-4720-6116
CR [Anonymous], 2016, GAUSSIAN 16 REVISION
   Barreiro EJ, 1997, QUIM NOVA, V20, P300, DOI 10.1590/S0100-40421997000300011
   Brasil DSB, 2006, INT J QUANTUM CHEM, V106, P2706, DOI 10.1002/qua.21031
   Brasil DSB, 2008, INT J QUANTUM CHEM, V108, P2564, DOI 10.1002/qua.21673
   Brasil DSB, 2010, J BRAZIL CHEM SOC, V21, P731, DOI 10.1590/S0103-50532010000400021
   Cheeseman JR, 1996, J CHEM PHYS, V104, P5497, DOI 10.1063/1.471789
   Cimino P, 2004, MAGN RESON CHEM, V42, pS26, DOI 10.1002/mrc.1410
   Costa JD, 2018, QUIM NOVA, V41, P732, DOI 10.21577/0100-4042.20170239
   Da Costa R. A., 2017, J ENG TECHNOL IND AP, V3, P1, DOI [10.5935/2447-0228.20170003, DOI 10.5935/2447-0228.20170003]
   de Souza FS, 2015, QUIM NOVA, V38, P645, DOI 10.5935/0100-4042.20150057
   Gaudio AC, 2001, QUIM NOVA, V24, P658, DOI 10.1590/S0100-40422001000500013
   Kang J, 2015, PHYTOCHEMISTRY, V116, P337, DOI 10.1016/j.phytochem.2015.03.014
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   MIERTUS S, 1981, CHEM PHYS, V55, P117, DOI 10.1016/0301-0104(81)85090-2
   MIERTUS S, 1982, CHEM PHYS, V65, P239, DOI 10.1016/0301-0104(82)85072-6
   Santos CBR, 2014, MOLECULES, V19, P367, DOI 10.3390/molecules19010367
   Silva SD, 2012, J COMPUT THEOR NANOS, V9, P953, DOI 10.1166/jctn.2012.2123
   Silva SD, 2011, INT J MOL SCI, V12, P9389, DOI 10.3390/ijms12129389
   Xin DY, 2017, J ORG CHEM, V82, P5135, DOI 10.1021/acs.joc.7b00321
   Xin DY, 2017, ORG BIOMOL CHEM, V15, P928, DOI 10.1039/c6ob02450e
NR 20
TC 0
Z9 0
U1 0
U2 0
PU SERBIAN CHEMICAL SOC
PI BELGRADE
PA KARNEGIJEVA 4, 11 120 BELGRADE, SERBIA
SN 0352-5139
J9 J SERB CHEM SOC
JI J. Serb. Chem. Soc.
PY 2019
VL 84
IS 6
BP 591
EP 598
DI 10.2298/JSC180927081D
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA IH2TI
UT WOS:000474347000006
OA DOAJ Gold
DA 2020-12-09
ER

PT J
AU de Souza, GC
   Pereira, ACM
   Viana, MD
   Ferreira, AM
   da Silva, IDR
   de Oliveira, MMR
   Barbosa, WLR
   Silva, LB
   Ferreira, IM
   dos Santos, CBR
   Carvalho, JCT
AF de Souza, Gisele Custodio
   Matias Pereira, Arlindo Cesar
   Viana, Muller Duarte
   Ferreira, Adriana Maciel
   Ribeiro da Silva, Ianna Dias
   Rebelo de Oliveira, Monaliza Maia
   Ramos Barbosa, Wagner Luiz
   Silva, Luciane Barros
   Ferreira, Irlon Maciel
   Rodrigues dos Santos, Cleydson Breno
   Tavares Carvalho, Jose Carlos
TI Acmella oleracea (L) R. K. Jansen Reproductive Toxicity in Zebrafish: An
   In Vivo and In Silico Assessment
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
ID SPILANTHES-ACMELLA; DANIO-RERIO; ENDOCRINE DISRUPTION;
   HELIOPSIS-LONGIPES; JAPANESE MEDAKA; CHEMICAL-STRUCTURE; PARENTAL
   TRANSFER; DRUG-METABOLISM; EXPOSURE; EXTRACT
AB The plant species Acmella oleracea L. is used in the north of Brazil for the treatment of a range of illnesses, such as tuberculosis, flu, cough, and rheumatism and as an anti-inflammatory agent; besides, hydroethanolic formulations with this species are popularly used as a female aphrodisiac agent. However, currently, there are no studies performed evaluating its effect on embryonic development. Hence, this research aimed to evaluate the effects of the hydroethanolic extract of A. oleracea (EHFAo) on the reproductive performance (parental) and embryonic development (F1 generation) of zebrafish, at concentrations of 50, 100, and 200 g/L. Histopathology of parental gonads after 21 days of exposure to EHFAo reveals few alterations in the ovaries and testes, not impairing the reproduction; an increase of eggs deposition was observed in animals treated with EHFAo at the highest concentrations. Nevertheless, concerning the embryonic development of F1, teratogenic effects were observed including tail deformation, cardiac and yolk edema, scoliosis, and growth retardation; these alterations were more prominent in the groups born from progenitors exposed to the highest concentrations (100 and 200 g/L.); but only the occurrence of yolk and cardiac edema had a statistically significant difference when compared to the control group. The chromatographic analysis shows that spilanthol (affinin) was the primary compound found in the EHFAo. Hence, in silico assessment was performed to evaluate the pharmacokinetic and toxicological properties of this molecule and 37 metabolites derived from it. Overall, our data show that the treatment caused no detrimental changes in progenitors regarding their gonads or fertility but caused some potentially teratogenic activity in embryos, which may be due to the action of spilanthol's metabolites M3, M6, M7, M8, M16, M28, and M31.
C1 [de Souza, Gisele Custodio; Ferreira, Irlon Maciel; Rodrigues dos Santos, Cleydson Breno; Tavares Carvalho, Jose Carlos] Univ Fed Amapa, Colegiado Farm, Dept Ciencias Biol & Saude, Programa Posgrad Inovacao Farmaceut, Rodovia Juscelino Kubitschek,Km 02, BR-68902280 Macapa, AP, Brazil.
   [de Souza, Gisele Custodio; Matias Pereira, Arlindo Cesar; Viana, Muller Duarte; Ferreira, Adriana Maciel; Ferreira, Irlon Maciel; Tavares Carvalho, Jose Carlos] Univ Fed Amapa, Colegiado Farm, Dept Ciencias Biol & Saude, Lab Pesquisa Farmacos, Macapa, AP, Brazil.
   [Ribeiro da Silva, Ianna Dias; Rebelo de Oliveira, Monaliza Maia; Ramos Barbosa, Wagner Luiz] Univ Fed Para, Fac Farm, Programa Posgrad Ciencias Farmaceut, Belem, Para, Brazil.
   [Silva, Luciane Barros; Rodrigues dos Santos, Cleydson Breno] Univ Fed Amapa, Dept Ciencias Biol & Saude, Lab Modelagem & Quim Computac, Macapa, AP, Brazil.
RP Carvalho, JCT (corresponding author), Univ Fed Amapa, Colegiado Farm, Dept Ciencias Biol & Saude, Programa Posgrad Inovacao Farmaceut, Rodovia Juscelino Kubitschek,Km 02, BR-68902280 Macapa, AP, Brazil.; Carvalho, JCT (corresponding author), Univ Fed Amapa, Colegiado Farm, Dept Ciencias Biol & Saude, Lab Pesquisa Farmacos, Macapa, AP, Brazil.
EM custodio_gisele@yahoo.com.br; arlindo.bio@outlook.com;
   mvianna987@gmail.com; adrianmaciel@gmail.com; iannadrs@gmail.com;
   monalizamaia@yahoo.com.br; zweigw@gmail.com; luciaanebarros@hotmail.com;
   irlon.ferreira@gmail.com; breno@unifap.br; farmacos@unifap.br
RI Barbosa, Wagner Luiz R/S-3055-2016; Pereira, Arlindo Cesar
   Matias/AAD-3949-2019; Barbosa, Wagner/AAE-8154-2020
OI Pereira, Arlindo Cesar Matias/0000-0001-9504-5081; Barbosa,
   Wagner/0000-0002-2421-8245
FU CAPESCAPES [3292/2013 AUXPE]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [402332/2013-0]
FX The authors would like to thank CAPES (no. 3292/2013 AUXPE) and CNPq
   Proc. 402332/2013-0.
CR Abeysiri GRPI, 2013, IND CROP PROD, V50, P852, DOI 10.1016/j.indcrop.2013.08.043
   Ajay, 1999, J MED CHEM, V42, P4942, DOI 10.1021/jm990017w
   Aluru N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010741
   [Anonymous], 2012, GID 229 FISH SHORT T
   [Anonymous], 2013, GUID 236 FISH EMBR A
   ASHBY J, 1989, MUTAT RES, V223, P73, DOI 10.1016/0165-1218(89)90037-2
   Ashby J, 1995, TOXICOLOGY, V103, P177, DOI 10.1016/0300-483X(95)03132-Y
   Blazer VS, 2002, FISH PHYSIOL BIOCHEM, V26, P85, DOI 10.1023/A:1023332216713
   Blazquez M, 1998, FISH PHYSIOL BIOCHEM, V18, P37, DOI 10.1023/A:1007736110663
   Boonen J, 2010, J PHARMACEUT BIOMED, V53, P243, DOI 10.1016/j.jpba.2010.02.010
   Boonen J, 2010, J ETHNOPHARMACOL, V127, P77, DOI 10.1016/j.jep.2009.09.046
   Cao FJ, 2019, SCI TOTAL ENVIRON, V646, P595, DOI 10.1016/j.scitotenv.2018.07.331
   Castro VLSS, 2013, USO ANIMAIS EXPT LEG, P27
   Christianson-Heiska I, 2007, COMP BIOCHEM PHYS C, V145, P518, DOI 10.1016/j.cbpc.2007.01.016
   CHUNG FL, 1988, J ORG CHEM, V53, P14, DOI 10.1021/jo00236a004
   Cilia-Lopez VG, 2010, PHARM BIOL, V48, P195, DOI 10.3109/13880200903078495
   Coimbra AM, 2007, B ENVIRON CONTAM TOX, V79, P488, DOI 10.1007/s00128-007-9288-2
   Coimbra AM, 2005, B ENVIRON CONTAM TOX, V75, P407, DOI 10.1007/s00128-005-0768-y
   da Rocha CF, 2018, J ETHNOPHARMACOL, V214, P301, DOI 10.1016/j.jep.2017.12.024
   de Freitas-Blanco VS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162850
   De Spiegeleer B, 2013, J ETHNOPHARMACOL, V148, P117, DOI 10.1016/j.jep.2013.03.076
   DEARFIELD KL, 1991, MUTAGENESIS, V6, P519, DOI 10.1093/mutage/6.6.519
   Deciga-Campos M, 2012, DRUG DEVELOP RES, V73, P130, DOI 10.1002/ddr.21002
   Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1
   Di Stasi L. C., 2002, PLANTAS MED AMAZONIA
   Dias AMA, 2012, J SUPERCRIT FLUID, V61, P62, DOI 10.1016/j.supflu.2011.09.020
   Du J, 2018, REGUL TOXICOL PHARM, V98, P41, DOI 10.1016/j.yrtph.2018.07.005
   Dubey S, 2013, ADV PHARMACOL SCI, V2013, DOI 10.1155/2013/423750
   Farias IV, 2018, PHYTOCHEM LETT, V27, P187, DOI 10.1016/j.phytol.2018.07.004
   Favoreto R., 2010, REV FITOS, V5, P83
   Forsatkar MN, 2018, PHARM BIOL, V56, P60, DOI 10.1080/13880209.2017.1421234
   Galus M, 2014, AQUAT TOXICOL, V151, P124, DOI 10.1016/j.aquatox.2014.01.016
   Gardiner T. H., 1993, PATTYS IND HYGIENE A, V2, P329
   Gerbino A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156021
   Gray MA, 1999, ENVIRON TOXICOL CHEM, V18, P1835, DOI [10.1897/1551-5028(1999)018&lt;1835:FATDOT&gt;2.3.CO;2, 10.1002/etc.5620180834]
   Hajdu A., 2014, ETHNOPHARMACOLOGICAL
   Han J, 2014, AQUAT TOXICOL, V150, P66, DOI 10.1016/j.aquatox.2014.02.020
   Hernandez I, 2009, J ETHNOPHARMACOL, V124, P649, DOI 10.1016/j.jep.2009.04.060
   Hoo JY, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9732780
   J. L. Schardein, 2000, CHEM INDUCED BIRTH D, P819
   Jacobson M, 1957, CHEM IND, V12, P50
   Ji K, 2013, ENVIRON SCI TECHNOL, V47, P8793, DOI 10.1021/es400329t
   Kanerva L., 1996, IRRITANT CONTACT DER, P127
   Kaptaner B, 2011, ENVIRON TOXICOL, V26, P610, DOI 10.1002/tox.20585
   KASAMAKI A, 1982, MUTAT RES, V105, P387, DOI 10.1016/0165-7992(82)90181-6
   Kiparissis Y, 2003, ENVIRON HEALTH PERSP, V111, P1158, DOI 10.1289/ehp.5928
   Kirchmair J, 2015, NAT REV DRUG DISCOV, V14, P387, DOI 10.1038/nrd4581
   Lorenzi H, 2002, PLANTAS MEDIS DO BRA
   Lu ZG, 2014, REPROD TOXICOL, V47, P33, DOI 10.1016/j.reprotox.2014.05.015
   Metcalfe CD, 2001, ENVIRON TOXICOL CHEM, V20, P297, DOI [10.1897/1551-5028(2001)020&lt;0297:EPOCDI&gt;2.0.CO;2, 10.1002/etc.5620200210]
   Mills LJ, 2005, SCI TOTAL ENVIRON, V343, P1, DOI 10.1016/j.scitotenv.2004.12.070
   Moreno SC, 2012, PEST MANAG SCI, V68, P386, DOI 10.1002/ps.2274
   NAGAHAMA Y, 1983, FISH PHYSIOL, V9, P223
   NAKATANI N, 1992, BIOSCI BIOTECH BIOCH, V56, P759, DOI 10.1271/bbb.56.759
   National Toxicology Program (NTP), 1994, BON MARR MICR STUD S
   National Toxicology Program (NTP), 1999, BON MARR MICR STUD S
   National Toxicology Program (NTP), 1998, PER BLOOD MICR STUD
   NEUDECKER T, 1989, MUTAT RES, V227, P131, DOI 10.1016/0165-7992(89)90009-2
   OECD, 2010, OECD ENV HLTH SAF PU, V123, P1
   Orn S, 2006, ARCH ENVIRON CON TOX, V51, P237, DOI 10.1007/s00244-005-0103-y
   Parkinson A., 2007, BIOTRANSFORMATION XE
   Patai S., 2010, CHEM ALKENES, V1, P469
   Paulraj J, 2013, ADV PHARMACOL SCI, V2013, DOI 10.1155/2013/510298
   Prachayasittikul V, 2013, EXCLI J, V12, P291
   PRATT W, 1990, PRINCIPLES DRUG ACTI
   Raine JC, 2016, B ENVIRON CONTAM TOX, V97, P331, DOI 10.1007/s00128-016-1849-9
   Ramchandani VA, 2013, ALCOHOL NUTR HLTH CO, P15, DOI DOI 10.1007/978-1-62703-047-2
   Ramsewak RS, 1999, PHYTOCHEMISTRY, V51, P729, DOI 10.1016/S0031-9422(99)00101-6
   Ratnasooriya WD, 2004, J ETHNOPHARMACOL, V91, P317, DOI 10.1016/j.jep.2004.01.006
   Sadym A, 2003, SAR QSAR ENVIRON RES, V14, P339, DOI 10.1080/10629360310001623935
   Saley A, 2016, ZEBRAFISH, V13, P399, DOI 10.1089/zeb.2016.1257
   SANDERSON DM, 1991, HUM EXP TOXICOL, V10, P261, DOI 10.1177/096032719101000405
   Santos I.V.F., 2018, HISTOPATHOLOGY ZEBRA
   SHARMA A, 2012, AM J PLANT SCI, V3, P1568, DOI DOI 10.4236/ajps.2012.311189
   Sharma V, 2011, PHYTOMEDICINE, V18, P1161, DOI 10.1016/j.phymed.2011.06.001
   Sies H, 1988, GLUTATHIONE CONJUGAT
   Sim E, 2014, BRIT J PHARMACOL, V171, P2705, DOI 10.1111/bph.12598
   Singh M, 2012, BIOPROC BIOSYST ENG, V35, P943, DOI 10.1007/s00449-012-0679-3
   SINGH S, 1993, MED RES REV, V13, P569, DOI 10.1002/med.2610130504
   Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336
   Souza GC, 2016, J NANOMEDICINE RES, V4, P18, DOI DOI 10.15406/JNMR.2016.04.00093
   Storey Christine, 1997, Acta Amazonica, V27, P175
   Taina S., 2009, DRUG METABOLISM DISP, V37
   Thomas JK, 2014, AQUAT TOXICOL, V152, P20, DOI 10.1016/j.aquatox.2014.03.022
   Tiwari Kishan Lal, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P1170
   Veryser L., 2016, BMC COMPLEM ALTERN M, V16, P1
   Vijendra N, 2010, AFR J PHARM PHARMACO, V4, P662
   VILLACHICA H, 1996, FRUTALES HORTALIZAS
   Wang QW, 2015, ENVIRON SCI TECHNOL, V49, P5123, DOI 10.1021/acs.est.5b00558
   Weber LP, 2003, AQUAT TOXICOL, V63, P431, DOI 10.1016/S0166-445X(02)00208-4
   Wood AW, 2001, BIOL REPROD, V64, P264, DOI 10.1095/biolreprod64.1.264
   Wu LC, 2008, J AGR FOOD CHEM, V56, P2341, DOI 10.1021/jf073057e
   Xu QL, 2017, AQUAT TOXICOL, V182, P163, DOI 10.1016/j.aquatox.2016.11.019
   Yadav R, 2011, INT J PHARM PHARM SC, V3, P245
   Yang LX, 2009, REPROD TOXICOL, V28, P245, DOI 10.1016/j.reprotox.2009.04.013
   Yin ES, 2015, BIOMETALS, V28, P783, DOI 10.1007/s10534-015-9855-7
   Rios MY, 2014, STUD NAT PROD CHEM, V43, P79, DOI 10.1016/B978-0-444-63430-6.00003-5
   Yu LQ, 2017, ENVIRON POLLUT, V220, P196, DOI 10.1016/j.envpol.2016.09.039
   Zillioux EJ, 2001, ENVIRON TOXICOL CHEM, V20, P1968, DOI 10.1002/etc.5620200915
NR 99
TC 6
Z9 6
U1 0
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PY 2019
VL 2019
AR 1237301
DI 10.1155/2019/1237301
PG 19
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA HP4DT
UT WOS:000461627300001
PM 30941185
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Costa, JD
   Ramos, RD
   Costa, KDL
   Brasil, DDB
   da Silva, CHTD
   Ferreira, EFB
   Borges, RD
   Campos, JM
   Macedo, WJD
   dos Santos, CBR
AF Costa, Josivan da Silva
   Ramos, Ryan da Silva
   Lopes Costa, Karina da Silva
   Barros Brasil, Davi do Socorro
   Tomich de Paula da Silva, Carlos Henrique
   Batista Ferreira, Elenilze Figueiredo
   Borges, Rosivaldo dos Santos
   Campos, Joaquin Maria
   da Cruz Macedo, Williams Jorge
   Rodrigues dos Santos, Cleydson Breno
TI An In Silico Study of the Antioxidant Ability for Two Caffeine Analogs
   Using Molecular Docking and Quantum Chemical Methods
SO MOLECULES
LA English
DT Article
DE antioxidant potential; molecular descriptors; molecular docking; binding
   free energy; free radicals; oxidative stress
ID STATISTICAL-ANALYSIS; CYTOCHROME P4502C9; CRYSTAL-STRUCTURE; OXIDATIVE
   STRESS; DIPOLE-MOMENT; DERIVATIVES; CANCER; MECHANISMS; SOFTNESS;
   HARDNESS
AB The antioxidant activity of molecules constitutes an important factor for the regulation of redox homeostasis and reduction of the oxidative stress. Cells affected by oxidative stress can undergo genetic alteration, causing structural changes and promoting the onset of chronic diseases, such as cancer. We have performed an in silico study to evaluate the antioxidant potential of two molecules of the zinc database: ZINC08706191 (Z91) and ZINC08992920 (Z20). Molecular docking, quantum chemical calculations (HF/6-31G**) and Pearson's correlation have been performed. Molecular docking results of Z91 and Z20 showed both the lower binding affinity (BA) and inhibition constant (Ki) values for the receptor-ligand interactions in the three tested enzymes (cytochrome P450CP450, myeloperoxidase-MP and NADPH oxidase-NO) than the control molecules (5-fluorouracil-FLU, melatonin-MEL and dextromethorphan-DEX, for each receptor respectively). Molecular descriptors were correlated with Ki and strong correlations were observed for the CP450, MP and NO receptors. These and other results attest the significant antioxidant ability of Z91 and Z20, that may be indicated for further analyses in relation to the control of oxidative stress and as possible antioxidant agents to be used in the pharmaceutical industry.
C1 [Costa, Josivan da Silva; Borges, Rosivaldo dos Santos; da Cruz Macedo, Williams Jorge] Fed Univ Para, Postgrad Program Biotechnol & Biodivers Network B, Rua Augusto Correa 01, BR-66075110 Belem, Para, Brazil.
   [Costa, Josivan da Silva; Ramos, Ryan da Silva; Lopes Costa, Karina da Silva; Batista Ferreira, Elenilze Figueiredo; Rodrigues dos Santos, Cleydson Breno] Univ Fed Amapa, Dept Biol Sci, Lab Modeling & Computat Chem, Rod Juscelino Kubitschek,Km 02 S-N, BR-68902280 Macapa, Amapa, Brazil.
   [Costa, Josivan da Silva; Ramos, Ryan da Silva; da Cruz Macedo, Williams Jorge; Rodrigues dos Santos, Cleydson Breno] Fed Rural Univ Amazonia, Lab Mol Modeling & Simulat Syst, Rua Joao Pessoa 121, BR-68700030 Capanema, Para, Brazil.
   [Barros Brasil, Davi do Socorro] Fed Univ Para, Inst Technol, Av Augusto Correa 01, BR-66075900 Belem, Para, Brazil.
   [Tomich de Paula da Silva, Carlos Henrique] Fac Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, BR-14040903 Sao Paulo, Brazil.
   [Campos, Joaquin Maria; Rodrigues dos Santos, Cleydson Breno] Univ Granada, Dept Pharmaceut & Organ Chem, Campus Cartuja, E-18071 Granada, Spain.
RP dos Santos, CBR (corresponding author), Univ Fed Amapa, Dept Biol Sci, Lab Modeling & Computat Chem, Rod Juscelino Kubitschek,Km 02 S-N, BR-68902280 Macapa, Amapa, Brazil.; dos Santos, CBR (corresponding author), Fed Rural Univ Amazonia, Lab Mol Modeling & Simulat Syst, Rua Joao Pessoa 121, BR-68700030 Capanema, Para, Brazil.; dos Santos, CBR (corresponding author), Univ Granada, Dept Pharmaceut & Organ Chem, Campus Cartuja, E-18071 Granada, Spain.
EM josivan.chemistry@gmail.com; ryanquimico@hotmail.com;
   karinalopesfarm@gmail.com; davibb@ufpa.br; tomich@fcfrp.usp.br;
   elenilze@yahoo.com.br; lqfmed@gmail.com; jmcampos@ugr.es;
   williams.macedo@ufra.edu.br; breno@unifap.br
RI Rosa, Joaquin/L-8436-2014; Borges, Rosivaldo RSB/K-4807-2016; Borges,
   Rosivaldo/U-3039-2019; Ramos, Ryan/X-5824-2019; Silva, Carlos H T
   P/J-3695-2015; da Silva Costa, Josivan/AAA-9565-2020
OI Rosa, Joaquin/0000-0002-9035-8123; Borges,
   Rosivaldo/0000-0003-4072-7573; Ramos, Ryan/0000-0003-1802-1320; Silva,
   Carlos H T P/0000-0001-6049-3650; da Silva Costa,
   Josivan/0000-0001-5069-5283; Macedo, Williams/0000-0002-0457-6993;
   Rodrigues dos Santos, Cleydson Breno/0000-0002-0271-335X
FU Postgraduate Program in Biodiversity and Biotechnology of Amazon
   (PPG-Bionorte), Paraense Museum Emilio Goeldi (MPEG); PROPESP/UFPA
FX We acknowledge the Postgraduate Program in Biodiversity and
   Biotechnology of Amazon (PPG-Bionorte), Paraense Museum Emilio Goeldi
   (MPEG). Laboratory of Molecular Modeling and Simulation System of
   Federal Rural University of Amazonia (UFRA-Brazil) and Laboratory of
   Modeling and Computational Chemistry of Federal University of Amapa by
   computational and methodological support. Finally, financial support
   provided by the PROPESP/UFPA is greatly acknowledged.
CR Akbas E, 2018, J MOL STRUCT, V1174, P177, DOI 10.1016/j.molstruc.2018.02.080
   Allegra M, 2001, BIOCHEM BIOPH RES CO, V282, P380, DOI 10.1006/bbrc.2001.4582
   ANH NT, 1980, TOP CURR CHEM, V88, P145
   Bandari SK, 2017, BIOORG MED CHEM LETT, V27, P1256, DOI 10.1016/j.bmcl.2017.01.047
   Bassindale AR, 1998, CHEM FUNCT, V2, P495, DOI 10.1002/0470857250.ch9
   Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808
   Cadenas E, 1997, BIOFACTORS, V6, P391, DOI 10.1002/biof.5520060404
   CARTER GW, 1991, J PHARMACOL EXP THER, V256, P929
   COOK G, 1995, AM J PHYS, V63, P737, DOI 10.1119/1.17844
   Costa JD, 2018, QUIM NOVA, V41, P732, DOI 10.21577/0100-4042.20170239
   Costa JD, 2018, CURR PHARM DESIGN, V24, P576, DOI 10.2174/1381612823666170711112510
   Cruz JV, 2018, J MOL MODEL, V24, DOI 10.1007/s00894-018-3756-y
   Cruz JV, 2018, MOLECULES, V23, DOI 10.3390/molecules23020453
   Cunha EL, 2015, J COMPUT THEOR NANOS, V12, P3682, DOI [10.1166/jctn.2015.4260, DOI 10.1166/jctn.2015.4260, DOI 10.1166/JCTN.2015.4260]
   da Silva AA, 2010, CIENC RURAL, V40, P994, DOI 10.1590/S0103-84782010005000037
   Dharmaraja AT, 2017, J MED CHEM, V60, P3221, DOI 10.1021/acs.jmedchem.6b01243
   Dzialo M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020160
   Farasat M, 2016, J MOL STRUCT, V1108, P341, DOI 10.1016/j.molstruc.2015.12.044
   Galijasevic S, 2008, BIOCHEMISTRY-US, V47, P2668, DOI 10.1021/bi702016q
   Ghanty TK, 2000, J PHYS CHEM A, V104, P2975, DOI 10.1021/jp993830b
   Gowthaman U, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S14
   Grant G.H., 1996, COMPUTATIONAL CHEM, P1
   Gubskaya AV, 2002, J CHEM PHYS, V117, P5290, DOI 10.1063/1.1501122
   Gunes A, 2006, BASIC CLIN PHARMACOL, V98, P197, DOI 10.1111/j.1742-7843.2006.pto_304.x
   Gupta M, 2018, COMPUT BIOL CHEM, V76, P210, DOI 10.1016/j.compbiolchem.2018.06.005
   Gur M, 2017, J MOL STRUCT, V1134, P40, DOI 10.1016/j.molstruc.2016.12.041
   Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n
   Job G, 2006, EUR J PHYS, V27, P353, DOI 10.1088/0143-0807/27/2/018
   Kaya S, 2015, COMPUT THEOR CHEM, V1060, P66, DOI 10.1016/j.comptc.2015.03.004
   Liu PH, 1995, J CHEM PHYS, V103, P10597, DOI 10.1063/1.469844
   Liu SL, 2009, CARDIOVASC RES, V82, P161, DOI 10.1093/cvr/cvp043
   Lountos GT, 2006, BIOCHEMISTRY-US, V45, P9648, DOI 10.1021/bi060692p
   Malik UZ, 2011, FREE RADICAL BIO MED, V51, P179, DOI 10.1016/j.freeradbiomed.2011.04.004
   Mihciokur O, 2017, J MOL STRUCT, V1149, P27, DOI 10.1016/j.molstruc.2017.07.064
   Mohan C., 2013, INTRO INHIBITORS THE, P1
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   NALEWAJSKI RF, 1988, INT J QUANTUM CHEM, P349
   Niu HD, 2017, EUR J MED CHEM, V138, P212, DOI 10.1016/j.ejmech.2017.06.033
   Padilha EC, 2016, J BRAZIL CHEM SOC, V27, P1636, DOI 10.5935/0103-5053.20160043
   Panayiotou C, 2017, J CHEM THERMODYN, V111, P207, DOI 10.1016/j.jct.2017.03.035
   Pereira ALE, 2018, J BIOMOL STRUCT DYN, V36, P318, DOI 10.1080/07391102.2016.1277163
   Reinisalo M, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/340520
   Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006
   dos Santos CBR, 2018, J ETHNOPHARMACOL, V222, P107, DOI 10.1016/j.jep.2018.04.041
   Rogozin EA, 2008, CARCINOGENESIS, V29, P1228, DOI 10.1093/carcin/bgn016
   Roy J, 2017, FASEB J, V31, P3729, DOI 10.1096/fj.201700170R
   Santos CBR, 2014, MOLECULES, V19, P367, DOI 10.3390/molecules19010367
   Saul D, 2017, BONE, V101, P134, DOI 10.1016/j.bone.2017.04.011
   Silva RC, 2019, J SERB CHEM SOC, V84, P153, DOI 10.2298/JSC180129047S
   StatSoft Inc, 2004, STATISTICA DAT AN SO
   TARAZONA MP, 1995, J CHEM EDUC, V72, P882, DOI 10.1021/ed072p882
   Fujishima MAT, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11030072
   Tognetti V, 2015, CHEM PHYS LETT, V635, P111, DOI 10.1016/j.cplett.2015.05.057
   Urbaniak A, 2017, CR CHIM, V20, P1072, DOI 10.1016/j.crci.2017.08.003
   Vieira JB, 2014, MOLECULES, V19, P10670, DOI 10.3390/molecules190810670
   Viloria JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01498-6
   White PAS, 2014, MOLECULES, V19, P14496, DOI 10.3390/molecules190914496
   Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862
   Wu TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046067
   YALKOWSKY SH, 1979, J CHEM ENG DATA, V24, P127, DOI 10.1021/je60081a021
   YANG W, 1985, J PHYS CHEM-US, V89, P5412, DOI 10.1021/j100271a019
   Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004
   Zhang G, 2007, J PHYS CHEM A, V111, P1554, DOI 10.1021/jp061633o
NR 63
TC 8
Z9 8
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD NOV
PY 2018
VL 23
IS 11
AR 2801
DI 10.3390/molecules23112801
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HC2OO
UT WOS:000451641900073
PM 30380600
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Cruz, JV
   Serafim, RB
   da Silva, GM
   Giuliatti, S
   Rosa, JMC
   Neto, MFA
   Leite, FHA
   Taft, CA
   da Silva, CHTP
   Santos, CBR
AF Cruz, Josiane, V
   Serafim, Rodolfo B.
   da Silva, Gabriel M.
   Giuliatti, Silvana
   Rosa, Joaquin M. C.
   Araujo Neto, Moyses F.
   Leite, Franco H. A.
   Taft, Carlton A.
   da Silva, Carlos H. T. P.
   Santos, Cleydson B. R.
TI Computational design of new protein kinase 2 inhibitors for the
   treatment of inflammatory diseases using QSAR,
   pharmacophore-structure-based virtual screening, and molecular dynamics
SO JOURNAL OF MOLECULAR MODELING
LA English
DT Article
DE Anti-inflammatory drugs; Molecular dynamics; Pharmacokinetic; RIPK2;
   Toxicological
ID QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; CONTINUUM SOLVENT; ARTEMISININ;
   DERIVATIVES; DISCOVERY; PROGRAM
AB Receptor-interacting protein kinase 2 (RIPK2) plays an essential role in autoimmune response and is suggested as a target for inflammatory diseases. A pharmacophore model was built from a dataset with ponatinib (template) and 18 RIPK2 inhibitors selected from BindingDB database. The pharmacophore model validation was performed by multiple linear regression (MLR). The statistical quality of the model was evaluated by the correlation coefficient (R), squared correlation coefficient (R (2)), explanatory variance (adjusted R (2)), standard error of estimate (SEE), and variance ratio (F). The best pharmacophore model has one aromatic group (LEU24 residue interaction) and two hydrogen bonding acceptor groups (MET98 and TYR97 residues interaction), having a score of 24.739 with 14 aligned inhibitors, which were used in virtual screening via ZincPharmer server and the ZINC database (selected in function of the RMSD value). We determined theoretical values of biological activity (logRA) by MLR, pharmacokinetic and toxicology properties, and made molecular docking studies comparing binding affinity (kcal/mol) results with the most active compound of the study (ponatinib) and WEHI-345. Nine compounds from the ZINC database show satisfactory results, yielding among those selected, the compound ZINC01540228, as the most promising RIPK2 inhibitor. After binding free energy calculations, the following molecular dynamics simulations showed that the receptor protein's backbone remained stable after the introduction of ligands.
C1 [Cruz, Josiane, V; Santos, Cleydson B. R.] Univ Fed Amapa, Programa Posgad Ciencias Farmaceut, BR-68902280 Macapa, Amapa, Brazil.
   [Cruz, Josiane, V; Santos, Cleydson B. R.] Univ Fed Amapa, Dept Ciencias Biol, Lab Modelagem & Quim Computac, BR-68902280 Macapa, Amapa, Brazil.
   [Serafim, Rodolfo B.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049900 Sao Paulo, Brazil.
   [da Silva, Gabriel M.; Giuliatti, Silvana] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Grp Bioinformat, BR-14049900 Sao Paulo, Brazil.
   [Rosa, Joaquin M. C.] Univ Granada, Fac Pharm, Dept Pharmaceut & Organ Chem, Campus Cartuja S-N, E-18071 Granada, Spain.
   [Araujo Neto, Moyses F.; Leite, Franco H. A.] Univ Estadual Feira de Santana, Lab Modelagem Mol, BR-44036900 Feira De Santana, BA, Brazil.
   [Taft, Carlton A.] Ctr Brasileiro Pesquisas Fis, Rua Dr Xavier Sigaud, BR-22290180 Rio De Janeiro, Brazil.
   [da Silva, Carlos H. T. P.; Santos, Cleydson B. R.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Lab Quim Farmaceut Computac, BR-14040020 Ribeirao Preto, SP, Brazil.
RP Cruz, JV; Santos, CBR (corresponding author), Univ Fed Amapa, Programa Posgad Ciencias Farmaceut, BR-68902280 Macapa, Amapa, Brazil.; Cruz, JV; Santos, CBR (corresponding author), Univ Fed Amapa, Dept Ciencias Biol, Lab Modelagem & Quim Computac, BR-68902280 Macapa, Amapa, Brazil.; Santos, CBR (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Lab Quim Farmaceut Computac, BR-14040020 Ribeirao Preto, SP, Brazil.
EM josianeviana2007@gmail.com; breno@unifap.br
RI Giuliatti, Silvana/E-4715-2013; Silva, Carlos H T P/J-3695-2015; Leite,
   Franco Henrique/AAV-2818-2020
OI Giuliatti, Silvana/0000-0002-7520-6420; Silva, Carlos H T
   P/0000-0001-6049-3650; Serafim, Rodolfo/0000-0002-8884-2303; Monteiro da
   Silva, Gabriel/0000-0002-9665-7597
CR Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   AMES BN, 1972, P NATL ACAD SCI USA, V69, P3128, DOI 10.1073/pnas.69.11.3128
   [Anonymous], 2015, DISC STUD MOD ENV
   Barbosa JP, 2011, J SERB CHEM SOC, V76, P1263, DOI 10.2298/JSC111227111B
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Birck MG, 2016, QUIM NOVA, V39, P567, DOI 10.5935/0100-4042.20160065
   Canning P, 2015, CHEM BIOL, V22, P1174, DOI 10.1016/j.chembiol.2015.07.017
   Chorus AMJ, 2003, ANN RHEUM DIS, V62, P1178, DOI 10.1136/ard.2002.004861
   Cruz JV, 2018, MOLECULES, V23, DOI 10.3390/molecules23020453
   Cunha EL, 2015, J COMPUT THEOR NANOS, V12, P3682, DOI [10.1166/jctn.2015.4260, DOI 10.1166/jctn.2015.4260, DOI 10.1166/JCTN.2015.4260]
   Dassault Systemes BIOVIA, 2018, DISC STUD 4 0
   Ferreira Luis Roberto Fernandes, 2008, Fisioter. Pesqui., V15, P136, DOI 10.1590/S1809-29502008000200005
   Gilson MK, 2016, NUCLEIC ACIDS RES, V44, pD1045, DOI 10.1093/nar/gkv1072
   Gupta S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/291214
   Harris PA, 2013, ACS MED CHEM LETT, V4, P1238, DOI 10.1021/ml400382p
   da Mota LMH, 2015, REV BRAS REUMATOL, V55, P512, DOI 10.1016/j.rbr.2015.08.004
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jayaram B, 1998, J PHYS CHEM B, V102, P9571, DOI 10.1021/jp982007x
   Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378
   Lemkul JA, 2010, J CHEM INF MODEL, V50, P2221, DOI 10.1021/ci100335w
   Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w
   Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Nachbur U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7442
   Najjar M, 2015, CELL REP, V10, P1850, DOI 10.1016/j.celrep.2015.02.052
   Ou-Yang SS, 2012, ACTA PHARMACOL SIN, V33, P1131, DOI 10.1038/aps.2012.109
   Panus PC, 2011, PHARM PHYS THERAPIST
   Pereira ALE, 2018, J BIOMOL STRUCT DYN, V36, P318, DOI 10.1080/07391102.2016.1277163
   dos Santos CBR, 2018, J ETHNOPHARMACOL, V222, P107, DOI 10.1016/j.jep.2018.04.041
   dos Santos CBR, 2015, CURR PHARM DESIGN, V21, P4112, DOI 10.2174/1381612821666150528121423
   Santos CBR, 2014, MOLECULES, V19, P367, DOI 10.3390/molecules19010367
   Schneidman-Duhovny D, 2008, J COMPUT BIOL, V15, P737, DOI 10.1089/cmb.2007.0130
   Schneidman-Duhovny D, 2008, NUCLEIC ACIDS RES, V36, pW223, DOI 10.1093/nar/gkn187
   Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f
   Silva NSR, 2015, BRIT J PHARM RES, V7, P247, DOI 10.9734/BJPR/2015/17591
   Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+
   Statsoft Inc, 2004, STATISTICA DAT AN SO
   Tijhuis GJ, 2001, RHEUMATOLOGY, V40, P1112, DOI 10.1093/rheumatology/40.10.1112
   vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047
   Vieira JB, 2014, MOLECULES, V19, P10670, DOI 10.3390/molecules190810670
   Xie T, 2013, CELL REP, V5, P70, DOI 10.1016/j.celrep.2013.08.044
   Yamashita S, 2000, EUR J PHARM SCI, V10, P195, DOI 10.1016/S0928-0987(00)00076-2
NR 42
TC 9
Z9 9
U1 1
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1610-2940
EI 0948-5023
J9 J MOL MODEL
JI J. Mol. Model.
PD SEP
PY 2018
VL 24
IS 9
AR 225
DI 10.1007/s00894-018-3756-y
PG 16
WC Biochemistry & Molecular Biology; Biophysics; Chemistry,
   Multidisciplinary; Computer Science, Interdisciplinary Applications
SC Biochemistry & Molecular Biology; Biophysics; Chemistry; Computer
   Science
GA GP8BD
UT WOS:000441133700002
PM 30088101
DA 2020-12-09
ER

PT J
AU Fujishima, MAT
   da Silva, NDR
   Ramos, RD
   Ferreira, EFB
   dos Santos, KLB
   da Silva, CHTD
   da Silva, JO
   Rosa, JMC
   dos Santos, CBR
AF Teles Fujishima, Mayara Amoras
   Raulino da Silva, Nayara dos Santos
   Ramos, Ryan da Silva
   Batista Ferreira, Elenilze Figueiredo
   Belem dos Santos, Kelton Luis
   Tomich de Paula da Silva, Carlos Henrique
   da Silva, Jocivania Oliveira
   Campos Rosa, Joaquin Maria
   Rodrigues dos Santos, Cleydson Breno
TI An Antioxidant Potential, Quantum-Chemical and Molecular Docking Study
   of the Major Chemical Constituents Present in the Leaves of Curatella
   americana Linn
SO PHARMACEUTICALS
LA English
DT Article
DE Curatella americana L.; natural antioxidant; quantum chemical; xanthine
   oxidase
ID XANTHINE-OXIDASE; CRYSTAL-STRUCTURE; INHIBITION; FLAVONOIDS; DENSITY;
   ENERGY; VALIDATION; REACTIVITY; CHEMISTRY; RADICALS
AB Reactive oxygen species (ROS) are continuously generated in the normal biological systems, primarily by enzymes as xanthine oxidase (XO). The inappropriate scavenging or inhibition of ROS has been considered to be linked with aging, inflammatory disorders, and chronic diseases. Therefore, many plants and their products have been investigated as natural antioxidants for their potential use in preventive medicine. The leaves and bark extracts of Curatella americana Linn. were described in scientific research as anti-inflammatory, vasodilator, anti-ulcerogenic, and hypolipidemic effects. So, the aim of this study was to evaluate the antioxidant potentials of leaf hydroalcoholic extract from C. americana (HECA) through the scavenging DPPH assay and their main chemical constituents, evaluated by the following quantum chemical approaches (DFT B3LYP/6-31G**): Maps of Molecular Electrostatic Potential (MEP), Frontier Orbital's (HOMO and LUMO) followed by multivariate analysis and molecular docking simulations with the xanthine oxidase enzyme. The hydroalcoholic extract showed significant antioxidant activity by free radical scavenging probably due to the great presence of flavonoids, which were grouped in the PCA and HCA analysis with the standard gallic acid. In the molecular docking study, the compounds studied presented the binding free energy (G) values close each other, due to the similar interactions with amino acids residues at the activity site. The descriptors Gap and softness were important to characterize the molecules with antioxidant potential by capturing oxygen radicals.
C1 [Teles Fujishima, Mayara Amoras; Batista Ferreira, Elenilze Figueiredo; da Silva, Jocivania Oliveira; Rodrigues dos Santos, Cleydson Breno] Univ Fed Amapa, Posgrad Program Pharmaceut Innovat, BR-68902280 Macapa, AP, Brazil.
   [Teles Fujishima, Mayara Amoras; Raulino da Silva, Nayara dos Santos; Ramos, Ryan da Silva; Batista Ferreira, Elenilze Figueiredo; Belem dos Santos, Kelton Luis; Rodrigues dos Santos, Cleydson Breno] Univ Fed Amapa, Dept Biol & Hlth Sci, Lab Modeling & Computat Chem, BR-68902280 Macapa, AP, Brazil.
   [Teles Fujishima, Mayara Amoras; da Silva, Jocivania Oliveira] Univ Fed Amapa, Dept Biol & Hlth Sci, Lab Toxicol, BR-68902280 Macapa, AP, Brazil.
   [Tomich de Paula da Silva, Carlos Henrique] Fac Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, BR-14040903 Sao Paulo, Brazil.
   [Campos Rosa, Joaquin Maria; Rodrigues dos Santos, Cleydson Breno] Univ Granada, Dept Pharmaceut Organ Chem, E-18071 Granada, Spain.
RP dos Santos, CBR (corresponding author), Univ Fed Amapa, Posgrad Program Pharmaceut Innovat, BR-68902280 Macapa, AP, Brazil.; dos Santos, CBR (corresponding author), Univ Fed Amapa, Dept Biol & Hlth Sci, Lab Modeling & Computat Chem, BR-68902280 Macapa, AP, Brazil.; dos Santos, CBR (corresponding author), Univ Granada, Dept Pharmaceut Organ Chem, E-18071 Granada, Spain.
EM mayarafuji@hotmail.com; nsraulino@gmail.com; ryanquimico@hotmail.com;
   elenilze@yahoo.com.br; keltonbelem@hotmail.com; tomich@fcfrp.usp.br;
   jocivania@unifap.br; jmcampos@ugr.es; breno@unifap.br
RI Rosa, Joaquin/L-8436-2014; Silva, Carlos H T P/J-3695-2015; Ramos,
   Ryan/X-5824-2019
OI Rosa, Joaquin/0000-0002-9035-8123; Silva, Carlos H T
   P/0000-0001-6049-3650; Ramos, Ryan/0000-0003-1802-1320
CR Alexandre-Moreira MS, 1999, J ETHNOPHARMACOL, V67, P171, DOI 10.1016/S0378-8741(99)00009-4
   Almeida IF, 2015, J PHOTOCH PHOTOBIO B, V144, P28, DOI 10.1016/j.jphotobiol.2015.01.010
   Amaral D.D., 2016, REV BRAS BIOCIENC, V14, P257
   Amic D, 2010, BIOORGAN MED CHEM, V18, P28, DOI 10.1016/j.bmc.2009.11.015
   [Anonymous], 2000, CHEMPLUS MOD EXT HYP
   [Anonymous], 2001, PIROUETTE VERS 3 01
   Arroio A, 2010, QUIM NOVA, V33, P694, DOI 10.1590/S0100-40422010000300037
   Arwa PS, 2015, J ETHNOPHARMACOL, V174, P410, DOI 10.1016/j.jep.2015.08.041
   Barbosa Reinaldo Imbrozio, 2005, Acta Bot. Bras., V19, P323, DOI 10.1590/S0102-33062005000200015
   Borges RS, 2013, MOLECULES, V18, P12663, DOI 10.3390/molecules181012663
   BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311
   Calvo-Castro L, 2013, PHOTOCHEM PHOTOBIOL, V89, P1199, DOI 10.1111/php.12104
   Cao H, 2005, J MOL STRUC-THEOCHEM, V719, P177, DOI 10.1016/j.theochem.2005.01.029
   Cao HN, 2014, J NAT PROD, V77, P1693, DOI 10.1021/np500320g
   Cao HN, 2010, J BIOL CHEM, V285, P28044, DOI 10.1074/jbc.M110.128561
   Cefali LC, 2015, J AOAC INT, V98, P1340, DOI 10.5740/jaoacint.14-151
   Contreras R, 1999, J PHYS CHEM A, V103, P1367, DOI 10.1021/jp982801i
   Costa JD, 2018, CURR PHARM DESIGN, V24, P576, DOI 10.2174/1381612823666170711112510
   Cruz JV, 2018, MOLECULES, V23, DOI 10.3390/molecules23020453
   Cunha EL, 2015, J COMPUT THEOR NANOS, V12, P3682, DOI [10.1166/jctn.2015.4260, DOI 10.1166/jctn.2015.4260, DOI 10.1166/JCTN.2015.4260]
   de Medeiros PM, 2013, J ETHNOPHARMACOL, V150, P729, DOI 10.1016/j.jep.2013.09.026
   de Toledo CEM, 2011, J ETHNOPHARMACOL, V133, P420, DOI 10.1016/j.jep.2010.10.021
   Draijer R, 2015, NUTRIENTS, V7, P3138, DOI 10.3390/nu7053138
   Dzialo M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020160
   ELAZIZI MM, 1980, J PHARM SCI, V69, P360, DOI 10.1002/jps.2600690333
   Elisha IL, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1301-z
   Estrada E, 2001, J MOL GRAPH MODEL, V20, P54, DOI 10.1016/S1093-3263(01)00100-0
   Fernandez ML, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-013-0396-1
   Frisch M. J., 2009, GAUSSIAN 09 REVISION
   Frisch M.J., 1992, GAUSSVIEW 3 07
   Ganesan K, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050455
   Guerrero MF, 2002, J ETHNOPHARMACOL, V80, P37, DOI 10.1016/S0378-8741(01)00420-2
   Gulcin I, 2012, ARCH TOXICOL, V86, P345, DOI 10.1007/s00204-011-0774-2
   GURNI AA, 1981, BIOCHEM SYST ECOL, V9, P109, DOI 10.1016/0305-1978(81)90028-4
   Heaton CA, 2001, J FLUORINE CHEM, V107, P1, DOI 10.1016/S0022-1139(00)00324-9
   Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5
   Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n
   Higgins P, 2012, CARDIOVASC THER, V30, P217, DOI 10.1111/j.1755-5922.2011.00277.x
   Hiruma-Lima CA, 2009, J ETHNOPHARMACOL, V121, P425, DOI 10.1016/j.jep.2008.10.017
   Jayathilake C, 2016, PROC FOOD SCI, V6, P123, DOI 10.1016/j.profoo.2016.02.028
   Jursic BS, 2000, J MOL STRUC-THEOCHEM, V505, P233, DOI 10.1016/S0166-1280(99)00385-1
   Khlebnikov AI, 2007, BIOORGAN MED CHEM, V15, P1749, DOI 10.1016/j.bmc.2006.11.037
   Krishnaiah D, 2011, FOOD BIOPROD PROCESS, V89, P217, DOI 10.1016/j.fbp.2010.04.008
   Landmesser U, 2002, CIRCULATION, V106, P3073, DOI 10.1161/01.CIR.0000041431.57222.AF
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Li YD, 2013, CHEM BIOL DRUG DES, V81, P537, DOI [10.1111/j.1747-0285.2011.01248.x, 10.1111/cbdd.1248]
   Lima C.C., 2014, J PHARMACOGN PHYTOCH, V3, P181
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   Liu K, 2014, AM J CLIN NUTR, V99, P1510, DOI 10.3945/ajcn.113.082024
   Lopes-Lutz D, 2008, PHYTOCHEMISTRY, V69, P1732, DOI 10.1016/j.phytochem.2008.02.014
   Malik UZ, 2011, FREE RADICAL BIO MED, V51, P179, DOI 10.1016/j.freeradbiomed.2011.04.004
   Mendes APS, 2012, J MOL MODEL, V18, P4073, DOI 10.1007/s00894-012-1397-0
   Okamoto K, 2003, J BIOL CHEM, V278, P1848, DOI 10.1074/jbc.M208307200
   Lopes RHO, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9681425
   Padilha EC, 2016, J BRAZIL CHEM SOC, V27, P1636, DOI 10.5935/0103-5053.20160043
   Pauff JM, 2009, J NAT PROD, V72, P725, DOI 10.1021/np8007123
   Pereira ALE, 2018, J BIOMOL STRUCT DYN, V36, P318, DOI 10.1080/07391102.2016.1277163
   Phan TT, 2001, BIOL PHARM BULL, V24, P1373, DOI 10.1248/bpb.24.1373
   Phan TT, 2001, BURNS, V27, P319, DOI 10.1016/S0305-4179(00)00137-6
   Pitaro S.P., 2012, Rev. bras. plantas med., V14, P686, DOI 10.1590/S1516-05722012000400017
   Rahman K, 2007, CLIN INTERV AGING, V2, P219
   Ratter J. A., 2003, Edinburgh Journal of Botany, V60, P57, DOI 10.1017/S0960428603000064
   Reinisalo M, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/340520
   dos Santos CBR, 2018, J ETHNOPHARMACOL, V222, P107, DOI 10.1016/j.jep.2018.04.041
   dos Santos CBR, 2015, CURR PHARM DESIGN, V21, P4112, DOI 10.2174/1381612821666150528121423
   dos Santos CBR, 2014, REV THEOR SCI, V2, P91, DOI 10.1166/rits.2014.1016
   Roy J, 2017, FASEB J, V31, P3729, DOI 10.1096/fj.201700170R
   Santos CBR, 2014, MOLECULES, V19, P367, DOI 10.3390/molecules19010367
   Scotti Luciana, 2007, Rev. Bras. Cienc. Farm., V43, P153, DOI 10.1590/S1516-93322007000200002
   Silva NSR, 2015, BRIT J PHARM RES, V7, P247, DOI 10.9734/BJPR/2015/17591
   SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204
   Souza CD, 2006, ACTA BOT BRAS, V20, P135, DOI DOI 10.1590/S0102-33062006000100013
   STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208
   Thring TSA, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-27
   Varetto U., 2009, MOLEKEL 4 1
   Vila Verde G.M., 2003, Rev. bras. farmacogn., V13, P64, DOI 10.1590/S0102-695X2003000300024
   Villarroel Daniel, 2010, Ecología en Bolivia, V45, P116
   Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001
   Wilson AJ, 2018, HEART, V104, P293, DOI 10.1136/heartjnl-2017-311448
   Wright JS, 2001, J AM CHEM SOC, V123, P1173, DOI 10.1021/ja002455u
   Zhan CG, 2003, J PHYS CHEM A, V107, P4184, DOI 10.1021/jp0225774
   Zhang G, 2007, J PHYS CHEM A, V111, P1554, DOI 10.1021/jp061633o
   Zhu Qin Yan, 2005, Clin Dev Immunol, V12, P27, DOI 10.1080/17402520512331329514
NR 83
TC 11
Z9 11
U1 1
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD SEP
PY 2018
VL 11
IS 3
AR 72
DI 10.3390/ph11030072
PG 20
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GY2UO
UT WOS:000448399500012
PM 30036950
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU dos Santos, CBR
   Ramos, RD
   Ortiz, BLS
   da Silva, GM
   Giuliatti, S
   Balderas-Lopez, JL
   Navarrete, A
   Carvalho, JCT
AF Rodrigues dos Santos, Cleydson Breno
   Ramos, Ryan da Silva
   Sanchez Ortiz, Brenda Lorena
   da Silva, Gabriel Monteiro
   Giuliatti, Silvana
   Luis Balderas-Lopez, Jose
   Navarrete, Andres
   Tavares Carvalho, Jose Carlos
TI Oil from the fruits of Pterodon emarginatus Vog.: A traditional
   anti-inflammatory. Study combining in vivo and in silico
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE 6 alpha,7 beta-dihydroxy-vouacapan-17 beta-oic acid; Anti-inflammatory;
   in silico; in vivo; Pterodon emarginatus Vog.; Cyclooxygenase
ID MOLECULAR DOCKING; ETHANOLIC EXTRACT; PUBESCENS BENTH.; ACETIC ACID;
   MOUSE EAR; DRUGS; DERIVATIVES; ARTHRITIS; NANOEMULSIONS; MODULATION
AB Ethnobotanical relevance: The oil obtained from the fruits of Pterodon emarginatus Vog. (OPe) is used orally and topically, in traditional medicine for some purposes, such as acute and chronic inflammatory states as rheumatoid arthritis.
   Materials and methods: In this work, the anti-inflammatory activity of the OPe was demonstrated based on several animal models and presented an in silico study based on the 6 alpha,7 beta-dihydroxy-vouacapan-17 beta-oic acid (DHVA) majority compound of the OPe to evaluate the interaction this compound, with cyclooxygenase-2 (COX-2) in 4COX (Mus musculus) and 5KIR (Homo sapiens) and molecular dynamics simulation.
   Results: The OPe (498 mg/kg, p.o) significantly inhibited (p < 0.05, Student t-test) the primary and secondary reactions of arthritis by Freund's Complete Adjuvant (FCA) and in dermatitis induced by croton oil in mice, OPe inhibited peak of edema. In vascular permeability test in rats, the treatment with OPe was able to block the response to PGE(2), serotonin, and bradykinin (p < 0.05, Student t-test). In the writhing test in mice, the OPe at doses of 498 and 980 mg/kg (p.o) produced inhibition of 73% and 92%, respectively, and was not significantly effective in the hot plate test. In the evaluation of the potency in relation to gastric injury (gastric ulcer induced by stress) and combined assay in the assessment of anti-inflammatory potency and gastric damage, it was observed that indomethacin (10 mg/kg, p.o.) inhibited carrageenan edema by 51% and produced a higher number of gastric lesions when compared to the group treated with OPe, where only areas of hyperemia were observed, without the occurrence of ulcerative lesion, and which inhibited the edema by 47%. In the in silico study, it was found that the DHVA is capable of binding to two organisms (4COX - Mus musculus and 5KIR - Homo sapiens), however, with higher binding affinity to the organism Homo sapiens.
   Conclusions: As expected, all tested ligands were capable of forming hydrogen interactions with residues at their respective binding sites, but the DHVA ligand was capable of creating slightly more hydrogen bonds when docked to either 4COX or 5KIR than the other tested ligands, thus demonstrating the participation of this compound in the anti-inflammatory and antialgic responses observed in the in vivo assays as a COX-2 inhibitor. Therefore, the results obtained support the traditional use of OPe for inflammatory and gastric problems.
C1 [Rodrigues dos Santos, Cleydson Breno; Sanchez Ortiz, Brenda Lorena; Tavares Carvalho, Jose Carlos] Univ Fed Amapa UNIFAP, Dept Ciencias Biol & Saude, Lab Pesquisa Farmacos, Rodovia Juscelino Kubitschek S-N, BR-68903419 Macapa, AP, Brazil.
   [Rodrigues dos Santos, Cleydson Breno; Ramos, Ryan da Silva] Univ Fed Amapa UNIFAP, Dept Ciencias Biol & Saude, LMQC, Rodovia Juscelino Kubitschek S-N, BR-68903419 Macapa, AP, Brazil.
   [Sanchez Ortiz, Brenda Lorena; Tavares Carvalho, Jose Carlos] Univ Fed Amapa UNIFAP, Dept Ciencias Biol & Saude, Programa Posgrad Inovacao Farmaceut, Rodovia Juscelino Kubitschek S-N, BR-68903419 Macapa, AP, Brazil.
   [da Silva, Gabriel Monteiro; Giuliatti, Silvana] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Grp Bioinformat,RP, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Luis Balderas-Lopez, Jose; Navarrete, Andres] Univ Nacl Autonoma Mexico, Dept Farm, Fac Quim, Lab Farmacol Prod Nat, Mexico City, DF, Mexico.
RP Carvalho, JCT (corresponding author), Univ Fed Amapa UNIFAP, Dept Ciencias Biol & Saude, Lab Pesquisa Farmacos, Rodovia Juscelino Kubitschek S-N, BR-68903419 Macapa, AP, Brazil.
EM farmacos@unifap.br
RI Giuliatti, Silvana/E-4715-2013; Ramos, Ryan/X-5824-2019; Navarrete,
   Andres/ABB-6148-2020; LOPEZ, JOSE LUIS BALDERAS/M-5431-2015
OI Giuliatti, Silvana/0000-0002-7520-6420; Ramos, Ryan/0000-0003-1802-1320;
   LOPEZ, JOSE LUIS BALDERAS/0000-0003-4662-7362; Monteiro da Silva,
   Gabriel/0000-0002-9665-7597
FU National Council for Scientific and Technological Development - CNPq
   (Biotec) [402332/2013-0]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [407768/2013-0]
FX This study was supported by National Council for Scientific and
   Technological Development - CNPq (Biotec - Process 402332/2013-0). We
   thank Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -
   CAPES - for the Senior internship (Proc. 88881.120909/2016-01), and CNPq
   Process number 407768/2013-0 (Rede Amazonica de Pesquisa em Biofarmacos
   - RAPBioFar). J.C. Tavares Carvalho acknowledges to DGAPA-UNAM -
   Direccion General de Asuntos del Personal Academico, Universidad
   Nacional Autonoma de Mexico - Programa de Estancias de Investigacion en
   la UNAM (PREI-2017).
CR Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   Adams TB, 1997, FOOD CHEM TOXICOL, V35, P739, DOI 10.1016/S0278-6915(97)00056-2
   Al-Saeed Abdulwahed, 2011, Oman Med J, V26, P385, DOI 10.5001/omj.2011.101
   [Anonymous], 2010, ACD CHEMSK FREW VERS
   [Anonymous], 2007, DER WIND VERS 10 0 2
   BASILE AC, 1990, J ETHNOPHARMACOL, V30, P185, DOI 10.1016/0378-8741(90)90007-G
   de Vasconcelos DIB, 2011, MEDIAT INFLAMM, V2011, P1, DOI 10.1155/2011/912925
   CAMPOS AM, 1994, PHYTOCHEMISTRY, V36, P403, DOI 10.1016/S0031-9422(00)97084-5
   Carvalho J. C. T., 1993, THESIS
   Carvalho JCT, 1999, J ETHNOPHARMACOL, V64, P127, DOI 10.1016/S0378-8741(98)00116-0
   CARVALHO JCT, 1998, THESIS
   Chandak N, 2014, J ENZYM INHIB MED CH, V29, P476, DOI 10.3109/14756366.2013.805755
   Coelho LP, 2005, J ETHNOPHARMACOL, V98, P109, DOI 10.1016/j.jep.2005.01.014
   Cunha JM, 2003, BRIT J PHARMACOL, V139, P1135, DOI 10.1038/sj.bjp.0705346
   Dalvie DK, 2002, CHEM RES TOXICOL, V15, P269, DOI 10.1021/tx015574b
   Davies G, 1979, HDB EXPT PHARMACOLOG, V50, P108, DOI DOI 10.1007/978-3-642-66891-3
   de Faria L.R.D., 2011, INT J PHARM SCI REV, V7, P1
   de Moraes WF, 2012, J NAT MED-TOKYO, V66, P202, DOI 10.1007/s11418-011-0547-5
   de Moraes WF, 2009, PHARM BIOL, V47, P146, DOI 10.1080/13880200802436117
   DERAEDT R, 1980, EUR J PHARMACOL, V61, P17, DOI 10.1016/0014-2999(80)90377-5
   DUARTE IDG, 1992, LIFE SCI, V50, P891, DOI 10.1016/0024-3205(92)90208-7
   Duarte IDG, 1996, J ETHNOPHARMACOL, V55, P13, DOI 10.1016/S0378-8741(96)01465-1
   DUARTE IDG, 1988, BRAZ J MED BIOL RES, V21, P341
   Favacho HAS, 2011, REV BRAS FARMACOGN, V21, P105, DOI 10.1590/S0102-695X2011005000007
   Galceran Camila Benatti, 2011, Inflammopharmacology, V19, P139, DOI 10.1007/s10787-011-0081-9
   Gowthaman U, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S14
   Grando R., 2013, PLANTA MED, V79
   Guilardi S, 2003, ACTA CRYSTALLOGR E, V59, pO1935, DOI 10.1107/S1600536803023997
   GYIRES K, 1994, AGENTS ACTIONS, V41, P73
   Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n
   Hoscheid J, 2017, REV BRAS FARMACOGN, V27, P375, DOI 10.1016/j.bjp.2016.08.012
   Hoscheid J, 2015, ARTHRITIS, DOI 10.1155/2015/379459
   Hoscheid J, 2015, COLLOID SURFACE A, V484, P19, DOI 10.1016/j.colsurfa.2015.07.040
   Hoscheid J, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/272795
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   INOUE H, 1989, BRIT J PHARMACOL, V96, P204, DOI 10.1111/j.1476-5381.1989.tb11801.x
   Jacob J. J. C., 1974, PSYCHOPHARMACOLOGY, V37, P213
   JACOB JJC, 1978, BRIT J PHARMACOL, V64, P91, DOI 10.1111/j.1476-5381.1978.tb08645.x
   Kim EY, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00203
   KOSTER R, 1959, FED PROC, V18, P412
   Lemkul JA, 2010, J PHYS CHEM B, V114, P1652, DOI 10.1021/jp9110794
   Lima TC, 2017, BIOORG MED CHEM LETT, V27, P176, DOI 10.1016/j.bmcl.2016.11.081
   LYKBE AMJ, 1969, BRIT J EXP PATHOL, V50, P309
   MAHAJAN JR, 1973, J CHEM SOC PERK T 1, P520, DOI 10.1039/p19730000520
   Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w
   MUSTARD JF, 1965, P SOC EXP BIOL MED, V119, P988
   NEWBOULD BB, 1963, BRIT J PHARM CHEMOTH, V21, P127, DOI 10.1111/j.1476-5381.1963.tb01508.x
   Nucci C, 2012, J ETHNOPHARMACOL, V143, P170, DOI 10.1016/j.jep.2012.06.020
   Nucci-Martins C, 2015, J ETHNOPHARMACOL, V175, P273, DOI 10.1016/j.jep.2015.09.005
   Padilha E. C., 2016, J BRAZIL CHEM SOC, V01, P1
   Pairet M., 2012, SIDE EFFECTS ANTIINF
   Pascoa H, 2015, BRAZ J PHARM SCI, V51, P117, DOI 10.1590/S1984-82502015000100013
   Pereira A. L. E., 2017, J BIOMOL STRUCT DYN, V35, P1
   Peterson LA, 2000, CHEM RES TOXICOL, V13, P531, DOI 10.1021/tx000065f
   RAINSFORD KD, 1977, LIFE SCI, V21, P371, DOI 10.1016/0024-3205(77)90517-3
   Rainsford KD, 2015, IBUPROFEN: DISCOVERY, DEVELOPMENT AND THERAPEUTICS, P1, DOI 10.1002/9781118743614
   Ridings JE, 1996, TOXICOLOGY, V106, P267, DOI 10.1016/0300-483X(95)03190-Q
   dos Santos CBR, 2015, CURR PHARM DESIGN, V21, P4112, DOI 10.2174/1381612821666150528121423
   Ruggiero SG, 2000, ACTA CRYSTALLOGR C, V56, P868, DOI 10.1107/S0108270100004790
   Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f
   Silva NSR, 2015, BRIT J PHARM RES, V7, P247, DOI 10.9734/BJPR/2015/17591
   SINGH B, 1987, J ETHNOPHARMACOL, V19, P255, DOI 10.1016/0378-8741(87)90003-1
   SOFIA RD, 1975, J PHARMACOL EXP THER, V193, P918
   Spindola HM, 2017, EUR J PHARMACOL, V804, P68, DOI 10.1016/j.ejphar.2017.03.030
   Spindola Humberto M., 2010, BMC Pharmacology, V10, P1, DOI 10.1186/1471-2210-10-1
   Spindola HM, 2011, EUR J PHARMACOL, V656, P45, DOI 10.1016/j.ejphar.2011.01.025
   SWINGLE KF, 1981, ARCH INT PHARMACOD T, V254, P168
   TAKAGI K, 1968, JPN J PHARMACOL, V18, P9, DOI 10.1254/jjp.18.9
   TAKAGI K, 1964, CHEM PHARM BULL, V12, P465
   Trowbridge H. O., 1996, MEDIADORES QUIMICOS, P27
   TUBARO A, 1986, AGENTS ACTIONS, V17, P347, DOI 10.1007/BF01982641
   vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047
   Young J. M., 1989, PHARM METHODS CONTRO, P215
   Zhang XH, 2018, ACTA MECH SINICA-PRC, V34, P266, DOI 10.1007/s10409-017-0699-y
   Zimmerman HJ, 1999, HEPATOTOXICITY ADVER, P427
NR 75
TC 10
Z9 10
U1 0
U2 12
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD AUG 10
PY 2018
VL 222
BP 107
EP 120
DI 10.1016/j.jep.2018.04.041
PG 14
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA GK5OP
UT WOS:000436224700011
PM 29723629
DA 2020-12-09
ER

PT J
AU Costa, JD
   dos Santos, CBR
   Costa, KDL
   Ramos, RD
   da Silva, CHTD
   Macedo, WJD
AF Costa, Josivan da Silva
   Rodrigues dos Santos, Cleydson Breno
   Lopes Costa, Karina da Silva
   Ramos, Ryan da Silva
   de Paula da Silva, Carlos Henrique Tomich
   da Cruz Macedo, Williams Jorge
TI VALIDATION OF COMPUTATIONAL METHODS APPLIED IN MOLECULAR MODELING OF
   CAFFEINE WITH EPITHELIAL ANTICANCER ACTIVITY: THEORETICAL STUDY OF
   GEOMETRIC, THERMOCHEMICAL AND SPECTROMETRIC DATA
SO QUIMICA NOVA
LA English
DT Article
DE validation; DFT/B3LYP; HF; basis set; correlation
ID ATOMS; ARTEMISININ; ENERGIES; SPECTRA; NMR; SET
AB Models validation in QSAR, pharmacophore, docking, and others, can ensure the accuracy and reliability of future predictions in design and selection of molecules with biological activity. In these study, the caffeine molecule was optimized using Hartree-Pock (HF) and Density Functional Theory (DFT/B3LYP) methods, with seven basis sets. Linear correlation data, errors and RMSD values between theoretical and experimental data allowed us to classify the methods and basis sets for evaluating their correspondence with experimental data (geometric parameters, heat capacity, as well as infrared, Raman and NMR spectra). The HF method has shown the highest correspondence with the experimental data, occupying the top-five rank of the general classification. The HF/6-31G** method was the best one classified and it can be used to model the biological activity of the caffeine molecule.
C1 [Costa, Josivan da Silva; Rodrigues dos Santos, Cleydson Breno] Univ Fed Para, Rua Augusto Correa,1 Guama, BR-66075110 Belem, Para, Brazil.
   [Costa, Josivan da Silva; Rodrigues dos Santos, Cleydson Breno; Lopes Costa, Karina da Silva; Ramos, Ryan da Silva] Univ Fed Amapa, Dept Ciencias Biol, Rod Juscelino Kubitschek,Km 02 S-N, BR-68902280 Macapa, AP, Brazil.
   [Costa, Josivan da Silva; da Cruz Macedo, Williams Jorge] Univ Fed Rural Amazonia, Rua Joao Pessoa,121,Campus Capanema Ctr, BR-68700030 Capanema, PA, Brazil.
   [de Paula da Silva, Carlos Henrique Tomich] Univ Sao Paulo, Escola Ciencias Farmaceut Ribeirao Preto, BR-14040903 Ribeirao Preto, PR, Brazil.
RP Costa, JD (corresponding author), Univ Fed Para, Rua Augusto Correa,1 Guama, BR-66075110 Belem, Para, Brazil.; Costa, JD (corresponding author), Univ Fed Amapa, Dept Ciencias Biol, Rod Juscelino Kubitschek,Km 02 S-N, BR-68902280 Macapa, AP, Brazil.; Costa, JD (corresponding author), Univ Fed Rural Amazonia, Rua Joao Pessoa,121,Campus Capanema Ctr, BR-68700030 Capanema, PA, Brazil.
EM josivan.chemistry@gmail.com
RI Silva, Carlos H T P/J-3695-2015; Ramos, Ryan/X-5824-2019; da Silva
   Costa, Josivan/AAA-9565-2020
OI Silva, Carlos H T P/0000-0001-6049-3650; Ramos,
   Ryan/0000-0003-1802-1320; da Silva Costa, Josivan/0000-0001-5069-5283;
   Macedo, Williams/0000-0002-0457-6993
FU Postgraduate Program in Biodiversity and Biotechnology of Amazon
   (PPG-Bionorte); Laboratory of Molecular Modeling and Simulation System
   of Federal Rural University of Amazonia (UFRA-Brazil); Computational
   Laboratory of Pharmaceutical Chemistry, School of Pharmaceutical
   Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto
   (USP/RP); PROPESP/UFPA
FX We acknowledge support provided by the Postgraduate Program in
   Biodiversity and Biotechnology of Amazon (PPG-Bionorte), To the,
   Paraense Museum Emilio Goeldi (MPEG). Laboratory of Molecular Modeling
   and Simulation System of Federal Rural University of Amazonia
   (UFRA-Brazil) and Computational Laboratory of Pharmaceutical Chemistry,
   School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao
   Paulo, Ribeirao Preto (USP/RP) and PROPESP/UFPA.
CR ACD/Chemsketch Freeware, 2010, VERS 12 00 ADV CHEM
   Alcantara AFD, 2004, QUIM NOVA, V27, P371, DOI 10.1590/S0100-40422004000300003
   ANDERSON JE, 1981, J ELECTROANAL CHEM, V130, P113
   Atkins P., 2014, PHYS CHEM
   BECKE AD, 1992, J CHEM PHYS, V97, P9173, DOI 10.1063/1.463343
   ChemPlus, 2000, MOD EXT HYP REL 6 02
   Chen LD, 2016, CHIN HERB MED, V8, P126, DOI 10.1016/S1674-6384(16)60021-7
   Chicone C, 2016, INVITATION APPL MATH
   Costa J. S., 2017, CURR PHARM DESIGN, V23, P1
   Csonka GI, 1996, THEOCHEM-J MOL STRUC, V362, P199, DOI 10.1016/0166-1280(95)04393-4
   DeTar DF, 1998, J PHYS CHEM A, V102, P5128, DOI 10.1021/jp981195o
   Dong JX, 2007, J CHEM THERMODYN, V39, P108, DOI 10.1016/j.jct.2006.05.009
   FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267
   Frisch M. J., 2009, GAUSSIAN 09 REVISION
   Gunasekaran S, 2005, SPECTROCHIM ACTA A, V61, P117, DOI 10.1016/j.saa.2004.03.030
   HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485
   Kadian N, 2016, J PHARMACEUT BIOMED, V126, P83, DOI 10.1016/j.jpba.2016.03.052
   KAN LS, 1980, BIOPOLYMERS, V19, P1641, DOI 10.1002/bip.1980.360190908
   Kandakatla Naresh, 2014, Advances in Bioinformatics, V2014, P812148, DOI 10.1155/2014/812148
   Kumar L., 2017, J APPL PHYS, V9, P30
   Leach A.R., 2001, MOL MODELLING PRINCI
   Levine I, 1991, QUANTUM CHEM
   MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980
   Melo U. Z., 2015, J PHYS CHEM A, V119, P2111
   Muthu S, 2014, SPECTROCHIM ACTA A, V120, P185, DOI 10.1016/j.saa.2013.09.150
   ORTI E, 1995, J PHYS CHEM-US, V99, P4955, DOI 10.1021/j100014a014
   Pavel I, 2003, BIOPOLYMERS, V72, P25, DOI 10.1002/bip.10248
   PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671
   Pilla KB, 2017, BBA-PROTEINS PROTEOM, V1865, P1654, DOI 10.1016/j.bbapap.2017.06.016
   Puzyn T., 2017, FOOD CHEM TOXICOL, V17, P30556
   Rassolov VA, 2001, J COMPUT CHEM, V22, P976, DOI 10.1002/jcc.1058
   RICCA A, 1995, J PHYS CHEM-US, V99, P9003, DOI 10.1021/j100022a010
   dos Santos CBR, 2014, J COMPUT THEOR NANOS, V11, P553, DOI 10.1166/jctn.2014.3394
   Rogozin EA, 2008, CARCINOGENESIS, V29, P1228, DOI 10.1093/carcin/bgn016
   Santos C. B. R., 2016, RATIONAL DESIGN ANTI, P204
   Santos C. B. R., 2013, COMP MOL BIOSC, V3, P66
   Schneidman-Duhovny D, 2008, J COMPUT BIOL, V15, P737, DOI 10.1089/cmb.2007.0130
   Schneidman-Duhovny D, 2008, NUCLEIC ACIDS RES, V36, pW223, DOI 10.1093/nar/gkn187
   Starosyla SA, 2014, BIOORG MED CHEM LETT, V24, P4418, DOI 10.1016/j.bmcl.2014.08.011
   STEPHENS PJ, 1994, FARADAY DISCUSS, V99, P103, DOI 10.1039/fd9949900103
   SUTOR DJ, 1958, ACTA CRYSTALLOGR, V11, P453, DOI 10.1107/S0365110X58001286
   Vieira JB, 2014, MOLECULES, V19, P10670, DOI 10.3390/molecules190810670
   Yang X.-S., 2017, ENG MATH EXAMPLES AP
   Zuschneid T, 2004, Z NATURFORSCH B, V59, P1153
NR 44
TC 3
Z9 3
U1 0
U2 1
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0100-4042
EI 1678-7064
J9 QUIM NOVA
JI Quim. Nova
PD JUL
PY 2018
VL 41
IS 7
BP 732
EP 742
DI 10.21577/0100-4042.20170239
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA GP3YE
UT WOS:000440790800003
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Picanco, LCD
   Ozela, PF
   Brito, MDD
   Pinheiro, AA
   Padilha, EC
   Braga, FS
   da Silva, CHTD
   dos Santos, CBR
   Rosa, JMC
   Hage-Melim, LID
AF dos Santos Picanco, Leide Caroline
   Ozela, Priscilla F.
   de Brito Brito, Maiara de Fatima
   Pinheiro, Abrado A.
   Padilha, Elias C.
   Braga, Francinaldo S.
   Tomich de Paula da Silva, Carlos Henrique
   Rodrigues dos Santos, Cleydson Breno
   Rosa, Joaquin M. C.
   da Silva Hage-Melim, Lorane Izabel
TI Alzheimer's Disease: A Review from the Pathophysiology to Diagnosis, New
   Perspectives for Pharmacological Treatment
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Review
DE Alzheimer's disease; pathophysiology; treatment; acetylcholinesterase;
   beta-secretase; glycogen synthase kinase-3 beta
ID GLYCOGEN-SYNTHASE KINASE-3-BETA; MILD COGNITIVE IMPAIRMENT; AMYLOID
   PRECURSOR PROTEIN; MINI-MENTAL-STATE; IN-VIVO; NEURODEGENERATIVE
   DISORDERS; TAU PHOSPHORYLATION; MOUSE MODEL; ACETYLCHOLINESTERASE
   INHIBITORS; PSYCHOLOGICAL SYMPTOMS
AB Dementia is characterized by the impairment of cognition and behavior of people over 65 years. Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder in the world, as approximately 47 million people are affected by this disease and the tendency is that this number will increase to 62% by 2030. Two microscopic features assist in the characterization of the disease, the amyloid plaques and neurofibrillary agglomerates. All these factors are responsible for the slow and gradual deterioration of memory that affect language, personality or cognitive control. For the AD diagnosis, neuropsychological tests are performed in different spheres of cognitive functions but since not all cognitive functions may be affected, cerebrospinal fluid biomarkers are used along with these tests. To date, cholinesterase inhibitors are used as treatment, they are the only drugs that have shown significant improvements in the cognitive functions of AD patients. Despite the proven effectiveness of cholinesterase inhibitors, an AD carrier, even while being treated, is continually subjected to progressive degeneration of the neuronal tissue. For this reason, other biochemical pathways associated with the pathophysiology of AD have been explored as alternatives to the treatment of this condition such as inhibition of beta-secretase and glycogen synthase kinase-3 beta. The present study aims to conduct a review of the epidemiology, pathophysiology, symptoms, diagnosis and treatment of Alzheimer's disease, emphasizing the research and development of new therapeutic approaches.
C1 [dos Santos Picanco, Leide Caroline; Ozela, Priscilla F.; de Brito Brito, Maiara de Fatima; Pinheiro, Abrado A.; da Silva Hage-Melim, Lorane Izabel] Univ Fed Amapa, Lab Quim Farmaceut & Med PharMedChem, Macapa, Brazil.
   [Padilha, Elias C.] Univ Estadual Paulista UNESP, Fac Ciencias Farmaceut, Dept Principios At Nat & Toxicol, Campus Araraquara, Araraquara, SP, Brazil.
   [Braga, Francinaldo S.; Rodrigues dos Santos, Cleydson Breno] Univ Fed Amapa, Lab Modelagem & Quim Computac, Macapa, Brazil.
   [Tomich de Paula da Silva, Carlos Henrique; Rosa, Joaquin M. C.] Univ Sao Paulo, Lab Computac Quim Farmaceut, Dept Ciencias Farmaceut, Fac Ciencias Farmaceut Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Rosa, Joaquin M. C.] Univ Granada, Fac Pharm, Chem Dept Pharmaceut & Organ, Univ Campus Cartuja, E-18071 Granada, Spain.
RP Picanco, LCD (corresponding author), Univ Fed Amapa, Lab Quim Farmaceut & Med, BR-68902280 Macapa, Brazil.
EM leidecaroline@outlook.com
RI Silva, Carlos H T P/J-3695-2015; Hage-Melim, Lorane I S/N-4214-2015;
   Padilha, Elias/J-5671-2015
OI Silva, Carlos H T P/0000-0001-6049-3650; Hage-Melim, Lorane I
   S/0000-0002-7851-7363; Padilha, Elias/0000-0002-3794-9389
FU Postgraduate Program in Pharmaceutical Sciences (UNIFAP); Laboratory of
   Modeling and Computational Chemistry of Federal University of Amapa
   (UNIFAP); Computational Laboratory of Pharmaceutical Chemistry of
   Faculty of Pharmaceutical Sciences of Ribeirao Preto in University of
   Sao Paulo
FX We gratefully acknowledge the support provided by the Postgraduate
   Program in Pharmaceutical Sciences (UNIFAP), Laboratory of Modeling and
   Computational Chemistry of Federal University of Amapa (UNIFAP) and
   Computational Laboratory of Pharmaceutical Chemistry of Faculty of
   Pharmaceutical Sciences of Ribeirao Preto in University of Sao Paulo.
CR Abib E., 2013, RMB, V70, P31
   Aghdam SY, 2007, CURR ALZHEIMER RES, V4, P21
   Aging N. I., 2008, NAT I AGING, P5
   Aguera Morales E., 2011, MEDICINE, V10, P5123
   Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819
   Almeida J. R, 2011, THESIS
   Almeida OP, 1998, ARQ NEURO-PSIQUIAT, V56, P605, DOI 10.1590/S0004-282X1998000400014
   Alves Luisa, 2012, Front Neurol, V3, P63, DOI 10.3389/fneur.2012.00063
   [Anonymous], 2014, DIAGN STAT MAN MENT
   [Anonymous], 2006, GUIDE CARING SOMEONE
   [Anonymous], 2010, WORLD ALZHEIMER REPO
   [Anonymous], 2012, SYNTHESIS SOCIAL IND
   [Anonymous], 2000, DIAGNOSTIC STAT MANU
   [Anonymous], 2015, WORLD ALZHEIMER REPO
   Arango D, 2001, AM J MED GENET, V103, P138, DOI 10.1002/1096-8628(20011001)103:2<138::AID-AJMG1529>3.0.CO;2-8
   Avrahami L, 2013, J BIOL CHEM, V288, P1295, DOI 10.1074/jbc.M112.409250
   Bagyinszky E, 2014, CLIN INTERV AGING, V9, P535, DOI 10.2147/CIA.S51571
   Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9
   Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330
   Bartolucci C, 2001, PROTEINS, V42, P182, DOI 10.1002/1097-0134(20010201)42:2<182::AID-PROT50>3.0.CO;2-1
   BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051
   Bartus RT, 1999, JAMA-J AM MED ASSOC, V282, P2208, DOI 10.1001/jama.282.23.2208
   Benevento C. E., 2011, MITOCHONDRIA DYSFUNC
   Berg S, 2012, J MED CHEM, V55, P9107, DOI 10.1021/jm201724m
   Bertolucci PHF, 2001, ARQ NEURO-PSIQUIAT, V59, P532, DOI 10.1590/S0004-282X2001000400009
   Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023
   Bonda DJ, 2010, NEUROPHARMACOLOGY, V59, P290, DOI 10.1016/j.neuropharm.2010.04.005
   Bottino CM, 2001, ARQ NEURO-PSIQUIAT, V59, P20
   Bottino CMC, 2002, ARQ NEURO-PSIQUIAT, V60, P70, DOI 10.1590/S0004-282X2002000100013
   Bouwman FH, 2007, NEUROBIOL AGING, V28, P1070, DOI 10.1016/j.neurobiolaging.2006.05.006
   Bullock R, 2006, ALZ DIS ASSOC DIS, V20, P23, DOI 10.1097/01.wad.0000201847.29836.a5
   Burns A., 1999, ASSESSMENT SCALES OL, P63
   Burns A., 1999, ASSESSMENT SCALES OL, P40
   Cabezas-Opazo FA, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/509654
   Cai Y, 2015, CLIN INTERV AGING, V10, P1163, DOI 10.2147/CIA.S85808
   Cai ZY, 2012, CURR ALZHEIMER RES, V9, P864, DOI 10.2174/156720512802455386
   Camargo I. E., 2003, ALZHEIMERS DIS TESTI
   Caramelli Paulo, 2011, Dement. neuropsychol., V5, P167, DOI 10.1590/S1980-57642011DN05030004
   Castano Z, 2010, J NEUROCHEM, V113, P117, DOI 10.1111/j.1471-4159.2010.06581.x
   Chen YY, 2008, BIOCHEM PHARMACOL, V76, P128, DOI 10.1016/j.bcp.2008.04.010
   Christensen Daniel D, 2007, Prim Care Companion J Clin Psychiatry, V9, P32
   Coffman K, 2011, BIOORG MED CHEM LETT, V21, P1429, DOI 10.1016/j.bmcl.2011.01.017
   Costa Durval C., 2001, Revista Brasileira de Psiquiatria, V23, P4, DOI 10.1590/S1516-44462001000500003
   Costa R. P., 2007, TEXTOS CONTEXTOS, V5, P107
   Cruz D.C., 2012, THESIS
   Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223
   da Rocha MD, 2011, CNS NEUROL DISORD-DR, V10, P251
   Danysz W, 2003, INT J GERIATR PSYCH, V18, pS23, DOI 10.1002/gps.938
   De Falco A, 2016, QUIM NOVA, V39, P63, DOI 10.5935/0100-4042.20150152
   De Melo GO, 2005, REV FITO, V1, P41
   De Sarno P, 2006, NEUROBIOL AGING, V27, P413, DOI 10.1016/j.neurobiolaging.2005.03.003
   Delay C, 2012, NEUROBIOL DIS, V46, P285, DOI 10.1016/j.nbd.2012.01.003
   Diamond J., 2008, REPORT ALZHEIMERS DI
   Dias KST, 2015, REV VIRTUAL QUIM, V7, P609, DOI 10.5935/1984-6835.20150027
   Dysken MW, 2014, JAMA-J AM MED ASSOC, V311, P33, DOI 10.1001/jama.2013.282834
   Easton A, 2013, PSYCHOPHARMACOLOGY, V230, P279, DOI 10.1007/s00213-013-3152-3
   Engelhardt E, 2005, ARQ NEURO-PSIQUIAT, V63, P1104, DOI 10.1590/S0004-282X2005000600035
   Engelhardt E., 2003, ARQ NEUROPSIQUIATR S, V61, pS54 
   Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730
   Ferri CP, 2012, REV BRAS PSIQUIATR, V34, P371, DOI 10.1016/j.rbp.2012.08.005
   Fischer H. U. S., 2010, MILITARY CASUALTY ST, P1
   Fleisher AS, 2011, NEUROLOGY, V77, P1263, DOI 10.1212/WNL.0b013e318230a16c
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Forestier A, 2015, INT J MOL SCI, V16, P17422, DOI 10.3390/ijms160817422
   Forlenza Orestes V., 2005, Arch. Clin. Psychiatry (São Paulo), V32, P137, DOI 10.1590/S0101-60832005000300006
   Forlenza OV, 2011, J PSYCHIATR RES, V45, P220, DOI 10.1016/j.jpsychires.2010.06.002
   Fox C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035185
   Francis P T, 2009, Curr Mol Pharmacol, V2, P77
   Franco E, 2011, MEDICINE, V10, P5129
   Friedman LG, 2015, NEUROTHERAPEUTICS, V12, P94, DOI 10.1007/s13311-014-0320-z
   Fukunaga K, 2013, BIOORG MED CHEM LETT, V23, P6933, DOI 10.1016/j.bmcl.2013.09.020
   Furazo G., 2015, THESIS, P103
   Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13
   Gertsch J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-135
   Ghanemi A, 2015, ALEX J MED, V51, P1, DOI 10.1016/j.ajme.2014.09.006
   Ghosh AK, 2008, BIOORG MED CHEM LETT, V18, P1031, DOI 10.1016/j.bmcl.2007.12.028
   Ghosh AK, 2012, J NEUROCHEM, V120, P71, DOI 10.1111/j.1471-4159.2011.07476.x
   Giacobini E, 2013, NAT REV NEUROL, V9, P677, DOI 10.1038/nrneurol.2013.223
   Goedert M, 2015, CLIN CHEM, V61, P1417, DOI 10.1373/clinchem.2015.245142
   Golde TE, 2006, J NEUROCHEM, V99, P689, DOI 10.1111/j.1471-4159.2006.04211.x
   Gordon ML, 2012, DEMENT GER COGN D EX, V2, P312, DOI 10.1159/000341604
   Grasso M, 2014, MOLECULES, V19, P6891, DOI 10.3390/molecules19056891
   Greenblatt HM, 1999, FEBS LETT, V463, P321, DOI 10.1016/S0014-5793(99)01637-3
   Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9
   Gross RG, 2008, CURR NEUROL NEUROSCI, V8, P490, DOI 10.1007/s11910-008-0078-y
   Hampel H, 2011, PROG NEUROBIOL, V95, P718, DOI 10.1016/j.pneurobio.2011.11.008
   Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   Haupt M, 2000, DEMENT GERIATR COGN, V11, P147, DOI 10.1159/000017228
   Helito A., 2003, SAUDE UNDERSTANDING
   Hellweg R, 2012, INT J GERIATR PSYCH, V27, P651, DOI 10.1002/gps.2766
   Hemmati F, 2013, BEHAV BRAIN RES, V252, P415, DOI 10.1016/j.bbr.2013.06.016
   Hendrie HC, 2015, ETHNIC DIS, V25, P345, DOI 10.18865/ed.25.3.345
   Herrera E, 2002, ALZ DIS ASSOC DIS, V16, P103, DOI 10.1097/00002093-200204000-00007
   Hers I, 1999, FEBS LETT, V460, P433, DOI 10.1016/S0014-5793(99)01389-7
   Herukka SK, 2007, NEUROBIOL AGING, V28, P507, DOI 10.1016/j.neurobiolaging.2006.02.001
   Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369
   Hongo H, 2012, BIOCHEM BIOPH RES CO, V426, P94, DOI 10.1016/j.bbrc.2012.08.042
   Hu SQ, 2013, NEUROCHEM INT, V62, P468, DOI 10.1016/j.neuint.2013.01.022
   Hu SX, 2009, NEUROBIOL DIS, V33, P193, DOI 10.1016/j.nbd.2008.10.007
   HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566
   Hyde C, 2013, AGE AGEING, V42, P14, DOI 10.1093/ageing/afs165
   Inouye K., 2004, INFARMA, V15, P80
   Inouye K, 2010, REV ESC ENFERM USP, V44, P1087
   Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103
   Kamat PK, 2013, NEUROSCIENCE, V238, P97, DOI 10.1016/j.neuroscience.2013.01.075
   Kaplan E. F., 1983, BOSTON NAMING TEST
   Kasa P, 1997, PROG NEUROBIOL, V52, P511, DOI 10.1016/S0301-0082(97)00028-2
   KORNHUBER J, 1989, J NEURAL TRANSM, V77, P231, DOI 10.1007/BF01248936
   Kreutz F., 2010, THESIS, P93
   Kumata K, 2015, BIOORG MED CHEM LETT, V25, P3230, DOI 10.1016/j.bmcl.2015.05.085
   Kunz L, 2015, SCIENCE, V350, P430, DOI 10.1126/science.aac8128
   Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004
   Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001
   Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200
   Leost M, 2000, EUR J BIOCHEM, V267, P5983, DOI 10.1046/j.1432-1327.2000.01673.x
   Lezak M. D., 1995, NEUROPSYCHOLOGICAL A, V3rd
   Li J, 2012, J BIOL CHEM, V287, P44593, DOI 10.1074/jbc.M112.420224
   Lim JW, 2001, LAB INVEST, V81, P349, DOI 10.1038/labinvest.3780243
   Lindeboom J, 2004, EUR J PHARMACOL, V490, P83, DOI 10.1016/j.ejphar.2004.02.046
   LIPTON SA, 1994, NEW ENGL J MED, V330, P613
   Liu JH, 2015, INDIAN J MED RES, V142, P190, DOI 10.4103/0971-5916.164254
   Lobo A, 2000, NEUROLOGY, V54, pS4
   Lu CJ, 2013, J MED CHEM, V56, P5843, DOI 10.1021/jm400567s
   Lu JY, 2014, BIOORG MED CHEM LETT, V24, P3392, DOI 10.1016/j.bmcl.2014.05.085
   Lunardi P. S., 2010, THESIS, P44
   Luo JL, 2010, J BIOL CHEM, V285, P19947, DOI 10.1074/jbc.M110.111286
   Ma SL, 2012, J BIOL CHEM, V287, P6969, DOI 10.1074/jbc.C111.298596
   Maidment ID, 2008, ANN PHARMACOTHER, V42, P32, DOI 10.1345/aph.1K372
   Marteli A., 2014, UNICIENCIAS, V18, P45
   Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u
   Martinez A, 2008, MED RES REV, V28, P773, DOI 10.1002/med.20119
   Martland H., 1928, JAMA-J AM MED ASSOC, V91, P1103, DOI DOI 10.1001/JAMA.1928.02700150029009
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   Meijer L, 2000, CHEM BIOL, V7, P51, DOI 10.1016/S1074-5521(00)00063-6
   Miguel-Hidalgo JJ, 2002, BRAIN RES, V958, P210, DOI 10.1016/S0006-8993(02)03731-9
   Modarresi Farzaneh, 2011, Int J Alzheimers Dis, V2011, P929042, DOI 10.4061/2011/929042
   Moreaud O, 2010, PSYCHOL NEUROPSYCHIA, V8, P43, DOI 10.1684/pnv.2009.0185
   Moser D. A., 2011, THESIS
   Nascimento E. C. M., 2009, THEORETICAL DETERMIN
   Nitrini R, 2005, ARQ NEURO-PSIQUIAT, V63, P720, DOI 10.1590/S0004-282X2005000400034
   Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102
   Noh MY, 2013, BIOCHEM BIOPH RES CO, V435, P274, DOI 10.1016/j.bbrc.2013.04.065
   Nowinski C, 2006, HEAD GAMES FOOTBALLS
   Onishi T, 2011, J NEUROCHEM, V119, P1330, DOI 10.1111/j.1471-4159.2011.07532.x
   Ostrosky-Solis F, 1999, J INT NEUROPSYCH SOC, V5, P413, DOI 10.1017/S1355617799555045
   PARSONS CG, 1993, NEUROPHARMACOLOGY, V32, P1337, DOI 10.1016/0028-3908(93)90029-3
   Pereira P. M. C., 2013, ALZHEIMERS DIS TREAT
   Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157
   Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303
   Petronilho E. D. C., 2011, CIENCIA E TECNOL, P3
   Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158
   Prado D., 2013, REV NEUROCIENC, V21, P118
   Racchi M, 2004, PHARMACOL RES, V50, P441, DOI 10.1016/j.phrs.2003.12.027
   Rang HP, 2011, FARMACOLOGIA
   Reitz C, 2014, BIOCHEM PHARMACOL, V88, P640, DOI 10.1016/j.bcp.2013.12.024
   REY A, 1964, EXAM CLIN PSYCHOL
   Richardson C, 2013, INT J GERIATR PSYCH, V28, P1312, DOI 10.1002/gps.3966
   Rogaeva E, 2002, NEUROMOL MED, V2, P1, DOI 10.1385/NMM:2:1:01
   ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356
   Rosenberg PB, 2015, MOL ASPECTS MED, V43-44, P25, DOI 10.1016/j.mam.2015.05.005
   ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698
   Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169
   Saitoh M, 2009, J MED CHEM, V52, P6270, DOI 10.1021/jm900647e
   Salim O., 2012, FACEN FAMENE, V10, P57
   Schwab C, 2008, J ALZHEIMERS DIS, V13, P359
   Seidl C., 2010, PRESEARCH NATURAL SU
   Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.3.CO;2-L
   Siemers E, 2004, NEUROBIOL AGING, V25, pS569, DOI 10.1016/S0197-4580(04)81891-8
   Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049
   Smith DG, 2001, BIOORG MED CHEM LETT, V11, P635, DOI 10.1016/S0960-894X(00)00721-6
   Stancu IC, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-51
   Steele TG, 2009, BIOORG MED CHEM LETT, V19, P17, DOI 10.1016/j.bmcl.2008.11.027
   STRUB RL, 1985, MENTAL STATUS EXAMIN
   Sugimoto H, 2002, JPN J PHARMACOL, V89, P7, DOI 10.1254/jjp.89.7
   Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469
   Sy M, 2011, AM J PATHOL, V178, P2811, DOI 10.1016/j.ajpath.2011.02.012
   Tariot PN, 2009, J CLIN PSYCHIAT, V70, P919, DOI 10.4088/JCP.09com05331
   Thotala DK, 2008, CANCER RES, V68, P5859, DOI 10.1158/0008-5472.CAN-07-6327
   Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003
   Uehara F, 2013, BIOORG MED CHEM LETT, V23, P6928, DOI 10.1016/j.bmcl.2013.09.021
   Vasques J. F., 2012, THESIS, P123
   Wang M, 2011, BIOORG MED CHEM LETT, V21, P245, DOI 10.1016/j.bmcl.2010.11.026
   Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI [10.1016/j.jalz.2013.03.005, 10.1016/j.jalz.2013.05.1769]
   WELSH K, 1991, ARCH NEUROL-CHICAGO, V48, P278, DOI 10.1001/archneur.1991.00530150046016
   Weschler D, 1987, WESCHLER MEMORY SCAL
   Winblad B, 2010, J NUTR HEALTH AGING, V14, P770, DOI 10.1007/s12603-010-0122-x
   Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x
   Wood-Kaczmar A, 2009, MOL CELL NEUROSCI, V42, P184, DOI 10.1016/j.mcn.2009.07.002
   Xiao K, 2006, BIOORGAN MED CHEM, V14, P4535, DOI 10.1016/j.bmc.2006.02.024
   Zhang C, 2012, DISCOV MED, V14, P189
   Zhang MR, 2004, J MED CHEM, V47, P2228, DOI 10.1021/jm0304919
   Zhu L, 2015, P NATL ACAD SCI USA, V112, P11965, DOI 10.1073/pnas.1510011112
   Zhu YP, 2009, BIOORGAN MED CHEM, V17, P1600, DOI 10.1016/j.bmc.2008.12.067
NR 194
TC 53
Z9 53
U1 9
U2 30
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PY 2018
VL 25
IS 26
BP 3141
EP 3159
DI 10.2174/0929867323666161213101126
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA GX0GP
UT WOS:000447388700007
PM 30191777
DA 2020-12-09
ER

PT J
AU Costa, JD
   Costa, KDL
   Cruz, JV
   Ramos, RD
   Silva, LB
   Brasil, DDB
   da Silva, CHTD
   dos Santos, CBR
   Macedo, WJD
AF Costa, Josivan da Silva
   Lopes Costa, Karina da Silva
   Cruz, Josiane Viana
   Ramos, Ryan da Silva
   Silva, Luciane Barros
   Barros Brasil, Davi Do Socorro
   Tomich de Paula da Silva, Carlos Henrique
   Rodrigues dos Santos, Cleydson Breno
   da Cruz Macedo, Williams Jorge
TI Virtual Screening and Statistical Analysis in the Design of New Caffeine
   Analogues Molecules with Potential Epithelial Anticancer Activity
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Epithelial cancer; caffeine; Chk1; Molecular modeling; multiple linear
   regression; Pharmacokinetic and toxicological properties
ID PROTEIN-BINDING; PREDICTION; DATABASE; PLASMA; MODEL
AB About 132 thousand cases of melanoma (more severe type of skin cancer) were registered in 2014 according to the World Health Organization. This type of cancer significantly affects the quality of life of individuals. Caffeine has shown potential inhibitory effect against epithelial cancer. In this study, it was proposed to obtain new caffeine-based molecules with potential epithelial anticancer activity. For this, a training set of 21 molecules was used for pharmacophore perception procedures. Multiple linear regression analyses were used to propose mono-, bi-, tri-, and tetra-parametric models applied in the prediction of the activity. The generated pharmacophore was used to select 350 molecules available at the ZINCpharmer server, followed by reduction to 24 molecules, after selection using the Tanimoto index, yielding 10 molecules after final selection by predicted activity values > 1.5229. These ten molecules had better pharmacokinetic properties than the other ones used as reference and within the clinically significant limits. Only two molecules show minor hits of toxicity and were submitted to molecular docking procedures, showing BFE (binding free energy) values lower than the reference values. Statistical analyses indicated strong negative correlations between BFE and pharmacophoric properties (high influence on BFE lowering) and practically null correlation between BFE and BBB. The two most promising molecules can be indicated as candidates for further in vitro and in vivo analyzes.
C1 [Costa, Josivan da Silva] Fed Univ Para, Postgrad Program Biotechnol & Biodivers Network B, Belem, Para, Brazil.
   [Costa, Josivan da Silva; Lopes Costa, Karina da Silva; Cruz, Josiane Viana; Ramos, Ryan da Silva; Silva, Luciane Barros; Rodrigues dos Santos, Cleydson Breno] Univ Fed Amapa, Lab Modeling & Computat Chem, Dept Biol Sci, Rod Juscelino Kubitschek,Km 02 S-N, BR-68902280 Macapa, AP, Brazil.
   [Costa, Josivan da Silva; Barros Brasil, Davi Do Socorro] Fed Univ Para, Inst Technol, Av Augusto Correa 01, BR-66075900 Belem, Para, Brazil.
   [Tomich de Paula da Silva, Carlos Henrique] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, Ribeirao Preto, SP, Brazil.
   [da Cruz Macedo, Williams Jorge] Fed Rural Univ Amazonia, Lab Mol Modeling & Simulat Syst, Rua Joao Pessoa,121,Campus Capanema Ctr, BR-68700030 Capanema, Para, Brazil.
RP Costa, JD (corresponding author), Univ Fed Amapa, Lab Modeling & Computat Chem, Dept Biol Sci, Rod Juscelino Kubitschek,Km 02 S-N, BR-68902280 Macapa, AP, Brazil.
EM josivan.chemistry@gmail.com
RI da Silva Costa, Josivan/AAA-9565-2020; Ramos, Ryan/X-5824-2019; Silva,
   Carlos H T P/J-3695-2015
OI da Silva Costa, Josivan/0000-0001-5069-5283; Ramos,
   Ryan/0000-0003-1802-1320; Silva, Carlos H T P/0000-0001-6049-3650;
   Macedo, Williams/0000-0002-0457-6993; Rodrigues dos Santos, Cleydson
   Breno/0000-0002-0271-335X
FU PROPESP/UFPA
FX We acknowledge the support provided by the PROPESP/UFPA. To the
   Postgraduate Program in Biodiversity and Biotecnoloy of Amazon
   (PPG-Bionorte), Paraense Museum Emilio Goeldi (MPEG). Laboratory of
   Molecular Modeling and Simulation System of Federal Rural University of
   Amazonia (UFRA-Brazil) and Computational Laboratory of Pharmaceutical
   Chemistry, Faculty of Pharmaceutical Sciences of Ribeirao Preto,
   University of Sao Paulo, Ribeirao Preto (USP/RP) for computational
   support. To Elias Carvalho Padilha for his assistance in the revision of
   the English language.
CR ACD, 2010, CHEMSK FREEW VERS 12
   Agrawal R, 2013, MED CHEM RES, V22, P5504, DOI 10.1007/s00044-013-0547-y
   Almeida JRC, 2004, FARMACEUTICOS ONCOLO
   Alves AB, 2002, BRAZ J PHARM SCI, V38, P237
   [Anonymous], 2004, DAT AN SOFTW SYST
   BABEL Open, 2011, OPEN SOURCE CHEM TOO
   Basketter DA, 2008, BRIT J DERMATOL, V159, P267, DOI 10.1111/j.1365-2133.2008.08625.x
   Berg J. M., 2002, BIOCHEMISTRY
   BLANCHARD J, 1982, J PHARM SCI, V71, P1415, DOI 10.1002/jps.2600711229
   Brentani RR, 1998, BASES DA ONCOLOGIA, P1
   CAIRNS J, 1981, NATURE, V289, P353, DOI 10.1038/289353a0
   ChemPlus, 2000, MOD EXT HYPERCHEM RE
   Cronin M T, 1994, SAR QSAR Environ Res, V2, P159, DOI 10.1080/10629369408029901
   Csizmadia F, 2000, J CHEM INF COMP SCI, V40, P323, DOI 10.1021/ci9902696
   Dassault Systemes BIOVIA, 2015, DISC STUD MOD ENV
   Souza Jacqueline de, 2007, Rev. Bras. Cienc. Farm., V43, P515, DOI 10.1590/S1516-93322007000400004
   Fausch K, 2012, CLIN KIDNEY J, V5, P150, DOI 10.1093/ckj/sfs020
   Gowthaman U, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S14
   Gupta S., 2014, BIOMED RES INT, V2014, P1, DOI DOI 10.1155/2014/93201725050379
   Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n
   John J.I., 2005, J CHEM INF MODEL, V45, P177
   Kandakatla Naresh, 2014, Advances in Bioinformatics, V2014, P812148, DOI 10.1155/2014/812148
   Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378
   KUHLMANN W, 1968, CANCER RES, V28, P2375
   Liu JB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147056
   Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999
   Lu YP, 2008, CANCER RES, V68, P2523, DOI 10.1158/0008-5472.CAN-07-5955
   Ma XL, 2005, ACTA PHARMACOL SIN, V26, P500, DOI 10.1111/j.1745-7254.2005.00068.x
   Matthews TP, 2009, J MED CHEM, V52, P4810, DOI 10.1021/jm900314j
   Mauro MD, 2010, REV BRAS FARMACOGN, V20, P334, DOI 10.1590/S0102-695X2010000300008
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   NEHLIG A, 1994, MUTAT RES, V317, P145, DOI 10.1016/0165-1110(94)90022-1
   Popim RC, 2008, CIENC SAUDE COLETIVA, V13, P1331, DOI 10.1590/S1413-81232008000400030
   Primo MS, 2010, REV BRAS FARMACOGN, V20, P340, DOI 10.1590/S0102-695X2010000300009
   dos Santos CBR, 2015, CURR PHARM DESIGN, V21, P4112, DOI 10.2174/1381612821666150528121423
   Rogozin EA, 2008, CARCINOGENESIS, V29, P1228, DOI 10.1093/carcin/bgn016
   Rojas Hugo, 2011, Rev. bras. ter. intensiva, V23, P222, DOI 10.1590/S0103-507X2011000200016
   Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246
   ROWLAND M, 1984, CLIN PHARMACOKINET, V9, P10, DOI 10.2165/00003088-198400091-00002
   Sakkiah S, 2012, ACTA PHARMACOL SIN, V33, P964, DOI 10.1038/aps.2012.21
   SANDERSON DM, 1991, HUM EXP TOXICOL, V10, P261, DOI 10.1177/096032719101000405
   Sarkaria JN, 1999, CANCER RES, V59, P4375
   Scheife R.T., 1989, ANN PHARMACOTHER, V23, P27
   Schneidman-Duhovny D, 2008, J COMPUT BIOL, V15, P737, DOI 10.1089/cmb.2007.0130
   Schneidman-Duhovny D, 2008, NUCLEIC ACIDS RES, V36, pW223, DOI 10.1093/nar/gkn187
   Silva NSR, 2015, BRIT J PHARM RES, V7, P247, DOI 10.9734/BJPR/2015/17591
   Starosyla SA, 2014, BIOORG MED CHEM LETT, V24, P4418, DOI 10.1016/j.bmcl.2014.08.011
   Vieira JB, 2014, MOLECULES, V19, P10670, DOI 10.3390/molecules190810670
   Wang JM, 2009, ANN REP COMP CHEM, V5, P101, DOI 10.1016/S1574-1400(09)00505-2
   WHO, 2014, WORLD CANC REPORT 20
   WILKINSON GR, 1983, DRUG METAB REV, V14, P427, DOI 10.3109/03602538308991396
   Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211
   Woo YT, 2003, QUANTITATIVE STRUCTU
   ZYLBERKATZ E, 1984, CLIN PHARMACOL THER, V36, P133, DOI 10.1038/clpt.1984.151
NR 54
TC 14
Z9 14
U1 0
U2 7
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2018
VL 24
IS 5
BP 576
EP 594
DI 10.2174/1381612823666170711112510
PG 19
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GF1RG
UT WOS:000431712300005
PM 28699538
OA Green Published
DA 2020-12-09
ER

PT J
AU Pereira, ALE
   dos Santos, GB
   Franco, MSF
   Federico, LB
   da Silva, CHTP
   Santos, CBR
AF Pereira, Alison L. E.
   dos Santos, Gabriela B.
   Franco, Marcia S. F.
   Federico, Leonardo B.
   da Silva, Carlos H. T. P.
   Santos, Cleydson B. R.
TI Molecular modeling and statistical analysis in the design of derivatives
   of human dipeptidyl peptidase IV
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article
DE dipeptidyl peptidase IV; molecular modeling; statistical analysis; QSAR
   analysis; pharmacokinetic and toxicological properties
ID INHIBITORS
AB Human dipeptidyl peptidase IV (hDDP-IV) has a considerable importance in inactivation of glucagon-like peptide-1, which is related to type 2 diabetes. One approach for the treatment is the development of small hDDP-IV inhibitors. In order to design better inhibitors, we analyzed 5-(aminomethyl)-6-(2,4-dichlrophenyl)-2-(3,5-dimethoxyphenyl) pyrimidin-4-amine and a set of 24 molecules found in the BindingDB web database for model designing. The analysis of their molecular properties allowed the design of a multiple linear regression model for activity prediction. Their docking analysis allowed visualization of the interactions between the pharmacophore regions and hDDP-IV. After both analyses were performed, we proposed a set of nine molecules in order to predict their activity. Four of them displayed promising activity, and thus, had their docking performed, as well as, the pharmacokinetic and toxicological study. Two compounds from the proposed set showed suitable pharmacokinetic and toxicological characteristics, and therefore, they were considered promising for future synthesis and in vitro studies.
C1 [Pereira, Alison L. E.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Lab Pesquisas Forenses & Genom, Ribeirao Preto, Brazil.
   [dos Santos, Gabriela B.; Franco, Marcia S. F.; Federico, Leonardo B.; da Silva, Carlos H. T. P.; Santos, Cleydson B. R.] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, Ribeirao Preto, SP, Brazil.
   [Santos, Cleydson B. R.] Univ Fed Amapa, Dept Biol Sci, Lab Modeling & Computat Chem, BR-68902280 Macapa, AP, Brazil.
RP Pereira, ALE (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Lab Pesquisas Forenses & Genom, Ribeirao Preto, Brazil.; Santos, CBR (corresponding author), Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, Ribeirao Preto, SP, Brazil.; Santos, CBR (corresponding author), Univ Fed Amapa, Dept Biol Sci, Lab Modeling & Computat Chem, BR-68902280 Macapa, AP, Brazil.
EM alisongonpereira@usp.br; breno@unifap.br
RI FRANCO, MARCIA/O-4220-2018; Silva, Carlos H T P/J-3695-2015; Federico,
   Leonardo Bruno/S-5368-2019
OI FRANCO, MARCIA/0000-0003-0977-4339; Silva, Carlos H T
   P/0000-0001-6049-3650; Federico, Leonardo Bruno/0000-0002-2943-8802
FU Brazilian Agency National Council of Scientific and Technological
   Development (CNPQ)National Council for Scientific and Technological
   Development (CNPq); Sao Paulo Research Foundation (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX This work was supported by the Brazilian Agency National Council of
   Scientific and Technological Development (CNPQ) and Sao Paulo Research
   Foundation (FAPESP).
CR Ajay, 1999, J MED CHEM, V42, P4942, DOI 10.1021/jm990017w
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Biovia D. S., 2015, DISCOVERY STUDIO MOD
   Brooks G. T., 1996, BIOACTIVE COMPOUND D, P1
   Jiang T, 2015, ACS MED CHEM LETT, V6, P602, DOI 10.1021/acsmedchemlett.5b00074
   Juillerat-Jeanneret L, 2014, J MED CHEM, V57, P2197, DOI 10.1021/jm400658e
   Laoui A, 2011, J COMPUT CHEM, V32, P1944, DOI 10.1002/jcc.21778
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999
   Ma XL, 2005, ACTA PHARMACOL SIN, V26, P500, DOI 10.1111/j.1745-7254.2005.00068.x
   Marchant CA, 2008, TOXICOL MECH METHOD, V18, P177, DOI 10.1080/15376510701857320
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Padilha EC, 2016, J BRAZIL CHEM SOC, V27, P1636, DOI 10.5935/0103-5053.20160043
   Patel BD, 2015, MED CHEM RES, V24, P1060, DOI 10.1007/s00044-014-1178-7
   Peters JU, 2004, BIOORG MED CHEM LETT, V14, P1491, DOI 10.1016/j.bmcl.2004.01.019
   dos Santos CBR, 2015, CURR PHARM DESIGN, V21, P4112, DOI 10.2174/1381612821666150528121423
   Schneidman-Duhovny D, 2008, NUCLEIC ACIDS RES, V36, pW223, DOI 10.1093/nar/gkn187
   Schwehm C, 2015, ACS MED CHEM LETT, V6, P324, DOI 10.1021/ml500503n
   Silva NSR, 2015, BRIT J PHARM RES, V7, P247, DOI 10.9734/BJPR/2015/17591
   STATSOFT Inc, 2005, STAT DAT AN SOFTW SY
NR 20
TC 15
Z9 15
U1 4
U2 17
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
PY 2018
VL 36
IS 2
BP 318
EP 334
DI 10.1080/07391102.2016.1277163
PG 17
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FZ8PC
UT WOS:000427871100003
PM 28027711
DA 2020-12-09
ER

PT J
AU Ferreira, JV
   Chaves, GA
   Marino, BLB
   Sousa, KPA
   Souza, LR
   Brito, MFB
   Teixeira, HRC
   da Silva, CHTP
   Santos, CBR
   Hage-Melim, LIS
AF Ferreira, Jaderson V.
   Chaves, Gisele A.
   Marino, Bianca L. B.
   Sousa, Kessia P. A.
   Souza, Lucilene R.
   Brito, Maiara F. B.
   Teixeira, Hueldem R. C.
   da Silva, Carlos H. T. P.
   Santos, Cleydson B. R.
   Hage-Melim, Lorane I. S.
TI Cannabinoid Type 1 Receptor (CB1) Ligands with Therapeutic Potential for
   Withdrawal Syndrome in Chemical Dependents of Cannabis sativa
SO CHEMMEDCHEM
LA English
DT Article; Proceedings Paper
CT 24th National Meeting in Medicinal Chemistry (NMMC) together with the
   10th Young Medicinal Chemists Symposium on Nuove Prospettive in Chimica
   Farmaceutica (NPCF)
CY SEP 11-14, 2016
CL Perugia, ITALY
DE Cannabis sativa; computational chemistry; medicinal chemistry;
   structural similarity; virtual screening
ID MARIJUANA USE; DRUG; PHARMACOLOGY; PERMEABILITY; BRAIN; EXPRESSION;
   PREDICTION; STEMPHOL; ANXIETY; DESIGN
AB Cannabis sativa withdrawal syndrome is characterized mainly by psychological symptoms. By using computational tools, the aim of this study was to propose drug candidates for treating withdrawal syndrome based on the natural ligands of the cannabinoid type 1 receptor (CB1). One compound in particular, 2-n-butyl-5-n-pentylbenzene-1,3-diol (ZINC1730183, also known as stemphol), showed positive predictions as a human CB1 ligand and for facile synthetic accessibility. Therefore, ZINC1730183 is a favorable candidate scaffold for further research into pharmacotherapeutic alternatives to treat C. sativa withdrawal syndrome.
C1 [Ferreira, Jaderson V.; Chaves, Gisele A.; Marino, Bianca L. B.; Sousa, Kessia P. A.; Souza, Lucilene R.; Brito, Maiara F. B.; Teixeira, Hueldem R. C.; Hage-Melim, Lorane I. S.] Univ Fed Amapa, Lab Pharmaceut & Med Chem, Rod JK,Km 02, Macapa, Brazil.
   [da Silva, Carlos H. T. P.] Univ Sao Paulo, Dept Pharmaceut Sci, Fac Pharmaceut Sci Ribeirao Preto, Ribeirao Preto, Brazil.
   [Santos, Cleydson B. R.] Univ Fed Amapa, Lab Modeling & Computat Chem, Rod JK,Km 02, Macapa, Brazil.
RP Hage-Melim, LIS (corresponding author), Univ Fed Amapa, Lab Pharmaceut & Med Chem, Rod JK,Km 02, Macapa, Brazil.
EM loranehage@gmail.com
RI Hage-Melim, Lorane I S/N-4214-2015
OI Hage-Melim, Lorane I S/0000-0002-7851-7363; Ferreira,
   Jaderson/0000-0002-9355-9342
CR Abood ME, 1997, BIOCHEM PHARMACOL, V53, P207, DOI 10.1016/S0006-2952(96)00727-7
   ACHENBACH H, 1979, CHEM BER-RECL, V112, P209, DOI 10.1002/cber.19791120119
   [Anonymous], 2013, DISC STUD VERS 4 0
   [Anonymous], 2011, QIKPROP VERS 5 1
   ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U
   Augustijns P, 2014, EUR J PHARM SCI, V57, P322, DOI 10.1016/j.ejps.2013.08.027
   Balbach S, 2004, INT J PHARM, V275, P1, DOI 10.1016/j.ijpharm.2004.01.034
   Barreiro EJ, 1997, QUIM NOVA, V20, P300, DOI 10.1590/S0100-40421997000300011
   Beilin M, 2000, J OCUL PHARMACOL TH, V16, P217, DOI 10.1089/jop.2000.16.217
   Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086
   Bouaboula M, 1999, FEBS LETT, V449, P61, DOI 10.1016/S0014-5793(99)00395-6
   Budney AJ, 2004, AM J PSYCHIAT, V161, P1967, DOI 10.1176/appi.ajp.161.11.1967
   Budney AJ, 2010, REV BRAS PSIQUIATR, V32, pS46
   Carpenter TS, 2014, BIOPHYS J, V107, P630, DOI 10.1016/j.bpj.2014.06.024
   Chen K, 1997, DRUG ALCOHOL DEPEN, V46, P53, DOI 10.1016/S0376-8716(97)00047-1
   Compton D. R., 1998, J PHARMACOL EXP THER, V263, P1118
   Copeland J, 2001, J SUBST ABUSE TREAT, V20, P45, DOI 10.1016/S0740-5472(00)00148-3
   Cornelius JR, 1999, ADDICT BEHAV, V24, P111, DOI 10.1016/S0306-4603(98)00050-1
   Davies SN, 2002, NEUROPHARMACOLOGY, V42, P993, DOI 10.1016/S0028-3908(02)00060-6
   Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5
   DEVANE WA, 1988, MOL PHARMACOL, V34, P605
   Doak BC, 2014, CHEM BIOL, V21, P1115, DOI 10.1016/j.chembiol.2014.08.013
   Eckert H, 2007, DRUG DISCOV TODAY, V12, P225, DOI 10.1016/j.drudis.2007.01.011
   Filimonov DA, 2014, CHEM HETEROCYCL COM+, V50, P444, DOI 10.1007/s10593-014-1496-1
   Friedrich A, 2011, REGUL TOXICOL PHARM, V60, P225, DOI 10.1016/j.yrtph.2011.04.001
   GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046
   Gissi A, 2014, ALTEX-ALTERN ANIM EX, V31, P23, DOI 10.14573/altex.1305221
   Gleeson MP, 2011, CURR TOP MED CHEM, V11, P358
   Godden JW, 2000, J CHEM INF COMP SCI, V40, P163, DOI 10.1021/ci990316u
   Hall W, 2014, DRUG TEST ANAL, V6, P39, DOI 10.1002/dta.1506
   Hall WD, 2005, DRUG ALCOHOL REV, V24, P39, DOI 10.1080/09595230500126698
   Haney M, 2003, PSYCHOPHARMACOLOGY, V165, P157, DOI 10.1007/s00213-002-1210-3
   Hanus LO, 2010, CURR MED CHEM, V17, P1341, DOI 10.2174/092986710790980096
   Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161
   Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030
   Jumpathong J, 2010, NAT PROD COMMUN, V5, P567
   Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284
   Kirchmair J, 2015, NAT REV DRUG DISCOV, V14, P387, DOI 10.1038/nrd4581
   Koes D. R., 2012, NUCLEIC ACIDS RES, V40
   Koes DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134697
   Lapoint J, 2011, CLIN TOXICOL, V49, P760, DOI 10.3109/15563650.2011.609822
   Lovett C, 2015, REANIMATION, V24, P527, DOI 10.1007/s13546-015-1104-4
   Ma XL, 2005, ACTA PHARMACOL SIN, V26, P500, DOI 10.1111/j.1745-7254.2005.00068.x
   Martellotta MC, 1998, NEUROSCIENCE, V85, P327, DOI 10.1016/S0306-4522(98)00052-9
   MARUMO S, 1985, AGR BIOL CHEM TOKYO, V49, P1521, DOI 10.1080/00021369.1985.10866933
   Mason JS, 1999, J MED CHEM, V42, P3251, DOI 10.1021/jm9806998
   MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0
   McRae A. L., 2000, P 62 ANN SCI M COLL
   McRae AL, 2003, J SUBST ABUSE TREAT, V24, P369, DOI 10.1016/S0740-5472(03)00041-2
   Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739
   MECHOULAR, 1967, J AM CHEM SOC, V89, P4552, DOI DOI 10.1021/JA00993A072
   MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0
   Padilha EC, 2016, J BRAZIL CHEM SOC, V27, P1636, DOI 10.5935/0103-5053.20160043
   Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247
   Schneidman-Duhovny D, 2008, J COMPUT BIOL, V15, P737, DOI 10.1089/cmb.2007.0130
   Schneidman-Duhovny D, 2008, NUCLEIC ACIDS RES, V36, pW223, DOI 10.1093/nar/gkn187
   Schoeler T, 2013, SUBST ABUSE REHABIL, V4, P11, DOI 10.2147/SAR.S25869
   Shen MX, 1998, MOL PHARMACOL, V54, P459
   STODOLA FH, 1973, PHYTOCHEMISTRY, V12, P1797, DOI 10.1016/0031-9422(73)80406-6
   Stone JM, 2000, PLANT CELL, V12, P1811, DOI 10.1105/tpc.12.10.1811
   Susimaire P.-M, 2014, CURR PHYS CHEM, V4, P35
   TSOU K, 1995, EUR J PHARMACOL, V280, pR13, DOI 10.1016/0014-2999(95)00360-W
   Verdurand M., 2011, INT J MOL IMAGING
   Wang NN, 2016, J CHEM INF MODEL, V56, P763, DOI 10.1021/acs.jcim.5b00642
   Wang YL, 2015, Q REV BIOPHYS, V48, P488, DOI 10.1017/S0033583515000190
   Wang ZH, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0130-x
   Yuan YX, 2011, J CHEM INF MODEL, V51, P1083, DOI 10.1021/ci100350u
   Zanettini C., 2011, NEUROSCIENCE, V5, P1
   Zvolensky MJ, 2009, EXP CLIN PSYCHOPHARM, V17, P31, DOI 10.1037/a0014961
NR 69
TC 7
Z9 7
U1 0
U2 8
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1860-7179
EI 1860-7187
J9 CHEMMEDCHEM
JI ChemMedChem
PD AUG 22
PY 2017
VL 12
IS 16
BP 1408
EP 1416
DI 10.1002/cmdc.201700129
PG 9
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GC2DL
UT WOS:000429592300019
PM 28417566
OA Bronze
DA 2020-12-09
ER

PT J
AU Padilha, EC
   Serafim, RB
   Sarmiento, DYR
   Santos, CF
   Santos, CBR
   Silva, CHTP
AF Padilha, Elias C.
   Serafim, Rodolfo B.
   Sarmiento, Deisy Y. R.
   Santos, Cesar F.
   Santos, Cleydson B. R.
   Silva, Carlos H. T. P.
TI New PPAR alpha/gamma/delta Optimal Activator Rationally Designed by
   Computational Methods
SO JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
LA English
DT Article
DE type 2 diabetes; PPAR pan agonist; molecular modeling; ADMET prediction
ID MYOCARDIAL-INFARCTION; GENE-EXPRESSION; RECEPTOR PPAR; FATTY-ACIDS;
   PROLIFERATOR; AGONIST; TISSUE; THIAZOLIDINEDIONES; IDENTIFICATION;
   MODULATORS
AB The peroxisome proliferator-activated receptor gamma (PPAR gamma) is a nuclear receptor that acts as a transcription factor, regulating glucose, lipid and inflammation signaling and it is exploited in type 2 diabetes treatment. However, the selective activation of this PPAR subtype has been linked to important adverse effects which can be mitigated through concomitant activation of PPAR alpha and PPAR delta. In this study, we proposed new PPAR gamma agonists using PharmaGist Server for pharmacophore prediction, the molecular docking was performed by GOLD (genetic optimization for ligand docking) v2.2, AutoDock 4.2 and AutoDock Vina 1.1 and QikProp v4.0 and Derek for absorption, distribution, metabolism, excretion and toxicity (ADMET) assessment. One molecule showed high predicted affinity to PPAR gamma and favorable pharmacokinetic and toxicity properties. It was then evaluated against PPAR alpha and PPAR delta and showed greater affinity to these receptors than the controls. Therefore this molecule is a promising drug lead for the development of derivatives and for the treatment of metabolic syndrome with the benefits of a PPAR pan activation.
C1 [Padilha, Elias C.] Univ Estadual Paulista, Dept Principios Ativos Nat & Toxicol, Fac Ciencias Farmaceut, Rodovia Araraquara Jau Km 1, BR-14801902 Araraquara, SP, Brazil.
   [Padilha, Elias C.; Serafim, Rodolfo B.; Sarmiento, Deisy Y. R.; Santos, Cleydson B. R.; Silva, Carlos H. T. P.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Ciencias Farmaceut, Av Prof Cafe, BR-14040903 Ribeirao Preto, SP, Brazil.
   [Serafim, Rodolfo B.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Sarmiento, Deisy Y. R.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Santos, Cesar F.; Santos, Cleydson B. R.] Univ Fed Amapa, Dept Ciencias Biol, Lab Modelagem & Quim Computat, Rod Juscelino Kubitschek,Km 02,Jardim Marco Zero, BR-68902280 Macapa, AP, Brazil.
RP Santos, CBR (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Ciencias Farmaceut, Av Prof Cafe, BR-14040903 Ribeirao Preto, SP, Brazil.; Santos, CBR (corresponding author), Univ Fed Amapa, Dept Ciencias Biol, Lab Modelagem & Quim Computat, Rod Juscelino Kubitschek,Km 02,Jardim Marco Zero, BR-68902280 Macapa, AP, Brazil.
EM breno@unifap.br
RI ; Padilha, Elias/J-5671-2015
OI Serafim, Rodolfo/0000-0002-8884-2303; Padilha, Elias/0000-0002-3794-9389
FU Brazilian Agency National Council of Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq); Sao Paulo Research Foundation (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX We gratefully acknowledge the financial support provided by the
   Brazilian Agency National Council of Scientific and Technological
   Development (CNPq) and Sao Paulo Research Foundation (FAPESP).
CR Barrera G, 2008, PPAR RES, V2008, DOI 10.1155/2008/524671
   Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354
   Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245
   Chen W., 2014, PLOS ONE, V9, P96056
   CONLON D, 2006, BR J DIABETES VASC D, V6, P135
   da Silva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030356
   da Silva FMC, 2013, BIOORG MED CHEM LETT, V23, P5795, DOI 10.1016/j.bmcl.2013.09.010
   EDER E, 1991, CHEM RES TOXICOL, V4, P50, DOI 10.1021/tx00019a007
   Garcia GM, 2015, J CONTROL RELEASE, V209, P207, DOI 10.1016/j.jconrel.2015.04.033
   Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920
   Guo Y, 2007, TOXICOL SCI, V96, P294, DOI 10.1093/toxsci/kfm009
   Hage-Melim L. I., 2014, CURR BIOACT COMPD, V10, P147
   Harrington WW, 2007, PPAR RES, V2007, DOI 10.1155/2007/97125
   He B. K., 2012, RES, V2012, P546
   Kidani Y, 2012, IMMUNOL REV, V249, P72, DOI 10.1111/j.1600-065X.2012.01153.x
   MacDonald MR, 2011, DIABETES CARE, V34, P1394, DOI 10.2337/dc10-2398
   MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Nevin DK, 2012, J MED CHEM, V55, P4978, DOI 10.1021/jm300068n
   Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198
   Oyama T, 2009, ACTA CRYSTALLOGR D, V65, P786, DOI 10.1107/S0907444909015935
   Pignone M, 2007, CLIN DIABETES, V25, P123, DOI 10.2337/diaclin.25.4.123
   Pourcet Benoit, 2006, Expert Opin Emerg Drugs, V11, P379, DOI 10.1517/14728214.11.3.379
   dos Santos CBR, 2015, CURR PHARM DESIGN, V21, P4112, DOI 10.2174/1381612821666150528121423
   Rubenstrunk A, 2007, BBA-MOL CELL BIOL L, V1771, P1065, DOI 10.1016/j.bbalip.2007.02.003
   Sadasivuni MK, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-83
   Santin JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076894
   Scheen Andre J., 2001, Drug Safety, V24, P873, DOI 10.2165/00002018-200124120-00002
   SCHOONJANS K, 1995, J BIOL CHEM, V270, P19269, DOI 10.1074/jbc.270.33.19269
   Schoonjans K, 1996, J LIPID RES, V37, P907
   Sfeir Z, 1997, PROSTAG LEUKOTR ESS, V57, P17, DOI 10.1016/S0952-3278(97)90487-7
   Soccio RE, 2014, CELL METAB, V20, P573, DOI 10.1016/j.cmet.2014.08.005
   Su JH, 2014, DRUG DES DEV THER, V8, P2555, DOI 10.2147/DDDT.S73476
   Tolman Keith G, 2003, Clin Liver Dis, V7, P369, DOI 10.1016/S1089-3261(03)00020-5
   TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X
   van de Waterbeemd H, 2003, NAT REV DRUG DISCOV, V2, P192, DOI 10.1038/nrd1032
   Vieira JB, 2014, MOLECULES, V19, P10670, DOI 10.3390/molecules190810670
   Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294
   Wickens P, 2007, BIOORG MED CHEM LETT, V17, P4369, DOI 10.1016/j.bmcl.2007.03.057
   Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033669
NR 40
TC 14
Z9 14
U1 1
U2 11
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0103-5053
EI 1678-4790
J9 J BRAZIL CHEM SOC
JI J. Braz. Chem. Soc.
PD SEP
PY 2016
VL 27
IS 9
BP 1636
EP 1647
DI 10.5935/0103-5053.20160043
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA DX7RF
UT WOS:000384585800014
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU Melo, SD
   Diniz, JED
   Guimaraes, JH
   Costa, JD
   Brasil, DDB
   de Morais, SSD
   Brito, DC
   Carvalho, JCT
   dos Santos, CBR
   da Silva, DL
AF Melo, Selma dos Santos
   de Melo Diniz, Joel Estevao
   Guimaraes, Jonilson Heslei
   Costa, Josivan da Silva
   Barros Brasil, Davi do Socorro
   dos Santos de Morais, Silvia Simone
   Brito, Damio Chaves
   Tavares Carvalho, Jose Carlos
   Rodrigues dos Santos, Cleydson Breno
   da Silva, Denilson Luz
TI Production and characterization of absorbent heat from the bark of
   residual Brazil nut bark (Bertholletia Excelsa l.)
SO CHEMISTRY CENTRAL JOURNAL
LA English
DT Article
DE Absorbent; Brazil nut; Thermal activation
ID ACTIVATED CARBON; ADSORPTION; CHROMIUM; BIOMASS
AB Background: The increasing efforts to reduce the environmental impact on the Amazon's natural resources are focusing on watercourses that pass through effluents with high concentrations of heavy metals. The adsorption by absorbent is one of the methods used to remove metallic ions. In this assignment, the preparation of activated carbon from Brazil nut bark (Bertholletia excelsa l.), which is a waste material produced from the use of seeds in foodstuffs and cosmetics, is shown.
   Results: The absorbent was carbonized at 400 degrees C in 3 h and activated at 800 degrees C in 2 h, having received the name of AC2, and, the specific area, pore size, real and apparent densities, porosity, scanning electron microscopy (SEM) coupled to energy-dispersive X-ray spectroscopy (EDS), X-ray diffraction (XRD), pH, moisture, fixed carbon and surface functional groups by Boehm method and Fourier transformed infrared spectroscopy (FTIR) were characterized. According to the results, the carbon presented alkaline characteristic, mesoporosity, average pore diameters of 2.203 nm and specific surface area by BET of 464.835 m(2) g(-1).
   The efficiency of removal was performed in synthetic solutions of copper sulphate (II) pentahydrate (CuSO4.5H(2)O), evaluating the influence of pH, initial concentration of copper solution (II), particle diameter and time contact of the adsorbent in solution. The results of higher removal percentages were to pH 5.09, initial concentration of 50, 100 and 150 mg(-1) diameter 0.595 < D < 1.19 mm and time contact of 5 min.
   Conclusions: The Brazil nut bark is shown to be an important bio-waste, being an excellent alternative material for the low-cost production of activated carbon for use in processes involving iterations of adsorption.
C1 [Melo, Selma dos Santos; da Silva, Denilson Luz] Fed Univ Para, Lab Environm Proc, BR-66075110 Belem, Para, Brazil.
   [de Melo Diniz, Joel Estevao; Guimaraes, Jonilson Heslei; dos Santos de Morais, Silvia Simone; Brito, Damio Chaves] State Univ Amapa, Lab Phys Chem, BR-68900070 Macapa, Amapa, Brazil.
   [de Melo Diniz, Joel Estevao; Costa, Josivan da Silva; Tavares Carvalho, Jose Carlos; Rodrigues dos Santos, Cleydson Breno] Univ Fed Amapa, Lab Gen & Analyt Chem, BR-68902280 Macapa, Amapa, Brazil.
   [Barros Brasil, Davi do Socorro] Fed Univ Para, Inst Technol, BR-66075110 Belem, Para, Brazil.
RP Melo, SD (corresponding author), Fed Univ Para, Lab Environm Proc, Rua Augusto Correa 01, BR-66075110 Belem, Para, Brazil.
EM selmaengquimica@yahoo.com.br
RI Carvalho, Jose Carlos Tavares/S-2427-2019; da Silva Costa,
   Josivan/AAA-9565-2020; Tavares Carvalho, Jose carlos/C-7220-2013;
   Santos, Cleydson/G-5744-2015
OI Carvalho, Jose Carlos Tavares/0000-0003-3662-9794; da Silva Costa,
   Josivan/0000-0001-5069-5283; Tavares Carvalho, Jose
   carlos/0000-0003-3662-9794; Santos, Cleydson/0000-0001-9878-6256; brito,
   daimio/0000-0003-3657-6530; Rodrigues dos Santos, Cleydson
   Breno/0000-0002-0271-335X
FU CAPESCAPES
FX To CAPES for granting the scholarship. To the Laboratory of
   Environmental Processes (LPA/FEQ/UFPA), the Laboratory of Electron
   Microscopy (LABMEV/IG/UFPA) and the Laboratory of Oil Chemistry
   (LCO/FQ/UFPA) of the Federal University of Para, where it was possible
   to perform analyzes for the development of this work.
CR Bansal R. C., 2005, ACTIVATED CARBON ADS
   BOEHM HP, 1994, CARBON, V32, P759, DOI 10.1016/0008-6223(94)90031-0
   Boehm HP, 2002, CARBON, V40, P145, DOI 10.1016/S0008-6223(01)00165-8
   Boniolo MR, 2010, QUIM NOVA, V33, P547, DOI 10.1590/S0100-40422010000300010
   Borba CE, 2006, THESIS CAMPINAS STAT
   Capobianco G, 2004, PREPARATION ACTIVATE
   Claudino A, 2003, THESIS FEDERAL U SAN
   Dabrowski A, 2005, CHEMOSPHERE, V58, P1049, DOI 10.1016/j.chemosphere.2004.09.067
   Di Bernardo L, 2005, METHODS TECHNIQUES W
   Franchi JG, 2004, THESIS SAO PAULO U B
   Gregg S.J., 1982, ADSORPTION SURFACE A
   Homma AKO, 2004, CIENCIA HOJE, V34, P202
   Karagoz S, 2008, BIORESOURCE TECHNOL, V99, P6214, DOI 10.1016/j.biortech.2007.12.019
   Lichawska ME, 2014, CHEM CENT J, V8, DOI 10.1186/s13065-014-0050-7
   Liu SX, 2007, J HAZARD MATER, V141, P315, DOI 10.1016/j.jhazmat.2006.07.006
   Melo SS, 2012, THESIS FEDERAL U PAR
   Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060
   Ng S, 2014, CHEM CENT J, V8, DOI 10.1186/s13065-014-0055-2
   Nunes AA, 2009, BIORESOURCE TECHNOL, V100, P1786, DOI 10.1016/j.biortech.2008.09.032
   Peruzzo LC, 2003, THESIS FEDERAL U SAN
   Pinto M. V. S, 2012, ACTA AMAZONICA, V42, P541
   Ramos MAB, 2005, THESIS FEDERAL U PAR
   Schettino MA, 2007, QUIM NOVA, V30, P1663, DOI 10.1590/S0100-40422007000700031
   Souza Renata Santos, 2009, Acta Amaz., V39, P661, DOI 10.1590/S0044-59672009000300022
   Tan IAW, 2007, CHEM ENG J, V127, P111, DOI 10.1016/j.cej.2006.09.010
   Yakout SM, 2014, CHEM CENT J, V8, DOI 10.1186/s13065-014-0052-5
   Yang R. T., 2003, ADSORBENTS FUNDAMENT
NR 27
TC 3
Z9 3
U1 0
U2 16
PU SPRINGEROPEN
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1752-153X
J9 CHEM CENT J
JI Chem. Cent. J.
PD JUN 16
PY 2015
VL 9
AR 36
DI 10.1186/s13065-015-0114-3
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CM1MG
UT WOS:000357444400001
PM 26150893
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU dos Santos, CBR
   Lobato, CC
   Braga, FS
   Costa, JD
   Favacho, HAS
   Carvalho, JCT
   Macedo, WJD
   Brasil, DDB
   da Silva, CHTD
   Hage-Melim, LID
AF Rodrigues dos Santos, Cleydson Breno
   Lobato, Cleison Carvalho
   Braga, Francinaldo Sarges
   Costa, Josivan da Silva
   Silva Favacho, Hugo Alexandre
   Tavares Carvalho, Jose Carlos
   da Cruz Macedo, Williams Jorge
   Barros Brasil, Davi Do Socorro
   Tomich de Paula da Silva, Carlos Henrique
   da Silva Hage-Melim, Lorane Izabel
TI Rational Design of Antimalarial Drugs Using Molecular Modeling and
   Statistical Analysis
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE ADME/Tox; artemisinin; HF/6-31G**; molecular modeling; quantum chemical
   methods; statistical analysis
ID DIHYDROARTEMISININ DERIVATIVES; ARTEMISININ DERIVATIVES;
   INTESTINAL-ABSORPTION; QINGHAOSU ARTEMISININ; QSAR; PERMEABILITY;
   DESCRIPTORS; PREDICTION; ANALOGS; POTENT
AB Artemisinin is an antimalarial compound isolated from Artemisia annua L. that is effective against Plasmodium falciparum. This paper proposes the development of new antimalarial derivatives of artemisinin from a SAR study and statistical analysis by multiple linear regression (MLR). The HF/6-31G** method was used to determine the molecular properties of artemisinin and 10 derivatives with antimalarial action. MEP maps and molecular docking were used to study the interface between ligand and receptor (heme). The Pearson correlation was used to choose the most important properties interrelated to the antimalarial activity: Hydration Energy (HE), Energy of the Complex (Ecplex), bond length (FeO1), and maximum index of R/Electronegativity of Sanderson (RTe+). After the Pearson correlation, 72 MLR models were built between antimalarial activity and molecular properties; the statistical quality of the models was evaluated by means of correlation coefficient (r), squared correlation coefficient (r(2)), explained variance (adjusted R-2), standard error of estimate (SEE), and variance ratio (F), and only four models showed predictive ability. The selected models were used to predict the antimalarial activity of ten new artemisinin derivatives (test set) with unknown activity, and only eight of these compounds were predicted to be more potent than artemisinin, and were therefore subjected to theoretical studies of pharmacokinetic and toxicological properties. The test set showed satisfactory results for six new artemisinin compounds which is a promising factor for future synthesis and biological assays.
C1 [Rodrigues dos Santos, Cleydson Breno; Lobato, Cleison Carvalho; Braga, Francinaldo Sarges; Costa, Josivan da Silva; da Silva Hage-Melim, Lorane Izabel] Univ Fed Amapa, Lab Modeling & Computat Chem, BR-68902280 Macapa, Amapa, Brazil.
   [Rodrigues dos Santos, Cleydson Breno; Lobato, Cleison Carvalho; Tavares Carvalho, Jose Carlos; da Silva Hage-Melim, Lorane Izabel] Univ Fed Amapa, Postgrad Program Pharmaceut Sci, BR-68902280 Macapa, Amapa, Brazil.
   [Rodrigues dos Santos, Cleydson Breno; Tomich de Paula da Silva, Carlos Henrique] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, BR-14040903 Sao Paulo, Brazil.
   [Silva Favacho, Hugo Alexandre; Tavares Carvalho, Jose Carlos] Univ Fed Amapa, Lab Drug Res, Sch Pharmaceut Sci, BR-68902280 Macapa, Amapa, Brazil.
   [Costa, Josivan da Silva; da Cruz Macedo, Williams Jorge] Fed Rural Univ Amazonia, Lab Mol Modeling & Simulat Syst, BR-68700030 Capanema, Para, Brazil.
   [Costa, Josivan da Silva; da Cruz Macedo, Williams Jorge] Fed Univ Para, Inst Technol, BR-66075900 Belem, Para, Brazil.
RP dos Santos, CBR (corresponding author), Univ Fed Amapa, Lab Modeling & Computat Chem, BR-68902280 Macapa, Amapa, Brazil.
EM breno@unifap.br
RI Hage-Melim, Lorane/N-4370-2015; Hage-Melim, Lorane I S/N-4214-2015;
   Santos, Cleydson/G-5744-2015; da Silva Costa, Josivan/AAA-9565-2020;
   Tavares Carvalho, Jose carlos/C-7220-2013
OI Hage-Melim, Lorane I S/0000-0002-7851-7363; Santos,
   Cleydson/0000-0001-9878-6256; da Silva Costa,
   Josivan/0000-0001-5069-5283; Tavares Carvalho, Jose
   carlos/0000-0003-3662-9794; Rodrigues dos Santos, Cleydson
   Breno/0000-0002-0271-335X; Favacho, Hugo/0000-0003-0662-5215; Macedo,
   Williams/0000-0002-0457-6993
FU Brazilian Agency National Council of Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq) [306676/2010-9]; Institute of Exact and Natural
   Sciences of Federal University of Para (UFPA-Brazil)
FX We gratefully acknowledge the support provided by the Brazilian Agency
   National Council of Scientific and Technological Development (CNPq Proc.
   306676/2010-9) and Institute of Exact and Natural Sciences of Federal
   University of Para (UFPA-Brazil) for use of the GaussView and Gaussian
   software. The authors would like to thank the Postgraduate Program in
   Pharmaceutical Sciences, FAPESP/USP, Laboratory of Modeling and
   Computational Chemistry (LMCC) of Federal University of Amapa
   (UNIFAP-Brazil) and Laboratory of Molecular Modeling and Simulation
   System of Federal Rural University of Amazonia (UFRA-Brazil) for
   computational support.
CR Ajay, 1999, J MED CHEM, V42, P4942, DOI 10.1021/jm990017w
   AMES BN, 1972, P NATL ACAD SCI USA, V69, P3128, DOI 10.1073/pnas.69.11.3128
   [Anonymous], 2000, MOD EXT HYPERCHEM RE
   Araujo JQ, 2008, BIOORGAN MED CHEM, V16, P5021, DOI 10.1016/j.bmc.2008.03.033
   Arav-Boger R, 2005, ANNU REV PHARMACOL, V45, P565, DOI 10.1146/annurev.pharmtox.45.120403.095946
   BERNARDINELLI G, 1994, INT J QUANTUM CHEM, P117
   Biagini GA, 2005, CURR OPIN PHARMACOL, V5, P473, DOI 10.1016/j.coph.2005.05.004
   BROSSI A, 1988, J MED CHEM, V31, P645, DOI 10.1021/jm00398a026
   Cardoso FJB, 2008, J MOL MODEL, V14, P39, DOI 10.1007/s00894-007-0249-9
   Cardoso FJB, 2007, INTERNET ELECT J MOL, V6, P122
   Carvalho I, 2005, J CHEM EDUC, V82, P588, DOI 10.1021/ed082p588
   Chatterjee S, 2000, REGRESSION ANAL EXAM
   Cohen N. C., 1996, GUIDEBOOK MOL MODELI
   Creek DJ, 2008, J MOL GRAPH MODEL, V27, P394, DOI 10.1016/j.jmgm.2008.06.008
   Costa MD, 2007, QUIM NOVA, V30, P25, DOI 10.1590/S0100-40422007000100006
   Debnath B, 2003, BIOORGAN MED CHEM, V11, P5493, DOI 10.1016/j.bmc.2003.09.022
   DIUDEA MV, 2000, QSPR QSAR STUDIES MO
   Estrada E, 2001, J MOL GRAPH MODEL, V20, P54, DOI 10.1016/S1093-3263(01)00100-0
   Flukiger P, 2002, MOLEKEL
   Grant GH, 1996, COMPUTATIONAL CHEM
   Guha R, 2004, J CHEM INF COMP SCI, V44, P1440, DOI 10.1021/ci0499469
   Haynes RK, 1996, TETRAHEDRON LETT, V37, P253, DOI 10.1016/0040-4039(95)02141-8
   Hou T, 2008, EXPERT OPIN DRUG MET, V4, P759, DOI 10.1517/17425255.4.6.759 
   Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205
   Jefford CW, 2001, CURR MED CHEM, V8, P1803, DOI 10.2174/0929867013371608
   KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571
   Kujawski J., 2012, CMST, V18, P81, DOI DOI 10.12921/cmst.2012.18.02.81-88
   Labet V, 2013, PHOTOCH PHOTOBIO SCI, V12, P1509, DOI 10.1039/c3pp50069a
   Leach A.R., 2001, MOL MODELLING PRINCI
   Lin AJ, 1997, J MED CHEM, V40, P1396, DOI 10.1021/jm9607919
   LIN AJ, 1995, J MED CHEM, V38, P764, DOI 10.1021/jm00005a004
   LIN AJ, 1992, J MED CHEM, V35, P1639, DOI 10.1021/jm00087a021
   LIN AJ, 1987, J MED CHEM, V30, P2147, DOI 10.1021/jm00394a037
   Lisgarten JN, 1998, J CHEM CRYSTALLOGR, V28, P539, DOI 10.1023/A:1023244122450
   Ma XL, 2005, ACTA PHARMACOL SIN, V26, P500, DOI 10.1111/j.1745-7254.2005.00068.x
   Morris G, 1998, AUTODOCK VERSION 2 4
   O'Neill PM, 2005, EXPERT OPIN INV DRUG, V14, P1117, DOI 10.1517/13543784.14.9.1117
   O'Neill PM, 1999, J MED CHEM, V42, P5487, DOI 10.1021/jm9903545
   Opsenica DM, 2009, J SERB CHEM SOC, V74, P1155, DOI 10.2298/JSC0911155O
   Pinheiro JC, 2003, QSAR COMB SCI, V22, P830, DOI 10.1002/qsar.200330829
   Politzer P, 2002, THEOR CHEM ACC, V108, P134, DOI 10.1007/s00214-002-0363-9
   POSNER GH, 1995, J MED CHEM, V38, P2273, DOI 10.1021/jm00013a001
   Ribeiro FAD, 2003, J MOL STRUC-THEOCHEM, V663, P109, DOI 10.1016/j.theochem.2003.08.107
   Ridley RG, 2003, NATURE, V424, P887, DOI 10.1038/424887a
   dos Santos CBR, 2014, REV THEOR SCI, V2, P91, DOI 10.1166/rits.2014.1016
   dos Santos CBR, 2014, J COMPUT THEOR NANOS, V11, P553, DOI 10.1166/jctn.2014.3394
   Sant'Anna CMR, 2002, QUIM NOVA, V25, P505, DOI 10.1590/S0100-40422002000300027
   Santos C. B. R., 2014, COMPUT MOL BIOSCI, V4, P1, DOI [10.4236/cmb.2014.41001, DOI 10.4236/CMB.2014.41001]
   Santos C. B. R., 2013, COMP MOL BIOSC, V3, P66
   Santos CBR, 2014, MOLECULES, V19, P367, DOI 10.3390/molecules19010367
   Silva NSR, 2014, COMP MOL BIOSC, V4, P47, DOI DOI 10.4236/CMB.2014.44006
   SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204
   Srivastava M, 2010, CURR RES J BIOL SCI, V2, P83
   StatSoft Inc, 2004, STATISTICA DAT AN SO
   Todeschini R, 1998, PERSPECT DRUG DISCOV, V9-11, P355, DOI 10.1023/A:1027284627085
   Tonmunphean S, 2001, J MOL MODEL, V7, P26, DOI 10.1007/s008940100013
   van de Waterbeemd H, 2003, NAT REV DRUG DISCOV, V2, P192, DOI 10.1038/nrd1032
   Vieira JB, 2014, MOLECULES, V19, P10670, DOI 10.3390/molecules190810670
   Vojtechovsky J, 1999, BIOPHYS J, V77, P2153, DOI 10.1016/S0006-3495(99)77056-6
   Wermuth CG, 2009, PRACTICE MED CHEM
   White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]
   Woolfrey JR, 1998, J COMPUT AID MOL DES, V12, P165, DOI 10.1023/A:1007967517859
   Yamashita S, 2000, EUR J PHARM SCI, V10, P195, DOI 10.1016/S0928-0987(00)00076-2
   Yazdanian M, 1998, PHARMACEUT RES, V15, P1490, DOI 10.1023/A:1011930411574
   Yee SY, 1997, PHARMACEUT RES, V14, P763, DOI 10.1023/A:1012102522787
   Zhang G, 2007, J PHYS CHEM A, V111, P1554, DOI 10.1021/jp061633o
   Zhao YH, 2001, J PHARM SCI-US, V90, P749, DOI 10.1002/jps.1031
NR 67
TC 12
Z9 12
U1 1
U2 6
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2015
VL 21
IS 28
BP 4112
EP 4127
DI 10.2174/1381612821666150528121423
PG 16
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CS1LS
UT WOS:000361827400014
PM 26017698
DA 2020-12-09
ER

PT J
AU Goncalves, LKS
   Viera, JB
   Silva, NSR
   Santos, CF
   Braga, FS
   Costa, JS
   Macedo, WJ
   Silva, CHTP
   Hage-Melim, LIS
   Santos, CBR
AF Goncalves, Luana K. S.
   Viera, Josinete B.
   Silva, Nayara S. R.
   Santos, Cesar F.
   Braga, Francinaldo S.
   Costa, Josivan S.
   Macedo, Williams J. C.
   Silva, Carlos H. T. P.
   Hage-Melim, Lorane I. S.
   Santos, Cleydson Breno R.
TI A QSAR Study of New Caffeine Derivatives with Epithelial Anticancer
   Activity
SO BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH
LA English
DT Article
DE Caffeine; epithelial cancer; molecular modeling; B3LYP/6-31G**; QSAR
AB Aims: To study and propose new caffeine derivatives with epithelial anticancer activity using quantum chemistry methods and multivariate analysis (PCA, HCA, PLS and PCR).
   Place and Duration of Study: Laboratory of Modeling and Computational Chemistry at Federal University of Amapa (UNIFAP), Macapa, Brazil, between March 2014 and February 2015.
   Methodology: Caffeine and 31 derivatives with epithelial anticancer activity were selected from the literature, and modeled with the GaussView 3.0 program. The optimization was performed using the DFT method and B3LYP/6-31G** base set implemented in the Gaussian 03 program. Principal component analysis (PCA) and hierarchical cluster analysis (HCA) were employed to select the molecular descriptors related to epithelial anticancer activity. The Pearson correlation between activity and important descriptors were used for the regression partial least squares (PLS) and principal component regression (PCR) models built, and these models were used to predict the anticancer activity of fourteen new caffeine derivatives (test set) with unknown activity.
   Results: The PCA results showed that the descriptors related to the compounds with anticancer activity were: area (A(2)), distance radical 1 (dR1), distance radical 3 (dR3), radical partition coefficient 1 (logPR1) and radical partition coefficient 3 (logPR3). HCA showed similar results obtained with PCA, and the compounds were grouped in accordance with their biological activities. The results obtained with the PLS and PCR models were close, with variation between the models of R-2=+/- 0.005, R(2)ajust=+/- 0.1998, s=+/- 0.0053, F(5,27)=+/- 49.2261, Q(2)=+/- 0.012, SEV=+/- 0.0117, PRESS=+/- 0.0473 and SPRESS=+/- 0.0087. The PLS model showed that eight compounds of the test set (37 and 40-46) are predicted to be more active, and they had values of ICT50<0.48mM. However, the PCR model only seven compounds of all test sets (33-36, 38, 39 and 42) were predicted as most active, which showed values of ICT50 >= 0.48mM, a total of 7 compounds proposed as less active of fourteen suggested compounds. However, compounds 37, 40, 41, 43, 44, 45 and 46 were the ones that had values of ICT50<0.48mM in both PLS and PCR models, suggesting that these new compounds in the two models are more potent than caffeine may be tested for epithelial anticancer activity.
   Conclusion: The PLS and PCR models showed good predictive ability. The test set showed for seven new caffeine compounds satisfactory results for epithelial anticancer activity. This strategy is fundamental for use in experimental syntheses and biological evaluation, and to understand the structural requirements for designing new ligands as anticancer agents.
C1 [Goncalves, Luana K. S.; Viera, Josinete B.; Silva, Nayara S. R.; Santos, Cesar F.; Braga, Francinaldo S.; Costa, Josivan S.; Hage-Melim, Lorane I. S.; Santos, Cleydson Breno R.] Univ Fed Amapa, Dept Biol Sci & Hlth, Lab Modeling & Computat Chem, Macapa, Brazil.
   [Costa, Josivan S.; Macedo, Williams J. C.; Santos, Cleydson Breno R.] Univ Fed Amazonas, Postgrad Program Biotechnol & Biodiversity Networ, Manaus, Amazonas, Brazil.
   [Macedo, Williams J. C.] Fed Rural Univ Amazonia, Lab Mol Modeling & Simulat Syst, Capanema, Para, Brazil.
   [Silva, Carlos H. T. P.; Santos, Cleydson Breno R.] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Ribeirao Preto, Brazil.
RP Goncalves, LKS (corresponding author), Univ Fed Amapa, Dept Biol Sci & Hlth, Lab Modeling & Computat Chem, Macapa, Brazil.
EM luana.unifap@gmail.com; breno@unifap.br
RI Hage-Melim, Lorane I S/N-4214-2015; Santos, Cleydson/G-5744-2015; da
   Silva Costa, Josivan/AAA-9565-2020
OI Hage-Melim, Lorane I S/0000-0002-7851-7363; Santos,
   Cleydson/0000-0001-9878-6256; da Silva Costa,
   Josivan/0000-0001-5069-5283; Macedo, Williams/0000-0002-0457-6993
FU Brazilian Agency National Council of Scientific and Technological
   Development (CNPq-Brazil)
FX We gratefully acknowledge the support provided by the Brazilian Agency
   National Council of Scientific and Technological Development
   (CNPq-Brazil). The authors would like to thank the Scientific Initiation
   Program (IC/CNPq/UNIFAP), and the Laboratory of Modeling and
   Computational Chemistry of Federal University of Amapa for computational
   support.
CR Aitken R.A., 1992, ASYMMETRIC SYNTHESIS
   Almeida Jr C., 2004, FARMACEUTICOS ONCOLO
   Altimari Leandro Ricardo, 2006, Rev. Bras. Cienc. Farm., V42, P17, DOI 10.1590/S1516-93322006000100003
   Alves Adriana Barreto, 2002, Rev. Bras. Cienc. Farm., V38, P237, DOI 10.1590/S1516-93322002000200013
   [Anonymous], 2001, PIR SOFTW VERS 3 01
   [Anonymous], 2000, MOL 4 3
   [Anonymous], 2000, CHEMPLUS MOD EXT HYP
   [Anonymous], 2004, MESQUITE MODULAR SYS
   [Anonymous], 1997, GAUSSVIEW 3 07
   Bergfeld WF, 1997, INT J FERTIL WOMEN M, V42, P57
   BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311
   Brentani R.R., 1998, BASES DA ONCOLOGIA, P91
   CAIRNS J, 1981, NATURE, V289, P353, DOI 10.1038/289353a0
   Carper J., 1995, ALIMENTOS MELHOR REM
   Carvalho J.E., 2001, CIENCIA SLIMENTOS AV, V2, P196
   Chatterjee S, 2000, REGRESSION ANAL EXAM
   Cummings SR, 1997, CANCER METAST REV, V16, P309, DOI 10.1023/A:1005804328268
   Custodio R, 1997, QUIM NOVA, V20, P219, DOI 10.1590/S0100-40421997000200016
   Debnath B, 2003, BIOORGAN MED CHEM, V11, P5493, DOI 10.1016/j.bmc.2003.09.022
   Devdutt C., 2011, OPPORTUNITY CHALLENG, P313
   Diggle GE, 2001, INT J CLIN PRACT, V55, P627
   DIUDEA MV, 2000, QSPR QSAR STUDIES MO
   Estrada E, 2001, J MOL GRAPH MODEL, V20, P54, DOI 10.1016/S1093-3263(01)00100-0
   Ferlay J, 2010, INT J CANC, V1
   Ferreira MMC, 2002, J BRAZIL CHEM SOC, V13, P742, DOI 10.1590/S0103-50532002000600004
   Friedman R, 1999, MANUAL ONCOLOGIA CLI, P245
   Frisch M J, 2004, GAUSSIAN 03
   Gasparini G, 2001, Curr Opin Investig Drugs, V2, P1302
   Gaudio AC, 2001, QUIM NOVA, V24, P658, DOI 10.1590/S0100-40422001000500013
   GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9
   Geladi P., 1988, J CHEMOMETR, V2, P231, DOI DOI 10.1002/CEM.1180020403
   Gramatica P, 2007, QSAR COMB SCI, V26, P694, DOI 10.1002/qsar.200610151
   Hales BF, 1999, NAT MED, V5, P489, DOI 10.1038/8371
   LENZ W, 1966, AM J DIS CHILD, V112, P99, DOI 10.1001/archpedi.1966.02090110043001
   LENZ W, 1988, TERATOLOGY, V38, P203, DOI 10.1002/tera.1420380303
   Longo EN, 2001, MANUAL DIETOTERARIPO
   Montanari CA, 2001, QUIM NOVA, V24, P105, DOI 10.1590/S0100-40422001000100018
   Mujagic H, 2002, CROAT MED J, V43, P274
   Pimentel MF, 1996, QUIM NOVA, V19, P268
   Popim RC, 2008, CIENC SAUDE COLETIVA, V13, P1331, DOI 10.1590/S1413-81232008000400030
   Prolla PA, 2002, GENETICA MOL CANC, P213
   Rajkumar S V, 2001, Expert Rev Anticancer Ther, V1, P20, DOI 10.1586/14737140.1.1.20
   dos Santos CBR, 2014, REV THEOR SCI, V2, P91, DOI 10.1166/rits.2014.1016
   dos Santos CBR, 2014, J COMPUT THEOR NANOS, V11, P553, DOI 10.1166/jctn.2014.3394
   Rogozin EA, 2008, CARCINOGENESIS, V29, P1228, DOI 10.1093/carcin/bgn016
   Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246
   Santos C. B. R., 2013, COMP MOL BIOSC, V3, P66
   Santos CBR, 2014, MOLECULES, V19, P367, DOI 10.3390/molecules19010367
   SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204
   Snedecor GW, 1967, STAT METHODS
   Vieira JB, 2014, MOLECULES, V19, P10670, DOI 10.3390/molecules190810670
   World Health Organization, 2009, SKIN CANC, V51
NR 52
TC 0
Z9 0
U1 0
U2 2
PU SCIENCEDOMAIN INT
PI GURGAON
PA SCIENCEDOMAIN INT, GURGAON, 00000, INDIA
SN 2231-2919
J9 BRIT J PHARM RES
JI Brit. J. Pharm. Res.
PY 2015
VL 7
IS 2
BP 122
EP 139
AR 2015.097
DI 10.9734/BJPR/2015/17914
PG 18
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA V4R9X
UT WOS:000219209200006
DA 2020-12-09
ER

PT J
AU Picanco, LCS
   Castro, LL
   Pinheiro, AA
   da Silva, KR
   de Souza, LR
   Braga, FS
   da Silva, CHTP
   Santos, CBR
   Hage-Melim, LIS
AF Picanco, Leide C. S.
   Castro, Leandro L.
   Pinheiro, Abraao A.
   da Silva, Karina R.
   de Souza, Lucilene R.
   Braga, Francinaldo S.
   da Silva, Carlos H. T. P.
   Santos, Cleydson B. R.
   Hage-Melim, Lorane I. S.
TI Study of Molecular Docking, Physicochemical and Pharmacokinetic
   Properties of GSK-3 beta Inhibitors
SO BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH
LA English
DT Article
DE Alzheimer's disease; GSK; 3 beta inhibitors; in silico drug design;
   docking molecular; pharmacophore derivation; ADME; prediction of
   activity; synthetic accessibility
ID GLYCOGEN-SYNTHASE KINASE-3-BETA; BRAIN-BARRIER PENETRATION; IN-SILICO;
   PERMEABILITY; PREDICTION; LIGAND; IDENTIFICATION; CACO-2; MODELS
AB Aims: Alzheimer disease (AD) affects people aged 65 to 90 years and is the most prevalent neurodegenerative disease in the world. The deposition of beta-amyloid peptide forming the amyloid plaques as well as neurofibrillary tangles deposition due to hyperphosphorylation of tau protein are the major cause of the disease in addition to the deficit of the neurotransmitter acetylcholine in the synaptic gap. Among the treatments for AD are acetylcholinesterase, beta-secretase and Glycogen Synthase Kinase-3 beta (GSK-3 beta) inhibitors. GSK-3 beta has been associated with all primary abnormalities of AD, because it interacts with the different components of the amyloid plaques production system and participates in the phosphorylation of tau protein. This regulates and stabilizes the microtubules in axons of the neurons of the Central Nervous System (CNS). Thepresent study aimed to propose three novel candidates for inhibitors of GSK-3 beta.
   Place and Duration of Study: Laboratory of Modeling and Computational Chemistry (LMCC) at Federal University of Amapa (UNIFAP), Macapa, Brazil, between November 2014 and March 2015.
   Methodology: First, we used the crystal structure of GSK-3 beta enzyme deposited in the the Protein Data Bank (PDB) (PDB ID: 3Q3B - at 2.7 A resolution). Then, we selected 50 inhibitors reported and available in the database BindingDB. Docking simulations were subsequently carried out using the AutoDock Vina 1.5.6 software. In sequence, a pharmacophore perception calculation was performed as well as and pharmacokinetic properties calculations. Finally, new proposals of GSK3 beta inhibitors candidates were designed, considering in addition potential biological activity and synthetic accessibility as well as.
   Results: In the study of physical and chemical parameters, most of the compounds violated no more than two parameters of the Lipinski's Rule of five, indicating suitable oral absorption. Along of the docking simulations, 22 inhibitors showed strong interaction with the amino acid residues of the enzyme active site (hydrogen bond and hydrophobic interactions). Along of the pharmacophore perception calculation, 30 molecules lined up with four pharmacophore points: two aromatic rings and two hydrogen bond acceptor groups (in the case, pyrimidine group). Along the prediction of pharmacokinetics, the most of the potential GSK-3 beta inhibitors showed good permeability of Caco2 and MDCK cells, high absorption in the human intestine and weak binding to plasma proteins, but only two ones showed absorption in the blood brain barrier. The three proposals of GSK-3 beta inhibitor candidates indicate biological activity for GSK-3 beta, as well as having average synthetic accessibility.
   Conclusion: This current study reveals three new promising compounds with in silico GSK-3 beta inhibitory activity. Therefore, further studies of quantitative structure-activity relationship as are necessary to investigate how the chemical structures of these molecules affect their biological potency and binding affinity for GSK-3 beta enzyme, and thus, selecting potential drug candidates for synthesis and biological testing.
C1 [Picanco, Leide C. S.; Castro, Leandro L.; Pinheiro, Abraao A.; da Silva, Karina R.; de Souza, Lucilene R.; Braga, Francinaldo S.; Santos, Cleydson B. R.; Hage-Melim, Lorane I. S.] Univ Fed Amapa, Lab Modeling & Computat Chem, BR-68902280 Macapa, Amapa, Brazil.
   [da Silva, Carlos H. T. P.; Santos, Cleydson B. R.] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, BR-14040903 Ribeirao Preto, SP, Brazil.
RP Hage-Melim, LIS (corresponding author), Univ Fed Amapa, Lab Modeling & Computat Chem, BR-68902280 Macapa, Amapa, Brazil.
EM lorane@unifap.br
RI Hage-Melim, Lorane I S/N-4214-2015
OI Hage-Melim, Lorane I S/0000-0002-7851-7363
CR Abraham MH, 2014, J PHARM SCI-US, V103, P1956, DOI 10.1002/jps.24024
   Acosta-Baena N, 2011, LANCET NEUROL, V10, P213, DOI 10.1016/S1474-4422(10)70323-9
   Agrawal R, 2013, MED CHEM RES, V22, P5504, DOI 10.1007/s00044-013-0547-y
   Almeida J. R, 2011, THESIS
   Alves VM, 2015, TOXICOL APP IN PRESS
   [Anonymous], 2000, CHEMPLUS MODULAR EXT
   Balakrishnan N, 2014, INT J PHARM SCI, V6, P413
   Bidon-Chanal A, 2013, EUR J MED CHEM, V60, P479, DOI 10.1016/j.ejmech.2012.12.014
   Boda K, 2007, J COMPUT AID MOL DES, V21, P311, DOI 10.1007/s10822-006-9099-2
   Botelho L., 2008, ALZHEIMER DOENCA ALM
   Brandt R, 2004, VIVER MENTE CEREBRO, V142, P68
   Castillo-Garit JA, 2014, AFINIDAD, V71, P129
   Cerqueira Andrea Vianna, 2009, THESIS
   Chen LJ, 2013, ADV DRUG DELIVER REV, V65, P295, DOI 10.1016/j.addr.2012.05.001
   Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495
   Codding JP, 1998, STRUCTURE BASED DRUG
   Coffman VC, 2011, J CELL BIOL, V195, P563, DOI 10.1083/jcb.201106078
   Cole JC, 2005, PROTEINS, V60, P325, DOI 10.1002/prot.20497
   Colmenarejo G., 2007, COMPREHENSIVE MED 2, V5
   Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697
   Darshit BS, 2014, J MOL GRAPH MODEL, V53, P31, DOI 10.1016/j.jmgm.2014.06.013
   De Britto AJ, 2001, ETHNOBOT LEAFLETS, V12, P801
   De Melo GO, 2005, REV FITO, V1, P41
   Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384
   Dror O, 2004, CURR MED CHEM, V11, P71, DOI 10.2174/0929867043456287
   Filimonov DA, 1996, BIOACTIVE COMPOUND D
   Fridman Cintia, 2004, Arch. Clin. Psychiatry (São Paulo), V31, P19, DOI 10.1590/S0101-60832004000100004
   Gallucci Neto José, 2005, Arch. Clin. Psychiatry (São Paulo), V32, P119, DOI 10.1590/S0101-60832005000300004
   Ghafourian T, 2013, BIOIMPACTS, V3, P21, DOI 10.5681/bi.2013.011
   Goodwin JT, 2005, J PHARMACOL EXP THER, V315, P477, DOI 10.1124/jpet.104.075705
   Greenlee W, 2001, FARMACO, V56, P247, DOI 10.1016/S0014-827X(01)01102-8
   Guner O. F., 2000, PHARMACOPHORE PERCEP
   Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1
   Hernandez L, 2010, DEV CELL, V19, P413, DOI 10.1016/j.devcel.2010.08.013
   Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205
   Jambhekar SS, 2008, FOYES PRINCIPLES MED
   Lagunin A, 2000, BIOINFORMATICS, V16, P747, DOI 10.1093/bioinformatics/16.8.747
   Lanevskij K, 2011, J PHARM SCI-US, V100, P2147, DOI 10.1002/jps.22442
   Le Corre M, 2007, COGNITION, V105, P395, DOI 10.1016/j.cognition.2006.10.005
   Lee G, 2012, PROG MOL BIOL TRANSL, V107, P263, DOI 10.1016/B978-0-12-385883-2.00004-7
   Lee SP, 2004, MAGN RESON MED, V52, P538, DOI 10.1002/mrm.20196
   Leroy X, 2010, HISTOPATHOLOGY, V56, P180, DOI 10.1111/j.1365-2559.2009.03458.x
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999
   Ma GL, 2006, J PHARM PHARM SCI, V9, P210
   Ma XL, 2005, ACTA PHARMACOL SIN, V26, P500, DOI 10.1111/j.1745-7254.2005.00068.x
   Manallack DT, 2007, PERSPECT MED CHEM, V1, P25
   Mensch J, 2009, J PHARM SCI-US, V98, P4429, DOI 10.1002/jps.21745
   Merlot C, 2010, DRUG DISCOV TODAY, V15, P16, DOI 10.1016/j.drudis.2009.09.010
   Moser D. A., 2011, THESIS
   Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587
   Muster WG, 2008, DRUG DISCOV TODAY, V13, P303, DOI 10.1016/j.drudis.2007.12.007
   Pauling L., 1960, NATURE CHEM BOND AN
   Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142
   Sahu M., 2014, INT J PHARM PHARM SC, V6, P193
   Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57
   Schneidman-Duhovny D, 2008, NUCLEIC ACIDS RES, V36, pW223, DOI 10.1093/nar/gkn187
   Sequeira A., 2012, THESIS
   Silva A. L. S, 2008, THESIS
   Taha MO, 2008, J MED CHEM, V51, P2062, DOI 10.1021/jm7009765
   Vieira L. V. L., 2010, THESIS
   VIEIRA Tamara R, 2007, THESIS
   Volpe DA, 2011, FUTURE MED CHEM, V3, P2063, DOI [10.4155/FMC.11.149, 10.4155/fmc.11.149]
   Xia XR, 2011, COMP PHARMACOKINETIC
   Yamashita Fumiyoshi, 2004, Drug Metab Pharmacokinet, V19, P327
   Zhang P, 2013, EUR J MED CHEM, V61, P95, DOI 10.1016/j.ejmech.2012.09.021
   Zidan M, 2012, REV PSIQ CLIN-BRAZIL, V39, P161
   Ziolkowski M, 2006, J PHYS CHEM A, V110, P6514, DOI 10.1021/jp060537k
NR 68
TC 1
Z9 1
U1 0
U2 4
PU SCIENCEDOMAIN INT
PI GURGAON
PA SCIENCEDOMAIN INT, GURGAON, 00000, INDIA
SN 2231-2919
J9 BRIT J PHARM RES
JI Brit. J. Pharm. Res.
PY 2015
VL 7
IS 3
BP 152
EP 175
DI 10.9734/BJPR/2015/18054
PG 24
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA V4S0A
UT WOS:000219209500001
DA 2020-12-09
ER

PT J
AU Pinhiero, AA
   da Silva, KR
   Silva, AES
   Braga, FS
   da Silva, CHTP
   Santos, CBR
   Hage-Melim, LIS
AF Pinhiero, Abraao A.
   da Silva, Karina R.
   Silva, Anna E. S.
   Braga, Francinaldo S.
   da Silva, Carlos H. T. P.
   Santos, Cleydson B. R.
   Hage-Melim, Lorane I. S.
TI In silico Identification of Novel Potential BACE-1 Inhibitors for
   Alzheimer's Disease Treatment: Molecular Docking, Pharmacophore Modeling
   and Activity and Synthetic Accessibility Predictions
SO BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH
LA English
DT Article
DE Alzheimer's disease; BACE-1 inhibitors; in silico drug design; molecular
   docking; pharmacophore derivation; prediction of activity; synthetic
   accessibility
AB Aims: Alzheimer's Disease (AD) is a progressive neurodegenerative disease accompanied by loss of memory and cognition. With its causes still unknown, one of the main hypotheses related to its pathogenesis is the amyloidal, where the abnormal metabolism of amyloid precursor protein (APP), in this case cleaved by beta-secretase enzyme (BACE-1), generates sAPP beta, subsequent action of beta-secretase generates beta-amyloid. This gives the beta-secretase importance as a therapeutic target of AD, since their inhibition can control the onset and progression of the disease. This work intends to propose three new compounds with inhibitory activity for BACE-1 that may be potential drug candidates for AD treatment.
   Place and Duration of Study: Laboratory of Modeling and Computational Chemistry (LMCC) at Federal University of Amapa (UNIFAP), Macapa, Brazil, between January 2014 and February 2015.
   Methodology: First, we selected a group of inhibitors deposited in the BindingDB database as well as a crystallographic protein solved in the Protein Data Bank (PDB). Then we performed a prediction of ligand binding sites of BACE-1. To propose the binding mode of the inhibitor with the enzyme, molecular docking and molecular interactions analyses were performed. New proposals with potential inhibitory activity of BACE-1 in addition to a pharmacophore perception calculation as well as biological activity and synthetic accessibility predictions were made.
   Results: A group of 40 inhibitors was selected from the database BindingDB, which were submitted to molecular docking simulation (for verification of the possible binding modes with the biological target), when analyzing the results of molecular docking, the hydrogen bond proved dominant over the others (approximately 74%). For pharmacophore perception calculation, the following characteristics were observed: a hydrophobic group, three aromatic groups, three donors and seven hydrogen bond acceptors. The target protein had its regions of the binding site predicted, and the most likely ligand binding site agree with the one already reported in the literature as the catalytic region of BACE-1. This allowed us to model three proposals that, in turn, had their predicted biological activities for BACE-1 as well as their synthetic accessibility.
   Conclusion: Results showed that the proposals are promising BACE-1 inhibitors, with suitable drug-like properties, for future AD tretament.
C1 [Pinhiero, Abraao A.; da Silva, Karina R.; Silva, Anna E. S.; Braga, Francinaldo S.; Santos, Cleydson B. R.; Hage-Melim, Lorane I. S.] Univ Fed Amapa, Lab Modeling & Computat Chem, BR-68902280 Amapa, Brazil.
   [da Silva, Carlos H. T. P.; Santos, Cleydson B. R.] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, BR-14040903 Ribeirao Preto, SP, Brazil.
RP Santos, CBR (corresponding author), Univ Fed Amapa, Lab Modeling & Computat Chem, BR-68902280 Amapa, Brazil.; Santos, CBR (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, BR-14040903 Ribeirao Preto, SP, Brazil.
EM breno@unifap.br
RI Hage-Melim, Lorane I S/N-4214-2015
OI Hage-Melim, Lorane I S/0000-0002-7851-7363
CR ACD/ Chemsketch Freeware, 2010, ACD CHEMSK FREEW
   [Anonymous], 2000, CHEMPL MOD EXT HYPER
   Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j
   Boda K, 2007, J COMPUT AID MOL DES, V21, P311, DOI 10.1007/s10822-006-9099-2
   Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495
   Cole JC, 2005, PROTEINS, V60, P325, DOI 10.1002/prot.20497
   Dietrich SW, 1995, BURGERS MED CHEM DRU
   Dror O, 2004, CURR MED CHEM, V11, P71, DOI 10.2174/0929867043456287
   Filimonov DA, 1996, BIOACTIVE COMPOUND D
   Forlenza Orestes V., 2005, Arch. Clin. Psychiatry (São Paulo), V32, P137, DOI 10.1590/S0101-60832005000300006
   Ghosh AK, 2007, CURR ALZHEIMER RES, V4, P418, DOI 10.2174/156720507781788864
   Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315
   Lengauer T, 1996, CURR OPIN STRUC BIOL, V6, P402, DOI 10.1016/S0959-440X(96)80061-3
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999
   McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458
   Morgon NH, 2007, THEORETICAL CHEM MOL
   Rang H. P., 2007, PHARMACOLOGY
   Schneidman-Duhovny D, 2008, NUCLEIC ACIDS RES, V36, pW223, DOI 10.1093/nar/gkn187
   Selkoe JD, 1999, BASIC NEUROCHEMISTRY
   Shen LL, 2007, ACTA PHARMACOL SIN, V28, P2053, DOI 10.1111/j.1745-7254.2007.00664.x
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Wermuth G, 1998, PURE APPL CHEM, V70, P1129
   Zou YQ, 2013, MOLECULES, V18, P5706, DOI 10.3390/molecules18055706
NR 24
TC 5
Z9 5
U1 0
U2 3
PU SCIENCEDOMAIN INT
PI GURGAON
PA SCIENCEDOMAIN INT, GURGAON, 00000, INDIA
SN 2231-2919
J9 BRIT J PHARM RES
JI Brit. J. Pharm. Res.
PY 2015
VL 7
IS 3
BP 217
EP 229
DI 10.9734/BJPR/2015/18013
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA V4S0A
UT WOS:000219209500006
DA 2020-12-09
ER

PT J
AU Vieira, JB
   Braga, FS
   Lobato, CC
   Santos, CF
   Costa, JS
   Bittencourt, JAHM
   Brasil, DSB
   Silva, JO
   Hage-Melim, LIS
   Macedo, WJC
   Carvalho, JCT
   Santos, CBR
AF Vieira, Josinete B.
   Braga, Francinaldo S.
   Lobato, Cleison C.
   Santos, Cesar F.
   Costa, Josivan S.
   Bittencourt, Jose Adolfo H. M.
   Brasil, Davi S. B.
   Silva, Jocivania O.
   Hage-Melim, Lorane I. S.
   Macedo, Williams Jorge C.
   Carvalho, Jose Carlos T.
   Santos, Cleydson Breno R.
TI A QSAR, Pharmacokinetic and Toxicological Study of New Artemisinin
   Compounds with Anticancer Activity
SO MOLECULES
LA English
DT Article
DE artemisinin; anticancer activity; molecular modeling; B3LYP/6-31G**;
   QSAR
ID INTESTINAL-ABSORPTION; PERMEABILITY; DERIVATIVES; VALIDATION;
   PREDICTION; CHEMISTRY; DENSITY; MODELS; CELLS
AB The Density Functional Theory (DFT) method and the 6-31G** basis set were employed to calculate the molecular properties of artemisinin and 20 derivatives with different degrees of cytotoxicity against the human hepatocellular carcinoma HepG2 line. Principal component analysis (PCA) and hierarchical cluster analysis (HCA) were employed to select the most important descriptors related to anticancer activity. The significant molecular descriptors related to the compounds with anticancer activity were the ALOGPS_log, Mor29m, IC5 and GAP energy. The Pearson correlation between activity and most important descriptors were used for the regression partial least squares (PLS) and principal component regression (PCR) models built. The regression PLS and PCR were very close, with variation between PLS and PCR of R-2 = +/- 0.0106, R-ajust(2) = +/- 0.0125, s = +/- 0.0234, F-(4,F-11) = +/- 12.7802, Q(2) = +/- 0.0088, SEV = +/- 0.0132, PRESS = +/- 0.4808 and SPRESS = +/- 0.0057. These models were used to predict the anticancer activity of eight new artemisinin compounds (test set) with unknown activity, and for these new compounds were predicted pharmacokinetic properties: human intestinal absorption (HIA), cellular permeability (P-CaCO2), cell permeability Maden Darby Canine Kidney (P-MDCK), skin permeability (P-Skin), plasma protein binding (PPB) and penetration of the blood-brain barrier (C-Brain/Blood), and toxicological: mutagenicity and carcinogenicity. The test set showed for two new artemisinin compounds satisfactory results for anticancer activity and pharmacokinetic and toxicological properties. Consequently, further studies need be done to evaluate the different proposals as well as their actions, toxicity, and potential use for treatment of cancers.
C1 [Vieira, Josinete B.; Braga, Francinaldo S.; Lobato, Cleison C.; Santos, Cesar F.; Costa, Josivan S.; Brasil, Davi S. B.; Hage-Melim, Lorane I. S.; Macedo, Williams Jorge C.; Santos, Cleydson Breno R.] Univ Fed Amapa, Lab Modeling & Computat Chem, BR-68902280 Macapa, Amapa, Brazil.
   [Lobato, Cleison C.; Silva, Jocivania O.; Hage-Melim, Lorane I. S.; Carvalho, Jose Carlos T.; Santos, Cleydson Breno R.] Univ Fed Amapa, Postgrad Program Pharmaceut Sci, BR-68902280 Macapa, Amapa, Brazil.
   [Bittencourt, Jose Adolfo H. M.; Silva, Jocivania O.; Carvalho, Jose Carlos T.; Santos, Cleydson Breno R.] Univ Fed Amapa, Sch Pharmaceut Sci, Lab Drug Res, BR-68902280 Macapa, Amapa, Brazil.
   [Brasil, Davi S. B.] Fed Univ Para, Inst Technol, BR-66075900 Belem, Para, Brazil.
   [Macedo, Williams Jorge C.] Fed Rural Univ Amazonia, Lab Mol Modeling & Simulat Syst, BR-68700030 Capanema, Para, Brazil.
RP Santos, CBR (corresponding author), Univ Fed Amapa, Lab Modeling & Computat Chem, Rod JK Km2, BR-68902280 Macapa, Amapa, Brazil.
EM jnetbio.unifap2011.ap@gmail.com; fsbraga@unifap.br;
   cleyson.cl@gmail.com; cesar.fs@globomail.com;
   josivan.chemistry@gmail.com; joseadolfo@unifap.br; davibb@ufpa.br;
   jocivania@unifap.br; lorane@unifap.br; williams.macedo@ufra.edu.br;
   farmacos@unifap.br; breno@unifap.br
RI Santos, Cleydson/G-5744-2015; Hage-Melim, Lorane/N-4370-2015; Carvalho,
   Jose Carlos Tavares/S-2427-2019; da Silva Costa, Josivan/AAA-9565-2020;
   Hage-Melim, Lorane I S/N-4214-2015; Tavares Carvalho, Jose
   carlos/C-7220-2013
OI Santos, Cleydson/0000-0001-9878-6256; Carvalho, Jose Carlos
   Tavares/0000-0003-3662-9794; da Silva Costa,
   Josivan/0000-0001-5069-5283; Hage-Melim, Lorane I S/0000-0002-7851-7363;
   Tavares Carvalho, Jose carlos/0000-0003-3662-9794; Macedo,
   Williams/0000-0002-0457-6993
CR Ajay, 1999, J MED CHEM, V42, P4942, DOI 10.1021/jm990017w
   Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890
   AMES BN, 1972, P NATL ACAD SCI USA, V69, P3128, DOI 10.1073/pnas.69.11.3128
   [Anonymous], 2013, LYMPHOLOGY, V46, P1
   [Anonymous], 2001, PIROUETTE 3 01
   [Anonymous], 1997, GAUSSVIEW 3 07
   Araujo JQ, 2008, BIOORGAN MED CHEM, V16, P5021, DOI 10.1016/j.bmc.2008.03.033
   Balunas MJ, 2005, LIFE SCI, V78, P431, DOI 10.1016/j.lfs.2005.09.012
   Barbosa JP, 2011, J SERB CHEM SOC, V76, P1263, DOI 10.2298/JSC111227111B
   BERNARDINELLI G, 1994, INT J QUANTUM CHEM, P117
   Bittencourt J. A. H. M., 2014, American Journal of Pharmacology and Toxicology, V9, P148, DOI 10.3844/ajptsp.2014.148.156
   BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311
   Brentani R.R., 1998, BASES DA ONCOLOGIA, P91
   CAIRNS J, 1981, NATURE, V289, P353, DOI 10.1038/289353a0
   Carvalho I, 2005, J CHEM EDUC, V82, P588, DOI 10.1021/ed082p588
   Carvalho J.E., 2001, CIENCIA SLIMENTOS AV, V2, P196
   Carvalho JRD, 2011, J COMPUT THEOR NANOS, V8, P2193, DOI 10.1166/jctn.2011.1943
   Chatterjee S, 2000, REGRESSION ANAL EXAM
   Chemplus, 2000, CHEMPL MOD EXT HYP R
   Cohen N. C., 1996, GUIDEBOOK MOL MODELI
   COHEN NC, 1990, J MED CHEM, V33, P883, DOI 10.1021/jm00165a001
   Cristino MDG, 2012, J THEOR COMPUT CHEM, V11, P241, DOI 10.1142/S0219633612500162
   Custodio R, 1997, QUIM NOVA, V20, P219, DOI 10.1590/S0100-40421997000200016
   Costa MD, 2007, QUIM NOVA, V30, P25, DOI 10.1590/S0100-40422007000100006
   Debnath B, 2003, BIOORGAN MED CHEM, V11, P5493, DOI 10.1016/j.bmc.2003.09.022
   Devdutt C., 2011, OPPORTUNITY CHALLENG, P313
   DIUDEA MV, 2000, QSPR QSAR STUDIES MO
   Dos Santos H.F., 2001, CADERNOS TEMATICOS Q, V4, P4
   Estrada E, 2001, J MOL GRAPH MODEL, V20, P54, DOI 10.1016/S1093-3263(01)00100-0
   Ferlay J, GLOBOCAN 2012 V1 0
   Ferreira MMC, 2002, J BRAZIL CHEM SOC, V13, P742, DOI 10.1590/S0103-50532002000600004
   Figueiredo AF, 2011, J COMPUT THEOR NANOS, V8, P1847, DOI 10.1166/jctn.2011.1892
   Frisch M. J., 2001, GAUSSIAN 98 REVISION
   Gaudio AC, 2001, QUIM NOVA, V24, P658, DOI 10.1590/S0100-40422001000500013
   GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9
   Geladi P., 1988, J CHEMOMETR, V2, P231, DOI DOI 10.1002/CEM.1180020403
   Ghantous A, 2010, DRUG DISCOV TODAY, V15, P668, DOI 10.1016/j.drudis.2010.06.002
   Godin DV, 1995, PRINCIPLES PHARM
   Gramatica P, 2007, QSAR COMB SCI, V26, P694, DOI 10.1002/qsar.200610151
   HEHRE WJ, 2003, GUIDE MOL MECH QUANT
   Hou T, 2008, EXPERT OPIN DRUG MET, V4, P759, DOI 10.1517/17425255.4.6.759 
   Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205
   KOKPOL SK, 1988, ANAL SCI, V4, P565, DOI 10.2116/analsci.4.565
   Leach A.R., 2001, MOL MODELLING PRINCI
   Levine I, 1991, QUANTUM CHEM
   Lisgarten JN, 1998, J CHEM CRYSTALLOGR, V28, P539, DOI 10.1023/A:1023244122450
   Liu YG, 2005, ORG LETT, V7, P1561, DOI 10.1021/ol050230o
   Ma XL, 2005, ACTA PHARMACOL SIN, V26, P500, DOI 10.1111/j.1745-7254.2005.00068.x
   MULLIKEN RS, 1971, J AM CHEM SOC, V93, P6738, DOI 10.1021/ja00754a004
   Ohgami Y, 2010, ANTICANCER RES, V30, P4467
   Pereira MSC, 2008, J CHEM INF MODEL, V48, P85, DOI 10.1021/ci700011f
   Pimentel MF, 1996, QUIM NOVA, V19, P268
   Pinheiro JC, 2003, QSAR COMB SCI, V22, P830, DOI 10.1002/qsar.200330829
   PRATT W, 1990, PRINCIPLES DRUG ACTI
   Ribeiro FAD, 2003, J MOL STRUC-THEOCHEM, V663, P109, DOI 10.1016/j.theochem.2003.08.107
   dos Santos CBR, 2014, REV THEOR SCI, V2, P91, DOI 10.1166/rits.2014.1016
   dos Santos CBR, 2014, J COMPUT THEOR NANOS, V11, P553, DOI 10.1166/jctn.2014.3394
   Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246
   Sant'Anna CMR, 2002, QUIM NOVA, V25, P505, DOI 10.1590/S0100-40422002000300027
   Santos C. B. R., 2013, COMP MOL BIOSC, V3, P66
   Santos C.B.R., 2014, DESENVOLVIMENTO RACI
   Santos CBR, 2014, MOLECULES, V19, P367, DOI 10.3390/molecules19010367
   SINGH S, 1993, MED RES REV, V13, P569, DOI 10.1002/med.2610130504
   SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204
   SNEDECOR GW, 1967, STATISTICAL METHODS, P381
   *SWISS CTR SCI COM, 2000, MOLEKEL 4 3
   Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y
   Tonmunphean S, 2001, J MOL MODEL, V7, P26, DOI 10.1007/s008940100013
   van de Waterbeemd H, 2003, NAT REV DRUG DISCOV, V2, P192, DOI 10.1038/nrd1032
   Virtual Computational Laboratory, VCCLAB 2005
   Wermuth CG, 2009, PRACTICE MED CHEM
   Yamashita S, 2000, EUR J PHARM SCI, V10, P195, DOI 10.1016/S0928-0987(00)00076-2
   Yazdanian M, 1998, PHARMACEUT RES, V15, P1490, DOI 10.1023/A:1011930411574
   Yee SY, 1997, PHARMACEUT RES, V14, P763, DOI 10.1023/A:1012102522787
   Zhang Siyuan, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P239, DOI 10.2174/1568011053765976
   Zhao YH, 2001, J PHARM SCI-US, V90, P749, DOI 10.1002/jps.1031
NR 76
TC 18
Z9 19
U1 0
U2 46
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD AUG
PY 2014
VL 19
IS 8
BP 10670
EP 10697
DI 10.3390/molecules190810670
PG 28
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA AO6ZW
UT WOS:000341502600001
PM 25061720
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU dos Santos, CBR
   Vieira, JB
   Formigosa, AD
   da Costa, EVM
   Pinheiro, MT
   da Silva, JO
   Macedo, WJD
   Carvalho, JCT
AF Rodrigues dos Santos, Cleydson Breno
   Vieira, Josinete Braga
   Formigosa, Adriane da Silva
   Moraes da Costa, Elizabeth Viana
   Pinheiro, Mayara Tania
   da Silva, Jocivania Oliveira
   da Cruz Macedo, Williams Jorge
   Tavares Carvalho, Jose Carlos
TI Validation of Computational Methods Applied in Molecular Modeling of
   Artemisinin with Antimalarial Activity
SO JOURNAL OF COMPUTATIONAL AND THEORETICAL NANOSCIENCE
LA English
DT Article
DE Artemisinin; HF/6-31G**; Molecular Modeling; Quantum Chemical Methods;
   Multivariate Analysis
ID CHEMISTRY; QINGHAOSU; DRUG
AB Artemisinin (qinghaosu) has a unique structure bearing a stable endoperoxide lactone (1,2,13trioxane) totally different from previous antimalarial in its structure and mode of action, are isolated from Artemisia annua is a composed of a remarkable life and antimalarial effective against Plasmodium falciparum and cerebral malaria. We propose a combination of chemical quantum methods and multivariate analysis to study the geometric parameters of artemisinin in the region endoperoxide of the ring (1,2,13-trioxane), in order to be effective in selecting the method and level of theory when compared with data crystallographic, aiming to classify and correlate. The most important geometrical parameters selected by principal component analysis (PCA) were O13C12, O1O2C3, C3O13C12C12a and C12C12aO1O2. The results of PCA showed that the model was built with three main components (3PCs), explains 97.0861% of the total variance. The level of theory HF/ 6-31G** show high similarity with the experimental data assuming that the combination of ab initio method can be used for modeling the molecular structure of artemisinin and its derivatives antimalarial drugs with mechanism of action in the ring region endoperoxide.
C1 [Rodrigues dos Santos, Cleydson Breno; Moraes da Costa, Elizabeth Viana; Pinheiro, Mayara Tania; da Silva, Jocivania Oliveira; Tavares Carvalho, Jose Carlos] Univ Fed Amapa, Sch Pharmaceut Sci, Lab Drug Res, BR-68902280 Macapa Amapa, Brazil.
   [Rodrigues dos Santos, Cleydson Breno; Pinheiro, Mayara Tania; Tavares Carvalho, Jose Carlos] Univ Fed Amapa, Postgrad Program Biotechnol & Biodiversity Networ, BR-68902280 Macapa Amapa, Brazil.
   [Rodrigues dos Santos, Cleydson Breno; Vieira, Josinete Braga; Formigosa, Adriane da Silva; da Silva, Jocivania Oliveira] Univ Fed Amapa, Lab Modelling & Computat Chem, BR-68902280 Macapa Amapa, Brazil.
   [da Cruz Macedo, Williams Jorge] Cent Lab State Para LACEN PA, BR-66823010 Belem, Para, Brazil.
RP dos Santos, CBR (corresponding author), Univ Fed Amapa, Sch Pharmaceut Sci, Lab Drug Res, Rod JK Km 2, BR-68902280 Macapa Amapa, Brazil.
RI Carvalho, Jose Carlos Tavares/S-2427-2019; Tavares Carvalho, Jose
   carlos/C-7220-2013; Santos, Cleydson/G-5744-2015
OI Carvalho, Jose Carlos Tavares/0000-0003-3662-9794; Tavares Carvalho,
   Jose carlos/0000-0003-3662-9794; Santos, Cleydson/0000-0001-9878-6256;
   Macedo, Williams/0000-0002-0457-6993; Rodrigues dos Santos, Cleydson
   Breno/0000-0002-0271-335X
FU Brazilian Agency Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico
FX We gratefully acknowledge the final support of the Brazilian Agency
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. We also
   thank the Instituto de Ciencias da Saude of Federal University of Para
   for the use of the GaussView and Gaussian softwares. The authors would
   like to thank the Postgraduate Program in Biotechnology and
   Biodiversity-Network BIONORTE and to the Laboratorio de Modelagem e
   Quimica Computacional, Federal University of Amapa for the computational
   support.
CR Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890
   [Anonymous], 2001, PIR 3 01
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Carvalho I, 2005, J CHEM EDUC, V82, P588, DOI 10.1021/ed082p588
   Carvalho JRD, 2011, J COMPUT THEOR NANOS, V8, P2193, DOI 10.1166/jctn.2011.1943
   Cohen N. C., 1996, GUIDEBOOK MOL MODELI
   Cumming J N, 1997, Adv Pharmacol, V37, P253
   de Silva O. S., 2012, J COMPUT THEOR NANOS, V9, P953
   Djemil R, 2012, J COMPUT THEOR NANOS, V9, P1571, DOI 10.1166/jctn.2012.2246
   Elhaes H, 2012, J COMPUT THEOR NANOS, V9, P901, DOI 10.1166/jctn.2012.2114
   Ferreira MMC, 2002, QUIM NOVA, V25, P439, DOI 10.1590/S0100-40422002000300017
   Ferreira MMC, 2002, J BRAZIL CHEM SOC, V13, P742, DOI 10.1590/S0103-50532002000600004
   Figueiredo AF, 2011, J COMPUT THEOR NANOS, V8, P1847, DOI 10.1166/jctn.2011.1892
   Franke R., 1996, CHEMOMETRICS METHODS, P115
   Frisch M. J., 2001, GAUSSIAN 98 REVISION
   *GAUSS INC, 1997, GAUSSV 1 0
   Haynes RK, 1996, TETRAHEDRON LETT, V37, P253, DOI 10.1016/0040-4039(95)02141-8
   Ibrahim MA, 2012, J COMPUT THEOR NANOS, V9, P1120, DOI 10.1166/jctn.2012.2154
   Jefford CW, 1996, HELV CHIM ACTA, V79, P1475, DOI 10.1002/hlca.19960790520
   Jung M, 1994, CURR MED CHEM, V1, P35
   KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571
   Lisgarten JN, 1998, J CHEM CRYSTALLOGR, V28, P539, DOI 10.1023/A:1023244122450
   Pinheiro JC, 2001, J MOL STRUC-THEOCHEM, V572, P35, DOI 10.1016/S0166-1280(01)00522-X
   POSNER GH, 1995, J AM CHEM SOC, V117, P5885, DOI 10.1021/ja00126a042
   Sant'Anna CMR, 2002, QUIM NOVA, V25, P505, DOI 10.1590/S0100-40422002000300027
   Srivastava M, 2010, CURR RES J BIOL SCI, V2, P83
   THOMSON C, 1991, INT J QUANTUM CHEM, V40, P231, DOI 10.1002/qua.560400723
   Todeschini R., 1988, PERSPECT DRUG DISCOV, V9-11, P355
   Tonmunphean S, 2001, J MOL MODEL, V7, P26, DOI 10.1007/s008940100013
   Wermuth CG, 2009, PRACTICE MED CHEM
NR 30
TC 9
Z9 9
U1 0
U2 25
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1546-1955
EI 1546-1963
J9 J COMPUT THEOR NANOS
JI J. Comput. Theor. Nanosci.
PD MAR
PY 2014
VL 11
IS 3
BP 553
EP 561
DI 10.1166/jctn.2014.3394
PG 9
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 276EF
UT WOS:000328730200002
DA 2020-12-09
ER

PT J
AU Santos, CBR
   Vieira, JB
   Lobato, CC
   Hage-Melim, LIS
   Souto, RNP
   Lima, CS
   Costa, EVM
   Brasil, DSB
   Macedo, WJC
   Carvalho, JCT
AF Santos, Cleydson Breno R.
   Vieira, Josinete B.
   Lobato, Cleison C.
   Hage-Melim, Lorane I. S.
   Souto, Raimundo N. P.
   Lima, Clarissa S.
   Costa, Elizabeth V. M.
   Brasil, Davi S. B.
   Macedo, Williams Jorge C.
   Carvalho, Jose Carlos T.
TI A SAR and QSAR Study of New Artemisinin Compounds with Antimalarial
   Activity
SO MOLECULES
LA English
DT Article
DE artemisinin; antimalarial activity; HF/6-31G**; molecular docking; MEPs;
   SAR; QSAR
ID STRUCTURE/RESPONSE CORRELATIONS; DIHYDROARTEMISININ DERIVATIVES;
   SIMILARITY/DIVERSITY ANALYSIS; QINGHAOSU ARTEMISININ; MOLECULAR
   DESCRIPTORS; GETAWAY DESCRIPTORS; CRYSTAL-STRUCTURES; DRUG; CHEMISTRY;
   MODELS
AB The Hartree-Fock method and the 6-31G** basis set were employed to calculate the molecular properties of artemisinin and 20 derivatives with antimalarial activity. Maps of molecular electrostatic potential (MEPs) and molecular docking were used to investigate the interaction between ligands and the receptor (heme). Principal component analysis and hierarchical cluster analysis were employed to select the most important descriptors related to activity. The correlation between biological activity and molecular properties was obtained using the partial least squares and principal component regression methods. The regression PLS and PCR models built in this study were also used to predict the antimalarial activity of 30 new artemisinin compounds with unknown activity. The models obtained showed not only statistical significance but also predictive ability. The significant molecular descriptors related to the compounds with antimalarial activity were the hydration energy (HE), the charge on the O11 oxygen atom (QO11), the torsion angle O1-O2-Fe-N2 (D2) and the maximum rate of R/Sanderson Electronegativity (RTe+). These variables led to a physical and structural explanation of the molecular properties that should be selected for when designing new ligands to be used as antimalarial agents.
C1 [Santos, Cleydson Breno R.; Vieira, Josinete B.; Lobato, Cleison C.; Hage-Melim, Lorane I. S.; Macedo, Williams Jorge C.] Univ Fed Amapa, Lab Modeling & Computat Chem, BR-68902280 Amapa, Amazon, Brazil.
   [Santos, Cleydson Breno R.; Souto, Raimundo N. P.; Carvalho, Jose Carlos T.] Postgrad Program Biotechnol & Biodivers Network B, BR-68902280 Amapa, Amazon, Brazil.
   [Santos, Cleydson Breno R.; Lima, Clarissa S.; Costa, Elizabeth V. M.; Carvalho, Jose Carlos T.] Univ Fed Amapa, Sch Pharmaceut Sci, Lab Drug Res, BR-68902280 Amapa, Amazon, Brazil.
   [Brasil, Davi S. B.] Fed Univ Para, Inst Technol, BR-66075900 Para, Amazon, Brazil.
RP Santos, CBR (corresponding author), Univ Fed Amapa, Lab Modeling & Computat Chem, BR-68902280 Amapa, Amazon, Brazil.
EM breno@unifap.br; jnetbio.unifap2011.ap@gmail.com; cleyson.cl@gmail.com;
   lorane@unifap.br; rnpsouto@unifap.br; lima.clarissa@gmail.com;
   elizabethviana@unifap.br; davibb@ufpa.br; williamsmacedo@yahoo.com.br;
   farmacos@unifap.br
RI Tavares Carvalho, Jose carlos/C-7220-2013; Besnard, Thomas/L-2303-2019;
   Santos, Cleydson/G-5744-2015; Souto, R.N.P. Souto/A-9706-2016;
   Hage-Melim, Lorane/N-4370-2015; BESNARD, Thomas/D-1329-2018; Brasil,
   Davi/J-4003-2014; Hage-Melim, Lorane I S/N-4214-2015; Carvalho, Jose
   Carlos Tavares/S-2427-2019
OI Tavares Carvalho, Jose carlos/0000-0003-3662-9794; Besnard,
   Thomas/0000-0003-4804-5147; Santos, Cleydson/0000-0001-9878-6256;
   BESNARD, Thomas/0000-0003-4804-5147; Hage-Melim, Lorane I
   S/0000-0002-7851-7363; Carvalho, Jose Carlos
   Tavares/0000-0003-3662-9794; Macedo, Williams/0000-0002-0457-6993;
   Souto, Raimundo/0000-0002-8795-1217
FU Brazilian Agency National Council of Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq) [306676/2010-9]; Institute of Exact and Natural
   Sciences of Federal University of Para
FX We gratefully acknowledge the financial support provided by the
   Brazilian Agency National Council of Scientific and Technological
   Development (CNPq Proc. 306676/2010-9) and Institute of Exact and
   Natural Sciences of Federal University of Para for use of the GaussView
   and Gaussian software. The authors would like to thank the Postgraduate
   Program in Biotechnology and Biodiversity-Network BIONORTE, Laboratory
   of Modeling and Computational Chemistry of Federal University of Amapa
   for computational support to the Francinaldo Sarges Braga and Adriana
   Maciel Ferreira for technical support.
CR Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890
   [Anonymous], 2001, PIR 3 01
   [Anonymous], 2007, AUT DOCK 4 0
   [Anonymous], 2000, SCI COMPUT
   [Anonymous], 1997, GAUSSIAN
   Araujo JQ, 2008, BIOORGAN MED CHEM, V16, P5021, DOI 10.1016/j.bmc.2008.03.033
   Arav-Boger R, 2005, ANNU REV PHARMACOL, V45, P565, DOI 10.1146/annurev.pharmtox.45.120403.095946
   BERNARDINELLI G, 1994, INT J QUANTUM CHEM, P117
   Biagini GA, 2005, CURR OPIN PHARMACOL, V5, P473, DOI 10.1016/j.coph.2005.05.004
   BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311
   Cardoso FJB, 2008, J MOL MODEL, V14, P39, DOI 10.1007/s00894-007-0249-9
   Cardoso FJB, 2007, INTERNET ELECT J MOL, V6, P122
   Carvalho I, 2005, J CHEM EDUC, V82, P588, DOI 10.1021/ed082p588
   Chatterjee S, 2000, REGRESSION ANAL EXAM
   ChemPlus, 2000, MOL MODELING
   Cheng F, 2002, BIOORGAN MED CHEM, V10, P2883, DOI 10.1016/S0968-0896(02)00161-X
   Cohen N. C., 1996, GUIDEBOOK MOL MODELI
   Consonni V, 2002, J CHEM INF COMP SCI, V42, P693, DOI 10.1021/ci0155053
   Consonni V, 2002, J CHEM INF COMP SCI, V42, P682, DOI 10.1021/ci015504a
   Creek DJ, 2008, J MOL GRAPH MODEL, V27, P394, DOI 10.1016/j.jmgm.2008.06.008
   Cristino MDG, 2012, J THEOR COMPUT CHEM, V11, P241, DOI 10.1142/S0219633612500162
   Cumming J N, 1997, Adv Pharmacol, V37, P253
   Custodio R, 1997, QUIM NOVA, V20, P219, DOI 10.1590/S0100-40421997000200016
   Costa MD, 2007, QUIM NOVA, V30, P25, DOI 10.1590/S0100-40422007000100006
   Debnath B, 2003, BIOORGAN MED CHEM, V11, P5493, DOI 10.1016/j.bmc.2003.09.022
   DIUDEA MV, 2000, QSPR QSAR STUDIES MO
   Estrada E, 2001, J MOL GRAPH MODEL, V20, P54, DOI 10.1016/S1093-3263(01)00100-0
   Ferreira JEV, 2010, J SERB CHEM SOC, V75, P1533, DOI 10.2298/JSC100126124F
   Ferreira MMC, 2002, J BRAZIL CHEM SOC, V13, P742, DOI 10.1590/S0103-50532002000600004
   Frisch M.J., 2001, GAUSSIAN
   Gaudio AC, 2001, QUIM NOVA, V24, P658, DOI 10.1590/S0100-40422001000500013
   GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9
   Geladi P., 1988, J CHEMOMETR, V2, P231, DOI DOI 10.1002/CEM.1180020403
   Gramatica P, 2007, QSAR COMB SCI, V26, P694, DOI 10.1002/qsar.200610151
   Guha R, 2004, J CHEM INF COMP SCI, V44, P1440, DOI 10.1021/ci0499469
   Haynes RK, 1996, TETRAHEDRON LETT, V37, P253, DOI 10.1016/0040-4039(95)02141-8
   HEHRE WJ, 2003, GUIDE MOL MECH QUANT
   Jefford CW, 1996, HELV CHIM ACTA, V79, P1475, DOI 10.1002/hlca.19960790520
   Jefford CW, 2001, CURR MED CHEM, V8, P1803, DOI 10.2174/0929867013371608
   Jung M, 1994, CURR MED CHEM, V1, P35
   Karelson M, 1996, CHEM REV, V96, P1027, DOI 10.1021/cr950202r
   KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571
   Leach A.R., 2001, MOL MODELLING PRINCI
   Levine I.N., 1991, QUANTUM CHEM
   Lin AJ, 1997, J MED CHEM, V40, P1396, DOI 10.1021/jm9607919
   LIN AJ, 1995, J MED CHEM, V38, P764, DOI 10.1021/jm00005a004
   LIN AJ, 1992, J MED CHEM, V35, P1639, DOI 10.1021/jm00087a021
   LIN AJ, 1987, J MED CHEM, V30, P2147, DOI 10.1021/jm00394a037
   Lisgarten JN, 1998, J CHEM CRYSTALLOGR, V28, P539, DOI 10.1023/A:1023244122450
   MESHNICK SR, 1993, ANTIMICROB AGENTS CH, V37, P1108, DOI 10.1128/AAC.37.5.1108
   MULLIKEN RS, 1971, J AM CHEM SOC, V93, P6738, DOI 10.1021/ja00754a004
   O'Neill PM, 2005, EXPERT OPIN INV DRUG, V14, P1117, DOI 10.1517/13543784.14.9.1117
   O'Neill PM, 1999, J MED CHEM, V42, P5487, DOI 10.1021/jm9903545
   Opsenica DM, 2009, J SERB CHEM SOC, V74, P1155, DOI 10.2298/JSC0911155O
   Pimentel MF, 1996, QUIM NOVA, V19, P268
   Pinheiro JC, 2003, QSAR COMB SCI, V22, P830, DOI 10.1002/qsar.200330829
   Politzer P, 2002, THEOR CHEM ACC, V108, P134, DOI 10.1007/s00214-002-0363-9
   POSNER GH, 1995, J MED CHEM, V38, P2273, DOI 10.1021/jm00013a001
   POSNER GH, 1994, J MED CHEM, V37, P1256, DOI 10.1021/jm00035a003
   Ribeiro FAD, 2003, J MOL STRUC-THEOCHEM, V663, P109, DOI 10.1016/j.theochem.2003.08.107
   Ridley RG, 2003, NATURE, V424, P887, DOI 10.1038/424887a
   dos Santos CBR, 2014, J COMPUT THEOR NANOS, V11, P553, DOI 10.1166/jctn.2014.3394
   Sant'Anna CMR, 2002, QUIM NOVA, V25, P505, DOI 10.1590/S0100-40422002000300027
   Santos C. B. R., 2013, COMP MOL BIOSC, V3, P66
   SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204
   SNEDECOR GW, 1967, STATISTICAL METHODS, P381
   Srivastava M, 2010, CURR RES J BIOL SCI, V2, P83
   Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y
   Tonmunphean S, 2001, J MOL MODEL, V7, P26, DOI 10.1007/s008940100013
   Vojtechovsky J, 1999, BIOPHYS J, V77, P2153, DOI 10.1016/S0006-3495(99)77056-6
   Wermuth C.G., 2009, PRACTICE MED CHEM
   White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]
   Woolfrey JR, 1998, J COMPUT AID MOL DES, V12, P165, DOI 10.1023/A:1007967517859
   Wulfsberg G., 1987, CHEMISTRY
NR 74
TC 19
Z9 21
U1 1
U2 18
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD JAN
PY 2014
VL 19
IS 1
BP 367
EP 399
DI 10.3390/molecules19010367
PG 33
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA AF0QY
UT WOS:000334420300024
PM 24381053
OA DOAJ Gold, Green Published
DA 2020-12-09
ER

PT J
AU dos Santos, CB
   Barbin, D
   Caliri, A
AF dos Santos, CB
   Barbin, D
   Caliri, A
TI Epidemic phase and the site percolation with distant-neighbor
   interactions
SO PHYSICS LETTERS A
LA English
DT Article
AB A generalized site percolation model is used to construct an analogy with the epidemic problem, involving spatial coordinates. Epidemic phase and concepts like herd immunity are analyzed in terms nf connectivity in a 2D square lattice. The epidemic model used in this work considers a specific interaction topology that includes up to the fifth-nearest neighbors, The results, obtained by Monte Carlo simulation, emphasize the meaning of the spatial coordinates and are illustrated by an epidemic/non-epidemic phase diagram. (C) 1998 Published by Elsevier Science B.V.
C1 Univ Sao Paulo, Dept Math & Phys, FFCLRP, BR-14040901 Ribeirao Preto, Brazil.
   Univ Sao Paulo, Dept Math & Stat, ESALQ, BR-13418900 Piracicaba, SP, Brazil.
   Univ Sao Paulo, Dept Chem & Phys, FCFRP, BR-14040903 Ribeirao Preto, Brazil.
RP dos Santos, CB (corresponding author), Univ Sao Paulo, Dept Math & Phys, FFCLRP, BR-14040901 Ribeirao Preto, Brazil.
RI caliri, antonio/A-3963-2012; santos, claudia b/E-9710-2012
CR ANGELETTI LR, 1994, AM J NEPHROL, V14, P282, DOI 10.1159/000168786
   BINDER K, 1992, MONTE CARLO METHOD C
   Binder K, 1988, MONTE CARLO SIMULATI
   CARDY JL, 1985, J PHYS A-MATH GEN, V18, pL267, DOI 10.1088/0305-4470/18/6/001
   DASGUPTA C, 1976, PHYS REV           B, V14, P1248
   Deutscher G, 1983, ANN ISRAEL PHYS SOC, V5
   DOMB C, 1966, P PHYS SOC LOND, V89, P859, DOI 10.1088/0370-1328/89/4/311
   GEVRILETS S, 1997, J THEOR BIOL, V184, P51
   GRASSBERGER P, 1979, ANN PHYS-NEW YORK, V122, P373, DOI 10.1016/0003-4916(79)90207-0
   KAREIVA P, 1995, NATURE, V373, P299, DOI 10.1038/373299a0
   OHTSUKI T, 1986, PHYS REV A, V33, P1223, DOI 10.1103/PhysRevA.33.1223
   ONSTAD DW, 1992, J THEOR BIOL, V158, P495, DOI 10.1016/S0022-5193(05)80712-X
   Stauffer D, 1985, INTRO PERCOLATION TH
   TATSUMI T, 1980, PROG THEOR PHYS, V64, P803, DOI 10.1143/PTP.64.803
   WARY YO, 1996, J CHIN AGR CHEM SOC, V34, P406
NR 15
TC 4
Z9 4
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0375-9601
J9 PHYS LETT A
JI Phys. Lett. A
PD JAN 26
PY 1998
VL 238
IS 1
BP 54
EP 58
DI 10.1016/S0375-9601(97)00889-X
PG 5
WC Physics, Multidisciplinary
SC Physics
GA YY134
UT WOS:000072116700008
DA 2020-12-09
ER

EF